
<html lang="en"     class="pb-page"  data-request-id="4e24c735-a62b-4cc4-b462-a564f5476755"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm901818u;website:website:acspubs;issue:issue:10.1021/jmcmar.2010.53.issue-6;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors" /></meta><meta name="dc.Creator" content="Fabrizio  Micheli" /></meta><meta name="dc.Creator" content="Paolo  Cavanni" /></meta><meta name="dc.Creator" content="Roberto  Arban" /></meta><meta name="dc.Creator" content="Roberto  Benedetti" /></meta><meta name="dc.Creator" content="Barbara  Bertani" /></meta><meta name="dc.Creator" content="Michela  Bettati" /></meta><meta name="dc.Creator" content="Letizia  Bettelini" /></meta><meta name="dc.Creator" content="Giorgio  Bonanomi" /></meta><meta name="dc.Creator" content="Simone  Braggio" /></meta><meta name="dc.Creator" content="Anna  Checchia" /></meta><meta name="dc.Creator" content="Silvia  Davalli" /></meta><meta name="dc.Creator" content="Romano  Di Fabio" /></meta><meta name="dc.Creator" content="Elettra  Fazzolari" /></meta><meta name="dc.Creator" content="Stefano  Fontana" /></meta><meta name="dc.Creator" content="Carla  Marchioro" /></meta><meta name="dc.Creator" content="Doug  Minick" /></meta><meta name="dc.Creator" content="Michele  Negri" /></meta><meta name="dc.Creator" content="Beatrice  Oliosi" /></meta><meta name="dc.Creator" content="Kevin D.  Read" /></meta><meta name="dc.Creator" content="Ilaria  Sartori" /></meta><meta name="dc.Creator" content="Giovanna  Tedesco" /></meta><meta name="dc.Creator" content="Luca  Tarsi" /></meta><meta name="dc.Creator" content="Silvia  Terreni" /></meta><meta name="dc.Creator" content="Filippo  Visentini" /></meta><meta name="dc.Creator" content="Alessandro  Zocchi" /></meta><meta name="dc.Creator" content="Laura  Zonzini" /></meta><meta name="dc.Description" content="The discovery of new highly potent and selective triple reuptake inhibitors is reported. The new classes of 1-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabic..." /></meta><meta name="Description" content="The discovery of new highly potent and selective triple reuptake inhibitors is reported. The new classes of 1-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabic..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 19, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901818u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901818u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901818u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901818u" /></link>
        
    
    

<title>1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901818u" /></meta><meta property="og:title" content="1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0018.jpeg" /></meta><meta property="og:description" content="The discovery of new highly potent and selective triple reuptake inhibitors is reported. The new classes of 1-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes are described together with detailed SAR. Appropriate decoration of the scaffolds was achieved with the help of a triple reuptake inhibitor pharmacophore model detailed here. Selected derivatives showed good oral bioavailability (&gt;30%) and brain penetration (B/B &gt; 4) in rats associated with high in vitro potency and selectivity at SERT, NET, and DAT. Among these compounds, microdialysis and in vivo experiments confirm that derivative 15 has an appropriate developability profile to be considered for further progression." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901818u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901818u">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901818u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901818u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901818u&amp;href=/doi/10.1021/jm901818u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2534-2551</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm9017543" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901773d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Micheli">Fabrizio Micheli</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paolo++Cavanni">Paolo Cavanni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Arban">Roberto Arban</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Benedetti">Roberto Benedetti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Bertani">Barbara Bertani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michela++Bettati">Michela Bettati</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Letizia++Bettelini">Letizia Bettelini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giorgio++Bonanomi">Giorgio Bonanomi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simone++Braggio">Simone Braggio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Checchia">Anna Checchia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Davalli">Silvia Davalli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Romano++Di+Fabio">Romano Di Fabio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elettra++Fazzolari">Elettra Fazzolari</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Fontana">Stefano Fontana</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carla++Marchioro">Carla Marchioro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Doug++Minick">Doug Minick</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michele++Negri">Michele Negri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beatrice++Oliosi">Beatrice Oliosi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+D.++Read">Kevin D. Read</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ilaria++Sartori">Ilaria Sartori</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giovanna++Tedesco">Giovanna Tedesco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luca++Tarsi">Luca Tarsi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Terreni">Silvia Terreni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Filippo++Visentini">Filippo Visentini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro++Zocchi">Alessandro Zocchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Zonzini">Laura Zonzini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="affa"><span class="aff-symbol">†</span> <span class="aff-text">Neurosciences Centre of Excellence for Drug Discovery</span></div><div class="aff-info" id="aff1"><span class="aff-symbol">‡</span> <span class="aff-text">Molecular Discovery Research</span></div><div class="aff-info" id="aff5"><span class="aff-text">GlaxoSmithKline Medicine Research Centre, Via Fleming 4, 37135 Verona, Italy</span></div><div class="aff-info" id="affb"><span class="aff-symbol">§</span> <span class="aff-text">Molecular Discovery Research, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">∥</span> <span class="aff-text">Biological Chemistry and Drug Discovery, College of Life Sciences, Sir James Black Centre, University of Dundee, Dundee DD1 5EH, Scotland, U.K.</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +39-045-8218515. Fax: +39-045-8118196. E-mail: <a href="/cdn-cgi/l/email-protection#f9bf989b8b90839096d7bcd7b4909a919c9590b99e8a92d79a9694"><span class="__cf_email__" data-cfemail="d294b3b0a0bba8bbbdfc97fc9fbbb1bab7bebb92b5a1b9fcb1bdbf">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901818u&amp;href=/doi/10.1021%2Fjm901818u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2534–2551</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 19, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 December 2009</li><li><span class="item_label"><b>Published</b> online</span>19 February 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 March 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901818u" title="DOI URL">https://doi.org/10.1021/jm901818u</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2534%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFabrizio%2BMicheli%252C%2BPaolo%2BCavanni%252C%2BRoberto%2BArban%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D6%26contentID%3Djm901818u%26title%3D1-%2528Aryl%2529-6-%255Balkoxyalkyl%255D-3-azabicyclo%255B3.1.0%255Dhexanes%2Band%2B6-%2528Aryl%2529-6-%255Balkoxyalkyl%255D-3-azabicyclo%255B3.1.0%255Dhexanes%253A%2BA%2BNew%2BSeries%2Bof%2BPotent%2Band%2BSelective%2BTriple%2BReuptake%2BInhibitors%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2551%26publicationDate%3DMarch%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901818u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2195</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">34</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901818u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Micheli&quot;},{&quot;first_name&quot;:&quot;Paolo&quot;,&quot;last_name&quot;:&quot;Cavanni&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Arban&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Benedetti&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Bertani&quot;},{&quot;first_name&quot;:&quot;Michela&quot;,&quot;last_name&quot;:&quot;Bettati&quot;},{&quot;first_name&quot;:&quot;Letizia&quot;,&quot;last_name&quot;:&quot;Bettelini&quot;},{&quot;first_name&quot;:&quot;Giorgio&quot;,&quot;last_name&quot;:&quot;Bonanomi&quot;},{&quot;first_name&quot;:&quot;Simone&quot;,&quot;last_name&quot;:&quot;Braggio&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Checchia&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Davalli&quot;},{&quot;first_name&quot;:&quot;Romano&quot;,&quot;last_name&quot;:&quot;Di Fabio&quot;},{&quot;first_name&quot;:&quot;Elettra&quot;,&quot;last_name&quot;:&quot;Fazzolari&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Fontana&quot;},{&quot;first_name&quot;:&quot;Carla&quot;,&quot;last_name&quot;:&quot;Marchioro&quot;},{&quot;first_name&quot;:&quot;Doug&quot;,&quot;last_name&quot;:&quot;Minick&quot;},{&quot;first_name&quot;:&quot;Michele&quot;,&quot;last_name&quot;:&quot;Negri&quot;},{&quot;first_name&quot;:&quot;Beatrice&quot;,&quot;last_name&quot;:&quot;Oliosi&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;D. Read&quot;},{&quot;first_name&quot;:&quot;Ilaria&quot;,&quot;last_name&quot;:&quot;Sartori&quot;},{&quot;first_name&quot;:&quot;Giovanna&quot;,&quot;last_name&quot;:&quot;Tedesco&quot;},{&quot;first_name&quot;:&quot;Luca&quot;,&quot;last_name&quot;:&quot;Tarsi&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Terreni&quot;},{&quot;first_name&quot;:&quot;Filippo&quot;,&quot;last_name&quot;:&quot;Visentini&quot;},{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;Zocchi&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Zonzini&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;2534-2551&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901818u&quot;},&quot;abstract&quot;:&quot;The discovery of new highly potent and selective triple reuptake inhibitors is reported. The new classes of 1-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes are described together with detailed SAR. Appropriate decoration of the scaffolds was achieved with the help of a triple reuptake inhibitor pharmacophore model detailed here. Selected derivatives showed good oral bioavailability (&gt;30%) and brain penetration (B/B &gt; 4) in rats associated with high in vitro potency and selectivity at SERT, NET, and DAT. Among these compounds, microdialysis and in vivo experiments confirm that derivative 15 has an appropriate developability profile to be considered for further progression.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901818u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901818u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901818u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901818u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901818u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901818u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901818u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901818u&amp;href=/doi/10.1021/jm901818u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901818u" /></input><a href="/doi/pdf/10.1021/jm901818u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901818u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901818u%26sid%3Dliteratum%253Aachs%26pmid%3D20170186%26genre%3Darticle%26aulast%3DMicheli%26date%3D2010%26atitle%3D1-%2528Aryl%2529-6-%255Balkoxyalkyl%255D-3-azabicyclo%255B3.1.0%255Dhexanes%2Band%2B6-%2528Aryl%2529-6-%255Balkoxyalkyl%255D-3-azabicyclo%255B3.1.0%255Dhexanes%253A%2BA%2BNew%2BSeries%2Bof%2BPotent%2Band%2BSelective%2BTriple%2BReuptake%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D6%26spage%3D2534%26epage%3D2551%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290663" title="Pharmacophores">Pharmacophores</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery of new highly potent and selective triple reuptake inhibitors is reported. The new classes of 1-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes are described together with detailed SAR. Appropriate decoration of the scaffolds was achieved with the help of a triple reuptake inhibitor pharmacophore model detailed here. Selected derivatives showed good oral bioavailability (>30%) and brain penetration (B/B > 4) in rats associated with high in vitro potency and selectivity at SERT, NET, and DAT. Among these compounds, microdialysis and in vivo experiments confirm that derivative <b>15</b> has an appropriate developability profile to be considered for further progression.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Drugs which are able to interfere with either the uptake or with the metabolism of aminergic neurotransmitters have been used for decades to treat depressed patients. The earliest medications, like monoamino oxidase (MAO) inhibitors or tricyclic antidepressants, gained a wide diffusion but are unfortunately linked to some side effects that may limit their efficacy.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> More recently, drugs which act by selectively blocking neurotransmitter reuptake in either serotoninergic neurons (SSRI, e.g., paroxetine, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) or noradrenergic neurons (SNRI, e.g., reboxetine, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) have become established as effective antidepressants. Furthermore, drugs which block reuptake at both serotoninergic and noradrenergic transporters (e.g., venlafaxine, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) or at both noradrenergic and dopaminergic neurons (e.g., bupropion, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), also known as dual uptake inhibitors, provide good efficacy and tolerability too.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of known monoaminergic reuptake inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An important recent development has been achieved with the discovery of triple reuptake inhibitors<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> (TRUI) like indatraline, SEP-225289, or DOV derivatives, which are reported in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. The idea behind a “broad-spectrum”<a onclick="showRef(event, 'cit2e'); return false;" href="javascript:void(0);" class="ref cit2e">(2e)</a> antidepressant that is capable of inhibiting amine uptake of the 5-HT,<a class="ref internalNav" href="#fn9" aria-label="a">a</a><div class="NLM_fn" id="fn9">a<p class="last">Abbreviations: hERG, human ether-a go-go K<sup>+</sup> channel; NCE, novel chemical entity; PK, pharmacokinetic; P450, cytochrome P450; hCli, human intrinsic clearance; <i>F</i>%, bioavailability; B/B, brain/blood; Clb, blood clearance; Vd, distribution volume; SPA, scintillation proximity assay; 5-HT, serotonin; NE, norepinephrine or noradrenaline; DA, dopamine; SERT, serotonin transporter; NET, noradrenaline transporter; DAT, dopamine transporter; MD, microdialysis; p<i>K</i><sub>i</sub>, inhibition constant from binding assays; fp<i>K</i><sub>i</sub>, functional inhibition constant for an antagonist from functional assays e.g. functional inhibition constant obtained form inhibition functional assays using Cheng−Prusoff equation.</p></div> NE, and DA transporters comes from both preclinical<a onclick="showRef(event, 'cit2d cit2e cit2f cit2g'); return false;" href="javascript:void(0);" class="ref cit2d cit2e cit2f cit2g">(2d-2g)</a> and clinical studies. It is known that dopamine agonists themselves (e.g., pergolide, bromocriptine) showed efficacy as augmenting agents with antidepressant in clinical studies.<a onclick="showRef(event, 'cit2i'); return false;" href="javascript:void(0);" class="ref cit2i">(2i)</a> Accordingly, the contemporary block of the three aminergic neurotransmitters may produce, in addition to the elevation of 5-HT and NE, an increase in the CNS levels of DA. It has been hypothesized<a onclick="showRef(event, 'cit2b cit2e cit2h'); return false;" href="javascript:void(0);" class="ref cit2b cit2e cit2h">(2b, 2e, 2h)</a> that such specific increase in DA levels might address the anhedonic component of depression as well as shorten the time to onset. Therefore, the TRUI might result in improved efficacy toward a broader range of the depressed population.</div><div class="NLM_p">Many of the TRUI templates reported to date show level of inhibition of the monoamine transporter such as SERT ≅ NET ≅ DAT.</div><div class="NLM_p">In the quest for the identification of potent and selective TRUI, we report the discovery of a new series of 1-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes, together with a new series of 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes, which are endowed with excellent pharmacokinetic (PK) properties in preclinical species and which work very effectively in different animal models related to the aminergic system.</div><div class="NLM_p">During the past decade, part of GSK research focus in CNS drug discovery has aimed at the discovery of novel chemical entities able to influence the reuptake of aminergic neurotransmitters by their transporters and the rational design was followed to achieve this task and the development of two new potent and selective series based on azabicyclo[3.1.0]hexanes is reported here.</div><div class="NLM_p">Considering the in house expertise and the general information available in the literature, it was hypothesized that an appropriate decoration of the azabicyclo[3.1.0]hexane scaffold would have led to an increased affinity for the three aminergic transporters.</div><div class="NLM_p">A TRUI pharmacophore model was developed in house exploiting both “mixed-activity” and selective transporter inhibitors, and more precisely, three specific pharmacophore models for SERT, NET, and DAT were built using structurally rigid and selective derivatives. These compounds derived both from GlaxoSmithKline’s proprietary collection and from the public domain (e.g., the examples reported in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> or in ref <a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">3</a>). The structures were modeled within the Maestro<a onclick="showRef(event, 'cit4a'); return false;" href="javascript:void(0);" class="ref cit4a">(4a)</a> modeling environment. Conformational analyses were carried out for the three structures with BatchMin<a onclick="showRef(event, 'cit4b'); return false;" href="javascript:void(0);" class="ref cit4b">(4b)</a> using the following parameters: 1000 steps/rotatable bond, OPLS_2005 FF, implicit water model of solvation, 5000 minimization steps with PRCG. Conformations lying within a 3 kcal/mol energy window were kept. A single-ligand pharmacophore was then built over these structures using the phase<a onclick="showRef(event, 'cit4c'); return false;" href="javascript:void(0);" class="ref cit4c">(4c)</a> module within Maestro and selecting the most relevant pharmacophoric features. The three pharmacophores were finally merged together to create the triple reuptake inhibitor pharmacophore. Average coordinates for the common pharmacophoric features were taken to determine their 3D arrangement, as illustrated pictorially in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. Further details can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> available.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. The triple reuptake inhibitors pharmacophore. Coding of features: blue sphere, positive ionizable; pink spheres, H-bond acceptor; green spheres, hydrophobic; orange sphere, aromatic ring. Distances among the pharmacophoric points are shown in angstroms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78567" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78567" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Given the features exemplified in the pharmacophore model (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and the relative distances among the pharmacophoric points there represented, it was decided to introduce an alkoxyalkyl side chain to potentially increase the point of interactions of the template with the transporter; in particular it was hypothesized that the ideal region to probe for a substituted azabicyclo[3.1.0]hexane was represented by the position 6 of the same scaffold, having been the position 5 previously explored in house in the past without any substantial improvement in the potency of the scaffold. It is also important to notice that, in this specific pharmacophore model, some uncertainty is related to the role of the H-bond acceptor mapped by the ether motif. An ether oxygen in general is not a particularly strong H-bond acceptor, and it may well be that this pharmacophoric point is an artifact, as this atom is present in topologically equivalent positions in all the compounds used to derive the pharmacophore.</div><div class="NLM_p">The compounds belonging to this new series were prepared in agreement to the synthetic route reported in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and results are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. In particular, in our quest for the “ideal” triple reuptake inhibitor the desired profile was defined as a compound having relative affinities in the order SERT ≥ NET > DAT, thus allowing the study in vivo of an alternative profile to the currently existing derivatives where SERT ≅ NET ≅ DAT. A different in vitro profile may theoretically account for a different in vivo read-out either in terms of desired activity or potential side effects.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0013.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Procedures for the Preparation of Compounds <b>1</b>−<b>39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>X = O, S, C; Ar = napthyl for derivatives <b>37</b>, <b>38</b>, <b>39</b>, and 3,4-dichlorophenyl for the other mentioned compounds. (i) ArNH<sub>2</sub>, CuCl<sub>2</sub>, tBuNO<sub>2</sub>, CH3CN, 0 °C; (ii) Me<sub>2</sub>SCH<sub>2</sub>CO<sub>2</sub>Et<sup>+</sup> Br<sup>−</sup>, NaH, or ethyldiazoacetate/THF 0 °C to rt; (iii) BH<sub>3</sub>−THF in THF at reflux; (iv) (a) BOC<sub>2</sub>O, TEA, CH<sub>2</sub>Cl<sub>2</sub>, (b) NaH, RX in THF/DMF, (c) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt; (v) (a) BOC<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, (b) MsCl/Et<sub>3</sub>N followed by RONa or RSNa or RMgBr, (c) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding at the Three Transporters (SERT, NET, DAT) Expressed as p<i>K</i><sub>i</sub><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0001.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">entry</th><th align="center">stereochemistry</th><th align="center">R</th><th align="center">R<sub>1</sub></th><th align="center">Ar</th><th align="center" char=".">hSERT SPA p<i>K</i><sub>i</sub></th><th align="center" char=".">hNET SPA p<i>K</i><sub>i</sub></th><th align="center" char=".">hDAT SPA p<i>K</i><sub>i</sub></th></tr></thead><tbody><tr valign="top"><td align="left">DOV 21,947</td><td align="left">NA</td><td align="left">NA</td><td align="left">H</td><td align="left">NA</td><td align="char" char=".">7.70</td><td align="char" char=".">7.20</td><td align="char" char=".">6.90</td></tr><tr valign="top"><td align="left">DOV 102,677</td><td align="left">NA</td><td align="left">NA</td><td align="left">H</td><td align="left">NA</td><td align="char" char=".">6.70</td><td align="char" char=".">6.10</td><td align="char" char=".">6.70</td></tr><tr valign="top"><td align="left"><b>1</b></td><td align="left">endo (rac)</td><td align="left">CH<sub>2</sub>OH</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">7.29</td><td align="char" char=".">6.74</td><td align="char" char=".">6.32</td></tr><tr valign="top"><td align="left"><b>2</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>OH</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">7.81</td><td align="char" char=".">7.54</td><td align="char" char=".">6.34</td></tr><tr valign="top"><td align="left"><b>3</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>OMe</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">8.82</td><td align="char" char=".">8.50</td><td align="char" char=".">6.96</td></tr><tr valign="top"><td align="left"><b>4</b></td><td align="left">endo (rac)</td><td align="left">CH<sub>2</sub>OMe</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">7.14</td><td align="char" char=".">5.89</td><td align="char" char=".">6.18</td></tr><tr valign="top"><td align="left"><b>5</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>OMe</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.12</td><td align="char" char=".">8.76</td><td align="char" char=".">7.25</td></tr><tr valign="top"><td align="left"><b>6</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>OMe</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">7.59</td><td align="char" char=".">6.65</td><td align="char" char=".">6.29</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>OCH<sub>2</sub><i>c</i>-Pr</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.02</td><td align="char" char=".">8.71</td><td align="char" char=".">7.60</td></tr><tr valign="top"><td align="left"><b>8</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>OCH<sub>2</sub><i>c</i>-Pr</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">8.30</td><td align="char" char=".">7.80</td><td align="char" char=".">6.70</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>OCH<sub>2</sub><i>c</i>-Pr</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.50</td><td align="char" char=".">9.20</td><td align="char" char=".">7.90</td></tr><tr valign="top"><td align="left"><b>10</b></td><td align="left">endo (rac)</td><td align="left">CH<sub>2</sub>OCH<sub>2</sub><i>c</i>-Pr</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">7.50</td><td align="char" char=".">6.90</td><td align="char" char=".">6.30</td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>O<i>n</i>-Pr</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.30</td><td align="char" char=".">9.30</td><td align="char" char=".">7.70</td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>O<i>n</i>-Pr</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">8.02</td><td align="char" char=".">7.50</td><td align="char" char=".">6.60</td></tr><tr valign="top"><td align="left"><b>13</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>O<i>n</i>-Pr</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.60</td><td align="char" char=".">9.20</td><td align="char" char=".">7.90</td></tr><tr valign="top"><td align="left"><b>14</b></td><td align="left">exo (rac.)</td><td align="left">CH<sub>2</sub>OEt</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.40</td><td align="char" char=".">8.80</td><td align="char" char=".">7.60</td></tr><tr valign="top"><td align="left"><b>15</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>OEt</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.80</td><td align="char" char=".">9.30</td><td align="char" char=".">8.10</td></tr><tr valign="top"><td align="left"><b>16</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>OEt</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">7.60</td><td align="char" char=".">6.70</td><td align="char" char=".">6.70</td></tr><tr valign="top"><td align="left"><b>17</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>OEt</td><td align="left">Me</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">8.90</td><td align="char" char=".">7.80</td><td align="char" char=".">7.40</td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>OCH<sub>2</sub>CF<sub>3</sub></td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">8.90</td><td align="char" char=".">8.40</td><td align="char" char=".">7.30</td></tr><tr valign="top"><td align="left"><b>19</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>OCH<sub>2</sub>CF<sub>3</sub></td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">7.25</td><td align="char" char=".">6.46</td><td align="char" char=".">6.20</td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>OCH<sub>2</sub>CF<sub>3</sub></td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.20</td><td align="char" char=".">8.80</td><td align="char" char=".">7.60</td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>O<i>i</i>-Pr</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.70</td><td align="char" char=".">9.40</td><td align="char" char=".">8.10</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>O<i>i</i>-Pr</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">7.40</td><td align="char" char=".">6.70</td><td align="char" char=".">6.60</td></tr><tr valign="top"><td align="left"><b>23</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>O<i>i</i>-Pr</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.90</td><td align="char" char=".">9.60</td><td align="char" char=".">8.30</td></tr><tr valign="top"><td align="left"><b>24</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>O<i>c</i>-butyl</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.20</td><td align="char" char=".">8.90</td><td align="char" char=".">7.90</td></tr><tr valign="top"><td align="left"><b>25</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>O<i>c</i>-butyl</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.50</td><td align="char" char=".">9.30</td><td align="char" char=".">8.40</td></tr><tr valign="top"><td align="left"><b>26</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>O<i>c</i>-butyl</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">7.60</td><td align="char" char=".">6.80</td><td align="char" char=".">6.60</td></tr><tr valign="top"><td align="left"><b>27</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>O<i>c</i>-pentyl</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.30</td><td align="char" char=".">9.10</td><td align="char" char=".">8.20</td></tr><tr valign="top"><td align="left"><b>28</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>O<i>c</i>-pentyl</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.60</td><td align="char" char=".">9.80</td><td align="char" char=".">8.60</td></tr><tr valign="top"><td align="left"><b>29</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>O<i>c</i>-pentyl</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">8.10</td><td align="char" char=".">7.90</td><td align="char" char=".">7.00</td></tr><tr valign="top"><td align="left"><b>30</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>O<i>c</i>-hexyl</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.00</td><td align="char" char=".">8.70</td><td align="char" char=".">7.70</td></tr><tr valign="top"><td align="left"><b>31</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>O(4-F-phenyl)</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">8.90</td><td align="char" char=".">7.40</td><td align="char" char=".">7.10</td></tr><tr valign="top"><td align="left"><b>32</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>NMe<sub>2</sub></td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">8.40</td><td align="char" char=".">7.50</td><td align="char" char=".">6.20</td></tr><tr valign="top"><td align="left"><b>33</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>SMe</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.10</td><td align="char" char=".">8.30</td><td align="char" char=".">7.10</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>SMe</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.40</td><td align="char" char=".">8.80</td><td align="char" char=".">7.40</td></tr><tr valign="top"><td align="left"><b>35</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>SMe</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">7.60</td><td align="char" char=".">6.50</td><td align="char" char=".">7.20</td></tr><tr valign="top"><td align="left"><b>36</b></td><td align="left">exo (rac)</td><td align="left"><i>n</i>-Pr</td><td align="left">H</td><td align="left">3,4-di Cl Ph</td><td align="char" char=".">9.00</td><td align="char" char=".">8.70</td><td align="char" char=".">7.60</td></tr><tr valign="top"><td align="left"><b>37</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>OMe</td><td align="left">H</td><td align="left">2-naphthyl</td><td align="char" char=".">9.80</td><td align="char" char=".">9.00</td><td align="char" char=".">7.30</td></tr><tr valign="top"><td align="left"><b>38</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>OMe</td><td align="left">H</td><td align="left">2-naphthyl</td><td align="char" char=".">7.90</td><td align="char" char=".">6.50</td><td align="char" char=".">6.40</td></tr><tr valign="top"><td align="left"><b>39</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>OMe</td><td align="left">H</td><td align="left">2-naphthyl</td><td align="char" char=".">10.10</td><td align="char" char=".">9.20</td><td align="char" char=".">7.60</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">SEM for hSERT/NET/DAT data sets is ±0.1. (rac) = racemate. (se) = single enantiomer. NA = Not applicable.</p></div></div></div><div class="NLM_p">All the compounds prepared were assayed for their capacity to bind to the three monoamine transporters (SERT, NET, and DAT) in SPA-binding primary assays on membranes from cells transiently transduced with BacMam virus. Additionally, the ability of the most interesting compounds to block [<sup>3</sup>H]5-HT, [<sup>3</sup>H]NE, and [<sup>3</sup>H]DA uptake were evaluated in functional uptake SPA assays using LLCPK cells stably transfected with human SERT, NET, or DAT. These more interesting compounds also underwent filtration binding assays on membranes prepared from LLCPK cells stably transfected with each of the three human transporters.</div><div class="NLM_p">Furthermore, to ensure that the selected templates were endowed with appropriate developability characteristics from the beginning of the exploration, the NCEs went through generic developability screens such as CYPEX bactosome P450 inhibition and rat and human in vitro clearance in liver microsomes early in the screening cascade.</div><div class="NLM_p">Given the route described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, the first compound to be tested was the intermediate alcohol prepared with the 3,4-dichlorophenyl aryl derivative so to directly compare with literature standard derivatives. This compound was separated into its endo (<b>1</b>) and exo (<b>2</b>) derivatives, and both compounds were tested as racemate. Interestingly enough, the introduction of the hydroxymethyl group had no major effect on the affinity for the transporters with respect to the unsubstituted derivative; nonetheless, a significant difference was observed between the endo and exo compound toward both SERT and NET affinity, while no major difference was noticed over DAT activity. The following alkylation of the alcohol to the corresponding methyl ether further increased this gap, with the exo derivative <b>3</b> much more active than the corresponding endo one (<b>4</b>); furthermore, in agreement with the original design, the introduction of this group greatly increased both SERT and NET affinity and also led to a moderate DAT affinity increase. The separation of the racemate <b>3</b> by chiral chromatography led to the single enantiomers <b>5</b> and <b>6</b>. Derivative <b>5</b> showed a nanomolar affinity at SERT and similar affinity over NET, while the DAT affinity was about 70-fold lower. The compound was also tested using filtration assay binding conditions, and the values obtained were in good agreement with the SPA binding (p<i>K</i><sub>i</sub> = 9.13/8.34/7.07 on SERT/NET/DAT respectively); finally, the rat-SERT native tissue binding in filtration was also verified, leading to a p<i>K</i><sub>i</sub> = 8.75. To verify, since the beginning, if the introduction of the alkoxyalkyl side chain was appropriate in terms of developability of the potential new class, <b>5</b> was further assayed in agreement to the above-described screening cascade. IC<sub>50</sub> values for all major P450 isoforms tested (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4) were greater than 6 μM and intrinsic clearance (Cl<sub>i</sub>) values both in human and in rat resulted moderately low (<0.5 and 3.8 mL/min/g of protein). Considering this positive in vitro data, the pharmacokinetic (PK) profile in vivo in rat was evaluated;<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> derivative <b>5</b> showed a relatively low blood clearance (Cl<sub>b</sub> = 16 mL/min/kg), leading to an appropriate half-life for in vivo testing in appropriate disease models (<i>t</i><sub>1/2</sub> = 2.4 h). The distribution volume was also relatively low (<i>V</i><sub>d</sub> = 2.9 L/kg) and the bioavailability was excellent (<i>F</i> = 94%). Considering that central nervous system (CNS) is the final target for this class of molecules, brain penetration was evaluated too. The compound demonstrated a brain/blood (B/B) ratio of 4, with a brain fraction unbound of 2.7% showing excellent penetration properties and low tissue binding values. Very encouraged by these initial results, which could be considered as the discovery of an interesting dual SERT/NET derivative, the investigation on this class was further expanded. The major objectives of the exploration were related to the dimension of the pocket available for binding within the transporter, to its sensitivity to polarity, and to the role played by the oxygen bridge. The introduction of a bulky cyclopropyl methyl derivative (<b>7</b>−<b>9</b>) was well tolerated, leading to a very potent molecule (<b>9</b>) on each of the three transporters; in particular, the greater relative increase was obtained on the dopamine transporter. The bulkiness was well tolerated also in terms of developability properties with all of the P450 isoforms inhibited with IC<sub>50</sub> greater than 10 μM with the exception of CYP2C19 and CYP2D6 (IC<sub>50</sub> = 3 and 1 μM, respectively). Human and rat Cl<sub>i</sub> were comparable to derivative <b>5</b> despite a higher lipophilicity of the molecule (<0.5 and 2.6 mL/min/g of protein, respectively). The in vivo PK evaluation in rat of derivative <b>9</b> demonstrated that the good results achieved by <b>5</b> were not related to a singleton derivative; actually, the compound, despite a higher lipophilicity, was still endowed with acceptable PK parameters: Cl<sub>b</sub> was high (72 mL/min/kg) with a high volume of distribution (5.2 L/kg), leading to a reduced half-life (<i>t</i><sub>1/2</sub> = 1 h). Bioavailability was moderate (<i>F</i> = 32%) and the brain penetration very high (B/B = 10), although this was driven by higher nonspecific binding as the key parameter, fraction unbound, was very low (<i>F</i><sub>ub</sub> = 0.1%). As observed for the previous compounds, also in this case the endo derivative was much less potent (<b>10</b>). Therefore, considering the superiority of the exo substitution with respect to the endo one, the exploration was continued on the former template. This experimental result was also in agreement with the predictions of the pharmacophore model used during the planning of the series. Actually, when all the four potential stereoisomers of the [3.1.0] scaffold were fitted in the model, the exo derivatives showed a better fit than the corresponding endo ones as exemplified in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. The exo derivatives <b>15</b> and <b>16</b> fitted in the pharmacophore model in comparison with the potential endo isomers. It can be clearly seen, both in terms of visual overlapping and in terms of phase Fitness (ranging from 0 to 1, the higher the better), that the triple reuptake inhibitors pharmacophore superimposes much better with the exo isomers with respect to the corresponding endo isomers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The introduction of a linear and slightly less lipophilic moiety (<i>n</i>-Pr, <b>11</b>−<b>13</b>) led to a superimposable in vitro profile of derivative <b>13</b> with <b>9</b>, both from the primary binding at the transporters and from the DMPK point of view. The further reduction by one carbon atom (Et, <b>14</b>−<b>16</b>) led to similar affinity properties (<b>15</b>) but greatly improved in vitro DMPK characteristics. All of the major P450 isoforms were inhibited with IC<sub>50</sub> greater than 9 μM with one exception (CYP2D6 IC<sub>50</sub> = 4 μM) and human and rat Cl<sub>i</sub> were relatively low (1.2 and 1.3 mL/min/g of protein, respectively). The in vivo PK profile in rat was excellent too: <b>15</b> showed low Cl<sub>b</sub> (18 mL/min/kg) and distribution volume (<i>V</i><sub>d</sub> = 1.4 L/kg), with acceptable half-life (<i>t</i><sub>1/2</sub> = 1.2 h) and very good bioavailability (<i>F</i> = 61%). Brain penetration was good (B/B = 4.6) as well as the fraction unbound (1.4%).</div><div class="NLM_p">Considering its overall profile, <b>15</b> was further characterized and shown to efficiently inhibit the uptake of all of the three monoamines (pIC<sub>50</sub> = 8.90/9.80/8.30 on SERT/NET and DAT, respectively). However, whereas the functional pIC<sub>50</sub> observed in the DAT assay was in line with the affinity of <b>15</b> in the respective binding assay, the functional pIC<sub>50</sub> observed at NET was higher than the binding affinity for NET. On the contrary, functional potency of <b>15</b> at SERT was lower than its binding affinity for this transporter. With the latter, it is important to notice that a difference was expected because the SERT uptake-SPA assay is known to be particularly sensitive to test conditions (e.g., cell numbers) and, from previous in house experience, most SERT blockers tested in uptake assays showed pIC<sub>50</sub> values lower than the corresponding affinity in the binding assay. However, because pIC<sub>50</sub> values are a relative measure of compounds potency, being dependent on assay conditions, reliable comparison of the functional potency of the compounds at the three monoamine transporters is not possible. Therefore, the results of these functional uptake studies are to be considered only indicative of the likely functional ratio of effect in vivo, whereas the binding affinities must be considered a reliable basis on which to predict a potential in vivo effect.</div><div class="NLM_p"><i>N</i>-Methylation of the secondary amine, <b>17</b>, led to approximately a 10-fold decrease in affinity at the three transporters, while the introduction of a dipole in the system (<b>18</b>−<b>20</b>) gave a 5-fold decrease (<b>20</b>). Moreover, the replacement of the terminal methyl group with a CF<sub>3</sub> derivative, despite a higher lipophilicity, did not substantially change the in vitro DMPK parameters and gave a similar in vivo PK profile (Cl<sub>b</sub> = 42 mL/min/kg; <i>V</i><sub>d</sub> = 3.2 L/kg; <i>t</i><sub>1/2</sub> = 1.4 h; <i>F</i> = 41%); the major differences were observed was in terms of brain penetration and fraction unbound (B/B = 18; <i>F</i><sub>ub</sub> = 0.6%). The introduction of a branching alpha to the oxygen atom (<i>i</i>-Pr, <b>21</b>−<b>23</b>) further increased the affinity for the three transporters (<b>23</b> vs <b>13</b>) by about 2.5-fold and was not detrimental for the in vitro developability profile (IC<sub>50</sub> greater than 8 μM on all major P450 isoforms; human and rat Cl<sub>i</sub> =1.4 and <0.5 mL/min/kg, respectively). A further increase in bulkiness had no major impact on affinity (<i>c</i>-butyl, <b>24</b>−<b>26</b>; <i>c</i>-pentyl <b>27</b>−<b>29</b>) with slightly higher NET values for <b>28</b> and started to become detrimental with the introduction of the bulkiest <i>c</i>-hexyl derivative <b>30</b>, still maintaining high levels of affinity on all the three transporters. The introduction of an aromatic moiety, <b>31</b>, had no major impact on SERT affinity but led to a more marked decrease in terms of NET and DAT when compared to <b>30</b>.</div><div class="NLM_p">Compared to the parent racemic compound <b>4</b>, the introduction of a strong polar component (NMe<sub>2</sub>, <b>32</b>) had no major impact in terms of loss of affinity; actually, the NET affinity decreased 10-fold while the SERT and DAT affinity decreased approximately 5-fold. The original question relating to the real existence of an H-bond acceptor feature in the pharmacophore model was potentially answered in the following steps. The replacement of the oxygen with a sulfur atom (<b>32</b>−<b>34</b>) potentially demonstrates that the ether probably does not constitute a weak hydrogen-bond acceptor in the transporter. The slightly higher lipophilicity of <b>34</b> compared to <b>5</b> has a slight impact on SERT but leaves NET and DAT affinity almost unaltered within experimental error. This evidence is also potentially confirmed by the replacement of the oxygen with a carbon atom where the racemate <b>36</b> is not different from the corresponding racemate <b>14</b> as far as NET and DAT are concerned and show a 2-fold decrease in terms of SERT affinity. Finally, among the different aryl derivative tested in the exploration (data not shown), in this specific series of derivatives, the 2-naphthyl group (<b>37</b>−<b>39</b>) seems to act well as 3,4-dichlorophenyl bioisoster. Actually, in this specific series, <b>39</b> showed a 10-fold higher SERT affinity with respect to <b>5</b> and approximately a 5-fold affinity increase over NET and DAT, leading to a picomolar affinity compound on serotonin transporter. In this case, human and rat Cl<sub>i</sub> were 2.2 and 3.9 mL/min/kg, respectively, and the CYP450 inhibition profile showed IC<sub>50</sub> greater than 4 μM for all the major P450 isoforms except CYP1A2 (0.9 μM).</div><div class="NLM_p">In the second part of the exploration, the ether position was moved one position further down the apical side chain and the compounds were prepared in agreement with the general Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, and the results are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Also in this case, the first compound to be tested as racemate was the exo intermediate alcohol <b>40</b>. Compared to the corresponding racemic derivative <b>2</b>, this compound showed an average increase of 5-fold in terms of affinity on the three transporters. Methylation of the alcohol led to derivatives <b>41</b>−<b>43</b>; the increased chain length of <b>42</b> compared to derivative <b>5</b> led to a 5-fold increase in the SERT activity, and a 2−3-fold increased affinity in terms of NET and DAT. The compound was tested for its ability to inhibit the uptake of the monoamines giving a pIC<sub>50</sub> of 8.80/9.40/7.80 on SERT, NET, and DAT respectively. Once again, the lower activity observed on SERT compared to the binding results has to be considered in light of the explanation previously reported. The increase in length of the ether chain from methyl to ethyl group (from <b>41</b> to <b>44</b>) did not show the same increase observed moving from <b>3</b> to <b>14</b>, possibly suggesting that the side chain had already reached the best fitting or explored the maximum length tolerated by the binding pocket. To probe if this was the case, some specific heterocycles were prepared according to the synthetic Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and the results are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0014.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Procedures for the Preparation of Compounds <b>40</b>−<b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>PG = H or BOC (i) (a) BOC<sub>2</sub>O, TEA, CH<sub>2</sub>Cl<sub>2</sub>, (b) Dess−Martin periodinane; (ii) Me(Ph)<sub>3</sub>P<sup>+</sup>Br<sup>−</sup>, BuLi, THF; (iii) (a) BH<sub>3</sub>−THF, THF, (b) NaOH, H<sub>2</sub>O<sub>2</sub> 30%, (c) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt; (iv) NaH, RX in THF/DMF; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt.</p></p></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0015.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. General Synthetic Procedures for the Preparation of Compounds <b>45</b>−<b>49</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>PG = H or BOC, R = OH or NHAlk, HET = heterocycle (i) (a) Jones reagent at 0 °C in CH<sub>2</sub>Cl<sub>2</sub>, (b) HOBT, EDC, NH<sub>4</sub>R; (ii) (a) heating with appropriate halo-ketone, (b) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt; (iii) steps from (i) to (iii) in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>; (iv) (a) Jones reagent at 0 °C in CH<sub>2</sub>Cl<sub>2</sub>, (b) HOBT, EDC, NH<sub>4</sub>OH, (c) Lawesson’s reagent, (d) heating with appropriate halo-ketone, (e) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding at the Three Transporters (SERT, NET, DAT) Expressed as p<i>K</i><sub>i</sub><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0002.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">entry</th><th align="center">stereochemistry</th><th align="center">R</th><th align="center" char=".">hSERT SPA p<i>K</i><sub>i</sub></th><th align="center" char=".">hNET SPA p<i>K</i><sub>i</sub></th><th align="center" char=".">hDAT SPA p<i>K</i><sub>i</sub></th></tr></thead><tbody><tr valign="top"><td align="left"><b>40</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>CH<sub>2</sub>OH</td><td align="char" char=".">8.60</td><td align="char" char=".">8.10</td><td align="char" char=".">7.10</td></tr><tr valign="top"><td align="left"><b>41</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>CH<sub>2</sub>OMe</td><td align="char" char=".">9.10</td><td align="char" char=".">8.50</td><td align="char" char=".">7.20</td></tr><tr valign="top"><td align="left"><b>42</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>CH<sub>2</sub>OMe</td><td align="char" char=".">9.60</td><td align="char" char=".">9.00</td><td align="char" char=".">7.30</td></tr><tr valign="top"><td align="left"><b>43</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>CH<sub>2</sub>OMe</td><td align="char" char=".">7.50</td><td align="char" char=".">6.00</td><td align="char" char=".">6.90</td></tr><tr valign="top"><td align="left"><b>44</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>CH<sub>2</sub>OEt</td><td align="char" char=".">9.10</td><td align="char" char=".">8.40</td><td align="char" char=".">7.10</td></tr><tr valign="top"><td align="left"><b>45</b></td><td align="left">exo (rac)</td><td align="left">5-methyl-1,3-oxazol-2-yl</td><td align="char" char=".">7.80</td><td align="char" char=".">7.70</td><td align="char" char=".">6.90</td></tr><tr valign="top"><td align="left"><b>46</b></td><td align="left">exo (rac)</td><td align="left">4-methyl-1,3-thiazol-2-yl</td><td align="char" char=".">9.00</td><td align="char" char=".">8.00</td><td align="char" char=".">7.50</td></tr><tr valign="top"><td align="left"><b>47</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>(4-methyl-1,3-thiazol-2-yl)</td><td align="char" char=".">9.70</td><td align="char" char=".">9.50</td><td align="char" char=".">7.70</td></tr><tr valign="top"><td align="left"><b>48</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>(4-methyl-1,3-thiazol-2-yl)</td><td align="char" char=".">10.10</td><td align="char" char=".">9.90</td><td align="char" char=".">7.70</td></tr><tr valign="top"><td align="left"><b>49</b></td><td align="left">exo (se)</td><td align="left">CH<sub>2</sub>(4-methyl-1,3-thiazol-2-yl)</td><td align="char" char=".">7.80</td><td align="char" char=".">7.10</td><td align="char" char=".">7.30</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">SEM for hSERT/NET/DAT data sets is ±0.1. (rac) = racemate. (se) = single enantiomer.</p></div></div></div><div class="NLM_p">The oxazolyl derivative <b>45</b> was probably able to pick up no more interactions than derivative <b>2</b>, but its introduction was not detrimental for activity, confirming the availability of enough space in that region of the transporter; the slightly more lipophilic thiazolyl derivative <b>46</b> actually acted in the expected direction, increasing the affinity on the transporters by about 5-fold, confirming the general trend achieved up to that point of the exploration. Interestingly enough, the elongation of such a molecule (<b>47</b>−<b>49</b>) led to the very potent derivative <b>48</b>; differently from the 2-naphthyl derivative <b>39</b>, in this case not only the SERT affinity was picomolar but also the NET affinity was in the low nanomolar range with the DAT comparable and about 100-fold lower, thus leading to the identification of another potential dual activity derivative. For confirmation, experiments of reuptake were performed and <b>48</b> gave pIC<sub>50</sub> of 9.00/9.60/7.70 on SERT, NET, and DAT, respectively.</div><div class="NLM_p">To complete the exploration, given the new information provided for the pharmacophore model, it was decided to keep the side chain in position 6 of the bicyclic template and to move also the 3,4-dichlorophenyl derivative in the same position as a potential positive overlap might also have arisen from this combination. The results of the exploration are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, and the compounds were prepared according to Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> for the alkoxy methylene substituent and following Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a> for the alkoxyethylene derivatives. On this new scaffold, the presence of a plane of symmetry leads to a pro-chiral situation in which the aryl ring can sit exo or endo. In Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> the definition (rac) for racemate is referred only to the nature of the <i>sec</i>-butyl alcohol used in the coupling. By comparing derivatives <b>50</b> and <b>51</b>, it is possible to infer that the extended exo derivatives appear to provide a better fitting within the three transporters binding site, leading to a compound with high affinity for all of them. Once again, this was in agreement with the pharmacophore model predictions as reported in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. Derivative <b>50</b> also showed a positive P450 profile with IC<sub>50</sub> values greater than 5 μM on all the isoforms. Unfortunately, it was not as metabolically stable, with Cl<sub>i</sub> values slightly higher than in the previous template (h-and r-Cli being 3.4 and 5.1 mL/min/g of protein, respectively). The introduction of the cyclopropyl methyl substituent (<b>52</b>) led to a slight DAT affinity increase, while a bulkier alpha branched cyclo-butyl moiety (<b>53</b>) led to a substantial increase of both NET and DAT components, resulting in a very balanced triple reuptake inhibitor. These modifications led to a slight change in the P450 profile of the derivatives, with <b>52</b> having IC<sub>50</sub> values greater than 10 μM on all the isoforms with the exception of CYP2D6 and CYP3A4 DEF (IC<sub>50</sub> = 1 and 4 μM, respectively) and <b>53</b> having IC<sub>50</sub> values greater than 10 μM on all the isoforms with the exception of CYP3A4 DEF (IC<sub>50</sub> = 3 μM). The introduction of a slight dipole (<b>54</b>, −CH<sub>2</sub>CF<sub>3</sub>) with respect to <b>50</b> had no major effect on the affinity at the three transporters but introduced a potential liability in the P450 profile with the IC<sub>50</sub> of direct inhibition of CYP2D6 = 0.3 μM. The presence of an α branching (<i>s</i>-Butyl, <b>55</b>) endowed with higher conformational freedom when compared to <b>53</b> did not alter neither the primary affinity profile nor the positive P450 profile. The introduction of a further methylene to extend the position of the ether in the space is represented by derivatives <b>56</b>−<b>60</b>. For derivatives <b>56</b> and <b>57</b>, no major effect on the primary affinity profile was observed, but unfortunately <b>57</b> showed a potential liability in the P450 profile (CYP2D6, IC<sub>50</sub> < 0.1 μM). The introduction of the α branching (<b>58</b>−<b>60</b>) had a positive effect on the affinity, in particular on DAT being <b>60</b>, another potent and selective triple reuptake inhibitor, with no major effect on the previously observed P450 profile.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. The exo derivative <b>50</b> fitted in the pharmacophore model in comparison with the endo isomer <b>51</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0016.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Synthetic Procedures for the Preparation of Compounds <b>50</b>−<b>55</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>PG = H or BOC; (i) toluene, reflux; (ii) BH<sub>3</sub>−THF, refluxing THF; (iii) (a) RX, NaH, DMF from 0 °C to rt, (b) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt.</p></p></figure><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0017.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. General Synthetic Procedures for the Preparation of Compounds <b>56</b>−<b>60</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>PG = H or BOC; (i) (a) BOC<sub>2</sub>O, TEA, CH<sub>2</sub>Cl<sub>2</sub>, (b) Dess−Martin periodinane; (ii) Me(Ph)<sub>3</sub>P<sup>+</sup>Br<sup>−</sup>, BuLi, THF; (iii) (a) BH<sub>3</sub>−THF, THF, (b) NaOH, H<sub>2</sub>O<sub>2</sub> 30%; (iv) (a) or MsCl/TEA in CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt followed by RONa in DMF, (b) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding at the Three Transporters (SERT, NET, DAT) Expressed as p<i>K</i><sub>i</sub><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0003.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">entry</th><th align="center">stereochemistry</th><th align="center">R</th><th align="center" char=".">hSERT SPA p<i>K</i><sub>i</sub></th><th align="center" char=".">hNET SPA p<i>K</i><sub>i</sub></th><th align="center" char=".">hDAT SPA p<i>K</i><sub>i</sub></th></tr></thead><tbody><tr valign="top"><td align="left"><b>50</b></td><td align="left">exo</td><td align="left">CH<sub>2</sub>OEt</td><td align="char" char=".">9.30</td><td align="char" char=".">7.90</td><td align="char" char=".">7.70</td></tr><tr valign="top"><td align="left"><b>51</b></td><td align="left">endo</td><td align="left">CH<sub>2</sub>OEt</td><td align="char" char=".">5.60</td><td align="char" char=".">4.60</td><td align="char" char=".">5.20</td></tr><tr valign="top"><td align="left"><b>52</b></td><td align="left">exo</td><td align="left">CH<sub>2</sub>OCH<sub>2</sub><i>c</i>-Pr</td><td align="char" char=".">9.20</td><td align="char" char=".">8.10</td><td align="char" char=".">8.00</td></tr><tr valign="top"><td align="left"><b>53</b></td><td align="left">exo</td><td align="left">CH<sub>2</sub>O<i>c</i>-butyl</td><td align="char" char=".">9.40</td><td align="char" char=".">8.60</td><td align="char" char=".">8.20</td></tr><tr valign="top"><td align="left"><b>54</b></td><td align="left">exo</td><td align="left">CH<sub>2</sub>OCH<sub>2</sub>CF<sub>3</sub></td><td align="char" char=".">9.00</td><td align="char" char=".">7.60</td><td align="char" char=".">7.60</td></tr><tr valign="top"><td align="left"><b>55</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>O<i>sec</i>-butyl</td><td align="char" char=".">9.60</td><td align="char" char=".">8.70</td><td align="char" char=".">8.10</td></tr><tr valign="top"><td align="left"><b>56</b></td><td align="left">exo</td><td align="left">CH<sub>2</sub>CH<sub>2</sub>OMe</td><td align="char" char=".">9.50</td><td align="char" char=".">8.10</td><td align="char" char=".">8.00</td></tr><tr valign="top"><td align="left"><b>57</b></td><td align="left">exo</td><td align="left">CH<sub>2</sub>CH<sub>2</sub>OEt</td><td align="char" char=".">9.30</td><td align="char" char=".">8.10</td><td align="char" char=".">7.80</td></tr><tr valign="top"><td align="left"><b>58</b></td><td align="left">exo</td><td align="left">CH<sub>2</sub>CH<sub>2</sub>O<i>i</i>Pr</td><td align="char" char=".">9.50</td><td align="char" char=".">8.80</td><td align="char" char=".">8.20</td></tr><tr valign="top"><td align="left"><b>59</b></td><td align="left">exo (rac)</td><td align="left">CH<sub>2</sub>CH<sub>2</sub>O<i>sec</i>-butyl</td><td align="char" char=".">9.50</td><td align="char" char=".">8.40</td><td align="char" char=".">8.30</td></tr><tr valign="top"><td align="left"><b>60</b></td><td align="left">exo</td><td align="left">CH<sub>2</sub>CH<sub>2</sub>O<i>c</i>-butyl</td><td align="char" char=".">9.70</td><td align="char" char=".">8.40</td><td align="char" char=".">8.20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">SEM for hSERT/NET/DAT data sets is ±0.1. (rac) = racemate, referred to the nature of the <i>sec</i>-butyl alcohol used.</p></div></div></div><div class="NLM_p">Among the potent dual and triple reuptake inhibitors identified in the exploration, it was decided to select some of the best derivatives to be further characterized along the screening cascade, and derivative <b>15</b> is here reported as a model.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Further Characterization of Derivative <b>15</b></h3><div class="NLM_p">The first step for a more complete characterization of <b>15</b> was the determination of its absolute stereochemistry. The stereochemistry of this molecule and its enantiomer <b>16</b> were assigned using vibrational circular dichroism (VCD),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and derivative <b>15</b> was identified as the (1<i>S</i>,5<i>S</i>,6<i>S</i>) isomer in accordance to the methodology reported in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Interestingly enough, as reported in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, the pharmacophore model was also able to correctly identify the chirality of best fitting isomer <b>15</b>.</div><div class="NLM_p">The second step of the characterization, in agreement with the screening cascade, was related to increasing the information on the selectivity of the compound using a panel of binding and functional assays available in house. The compound showed at least 100-fold selectivity over a wide range of receptors, with the most notable results here reported (adrenergic α<sub>1A</sub>, fp<i>K</i><sub>i</sub> = 6.7; 5-HT<sub>2A</sub>, fp<i>K</i><sub>i</sub> = 6.8; H1, fp<i>K</i><sub>i</sub> = 6.0; muscarinic acetylcholine receptor: M1, fp<i>K</i><sub>i</sub> = 6.8; M2, fp<i>K</i><sub>i</sub> = 6.7; M3, fp<i>K</i><sub>i</sub> = 7.2; M4, fp<i>K</i><sub>i</sub> = 6.6; M5, fp<i>K</i><sub>i</sub> = 7.0). The compound was also submitted to a hERG electrophysiology assay<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> to assess its overall activity for this K<sup>+</sup> channel, and the results (IC<sub>50</sub> 4.2 μM) confirmed the hERG binding affinity (p<i>K</i><sub>i</sub> = 4.9).</div><div class="NLM_p">Considering the possibility to test <b>15</b> in vivo in preclinical species, the compound was tested in rat native tissues (filtration binding) where it showed an excellent profile with p<i>K</i><sub>i</sub> = 9.17/9.87/7.87 on SERT, NET, and DAT, respectively. The higher affinity on rat NET was also observed for other compounds of the same series and was also common to some standard derivatives. This is in line with a generally increased affinity for rat NET observed for other compounds in comparison to the human transporter and might support the existence of a species difference in NET pharmacology. Mouse SERT filtration binding data were also generated, and the compound showed a p<i>K</i><sub>i</sub> = 9.07, in good agreement with the above-reported rat data.</div><div class="NLM_p">Considering its overall balanced profile in terms of primary activity and PK properties, and considering the desired ratio among the human transporters with SERT ≥ NET > DAT (ratio ≈ 1/3/50), it was decided to explore the in vivo behavior of the compound. Nonetheless, considering that the rat profile showed a NET ≥ SERT > DAT, a further preliminary step was considered necessary to fully interpret the final results. Because of its mode of action, <b>15</b> was expected to increase the extracellular concentration of monoamines as measured by in vivo microdialysis.</div><div class="NLM_p">To test this hypothesis, microdialysis probes were implanted in the medial prefrontal cortex (MPC) in freely moving rats with concurrent locomotor activity measurement and quantification of NE, DA, and 5-HT brain levels<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> by HPLC analysis and electrochemical detection. Derivative <b>15</b> was tested at 0.1, 0.3, and 1 mg/kg (ip) and, as reported in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, at the highest dose tested, it induced a slow and sustained increase in the levels of the monoamines that lasted throughout the experiment (3 h post treatment); this was particularly significant for DA levels. At the same time, an increased locomotor activity was observed in rat at the same dose (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). These results demonstrate that the acute administration of <b>15</b> produced a slow onset/long lasting increase in the extracellular levels of all monoamines in MPC in rats, in agreement with the triple reuptake inhibitor profile.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Time course of the effect of <b>15</b> on norepinephrine (diamond), dopamine (square), and serotonin (triangle) outflow in the rat medial prefrontal cortex. Arrow shows injection. Data are mean ± SEM of neurotransmitter concentration expressed as percentage of basal values. Doses tested = 1 mg/kg, ip.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Time course of the effect of <b>15</b> on rat locomotor activity at 1 mg/kg ip.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">At this point, <b>15</b> was tested in three in vivo models in mice to further confirm its ability to inhibit the monoamine transport and produce antidepressant-like effects.</div><div class="NLM_p">In the first of these experiments (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, right), it was tested in the 5-hydroxytryptophan (5-HTP) potentiation assay.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The compound was administered orally 2 h before the experiment. The results demonstrate that <b>15</b> significantly increased in a dose dependent manner 5-HTP stereotyped behavior at 3, 10, and 30 mg/kg. In the same study, the standard SSRI drug citalopram significantly increased 5-HTP stereotyped behavior. Accordingly, these data confirm in vivo the inhibition of the 5-HT transporter.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of derivative <b>15</b> in the FST model (left panel) on the spontaneous locomotor activity (middle panel) and in the 5-HTP model (right panel) in mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the second experiment (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, center), <b>15</b> was evaluated for its effects on spontaneous locomotor activity in the rat.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The compound was administered orally 2 h before the experiment at 3, 10, and 30 mg/kg and it was found to significantly increase locomotor activity at 10 mg/kg., while the lack of effect at 30 mg/kg was unforeseen. The data are consistent with an increased dopaminergic neurotransmission due to the inhibition of the DA transporter by <b>15</b>.</div><div class="NLM_p last">In the last experiment, the potential antidepressant-like effect of <b>15</b> was evaluated in the forced swimming test<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (FST), which is sensitive to known antidepressant drugs (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, left). Once again, the compound was administered orally 2 h before the test in mice at 1, 3, and 10 mg/kg. As clearly seen in the figure, <b>15</b> significantly reduced immobility time at 3 and 10 mg/kg as predicted by its in vitro and PK profile. However, the possibility that the increase in locomotor activity (in rats) in the same dose range could have affected the results of the FST cannot be ruled out.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43508" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43508" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The planned introduction of an appropriate side chain into a 1-(aryl)-3-azabicyclo[3.1.0]hexane template and its transformation into a 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexane scaffold led to the identification of two different classes of potent and selective triple reuptake inhibitors. These molecules are endowed with an excellent developability profile and showed activity in preclinical animal models related to the increase of the monoamines.</div><div class="NLM_p last">Derivative <b>15</b>, in particular, was used to probe the role of a system in which SERT, NET, and DAT are appropriately chosen in a given ratio. MD and in vivo experiments performed on this molecule clearly indicate its mode of action through monoamine uptake inhibition.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Biological Test Methods</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> In Vitro Studies</h4><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> Filtration Binding Assay for Human Recombinant SERT, NET, and DAT</h5><div class="NLM_p last">Filtration binding assays were run using membranes prepared from LLCPK cells stably transfected with each of the three human transporters. Filtration [<sup>3</sup>H]citalopram binding assay for human SERT (hSERT) was conducted in deep-well 96-well plate in a total volume of 404 μL/well by adding 4 μL of test compound (100× solution in neat DMSO) or DMSO (to define total binding) or a final concentration of 10 μM fluoxetine (to define nonspecific binding, NSB), 200 μL of 0.25nM [<i>N</i>-methyl-<sup>3</sup>H]citalopram (Amersham Biosciences, 80 Ci/mmol) and 200 μL of hSERT-LLCPK membranes (about 2.5 μg protein/well). After 2 h at room temperature, the reaction was stopped by rapid filtration through GF/B Unifilter 96-filter plate (Perkin-Elmer) presoaked in 0.5% polyethylenimmine (PEI) using a Perkin-Elmer FilterMat-196 harvester. Filterplate was washed 3 times with 1 mL/well ice-cold 0.9% NaCl solution, dried, and finally 50 μL of Microscint 20 (Perkin-Elmer) were added to each well. The radioactivity was counted using TopCount liquid scintillation counter (Packard-Perkin-Elmer) and recorded as counts per minute (CPM). Data analysis was performed by using a 4-parameter logistic equation with GraphPad PRISM software and p<i>K</i><sub>i</sub> has been calculated from pIC<sub>50</sub> by using the Cheng−Prusoff equation. Competition binding assay for human NET (hNET) was conducted essentially as previously reported for SERT except for the use of hNET-LLCPK cell membranes (4.8 μg/well), 1.5 nM of [<i>N</i>-methyl-<sup>3</sup>H]nisoxetine as radioligand (Amersham Biosciences, 84 Ci/mmol), and 10 μM desipramine for NSB. Finally, the same procedure was adopted also for human DAT (hDAT) competition binding assay but using hDAT/LLCPK cell membranes (9.6 μg/well), 10 nM [<i>N</i>-methyl-<sup>3</sup>H]WIN-35,428 (Perkin-Elmer, 85.6 Ci/mmol), and 10 μM GBR-12909 for NSB.</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17"> Filtration Binding for Rat Native SERT, NET, and DAT and Mouse Native SERT</h5><div class="NLM_p last">Filtration binding studies were carried out on rat and mouse brain native tissue. The affinity of the compound was determined on rat or mouse cortex for SERT, on rat hippocampus for NET, and on rat striatum for DAT by using the appropriate radioligand. Competition binding assays for rat and mouse SERT, rat NET, and rat DAT were conducted essentially as previously reported for human recombinant monoamine transporters but using a different amount of membranes (20 and 7 μg of protein /well for rat and mouse SERT binding, 40 and 20 μg/well for rat NET and DAT binding, respectively).</div></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> hERG−[<sup>3</sup>H] Dofetilide Binding Assay</h4><div class="NLM_p last">hERG activity was measured using <sup>3</sup>H dofetilide binding in a scintillation proximity assay (SPA) format. The activity was measured with a PerkinElmer Viewlux imager.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> SPA-Binding for Human Recombinant SERT, NET, and DAT</h4><div class="NLM_p last">The affinity of the compounds to the human transporters has been assessed with radioligand displacement binding of [<sup>3</sup>H]citalopram, [<sup>3</sup>H]nisoxetine, and [<sup>3</sup>H]WIN-35,428 for SERT, NET, and DAT in BacMam-recombinant human SERT, NET, and DAT membranes with the SPA technology. Briefly, 0.3 μL of test compound were added by 30 μL of the SPA mixture, containing 1 mg/mL SPA (GE HealthCare, RPNQ0260) beads (SERT) or 2 mg/mL SPA beads (NET and DAT), 6 or 40 or 20 μg/mL of SERT or NET or DAT BacMam membranes, 0.02% Pluronic F-127, 3 nM [<sup>3</sup>H]citalopram, or 10 nM [<sup>3</sup>H]nisoxetine or 10 nM [<sup>3</sup>H]WIN-35,428 for SERT or NET or DAT binding SPA in the assay buffer (20 mM HEPES, 145 mM NaCl, 5 mM KCl, pH 7.4). Incubation was performed overnight at room temperature. Bound radioactivity was measured with the Viewlux instrument. Data analysis was performed by using a four-parameter logistic equation with ActivityBase software and p<i>K</i><sub>i</sub> has been calculated from pIC<sub>50</sub> by using the Cheng−Prusoff equation.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Functional Uptake for SERT, NET, and DAT</h4><div class="NLM_p last">The potency of the compounds in blocking the [<sup>3</sup>H]serotonin, [<sup>3</sup>H]noradrenalin, and [<sup>3</sup>H]dopamine uptake was evaluated in a functional uptake-SPA assay on LLCPK cells stably transfected with human SERT, NET, and DAT. Briefly, 0.2 μL of test compound were added by 10 μL of the bead-cell SPA mixture, containing 1.5 mg/mL SPA beads (SERT and NET) or 2 mg/mL of SPA beads (DAT), 25000 or 50000 or 75000 cell/well of SERT or NET or DAT LLCPK cells, 0.02% Pluronic F-127 in the assay buffer (20 mM HEPES, 145 mM NaCl, 5 mM KCl, pH 7.4). The uptake was started by the substrate addition of 10 μL of 35 nM [<sup>3</sup>H]serotonin or 45 nM [<sup>3</sup>H]noradrenalin or 75 nM [<sup>3</sup>H]dopamine for SERT or NET or DAT uptake SPA. Incubation was performed at room temperature for 1 h. Uptake was measured with the Viewlux instrument and data analysis was performed as before.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> P450 CYPEX Assay</h4><div class="NLM_p last">Inhibition (IC<sub>50</sub>) of human CYP1A2, 2C9, 2C19, 2D6, and 3A4 was determined using Cypex Bactosomes expressing the major human P450s. A range of concentrations (0.1, 0.2, 0.4, 1, 2, 4, and 10 μM) of test compound were prepared in methanol and preincubated at 37 °C for 10 min in 50 mM potassium phosphate buffer (pH 7.4) containing recombinant human CYP450 microsomal protein (0.1 mg/mL; Cypex Limited, Dundee, UK) and probe-fluorescent substrate. The final concentration of solvent was between 3 and 4.5% of the final volume. Following preincubation, NADPH regenerating system (7.8 mg glucose 6-phosphate, 1.7 mg NADP and 6 units glucose 6-phosphate dehydrogenase/mL of 2% (w/v) NaHCO<sub>3</sub>; 25 μL) was added to each well to start the reaction. Production of fluorescent metabolite was then measured over a 10 min time-course using a Spectrafluor plus plate reader. The rate of metabolite production (AFU/min) was determined at each concentration of compound and converted to a percentage of the mean control rate using Magellan (Tecan software). The inhibition (IC<sub>50</sub>) of each compound was determined from the slope of the plot using Grafit v5 (Erithacus software, UK). Miconazole was added as a positive control to each plate. CYP450 isoform substrates used were ethoxyresorufin (ER; 1A2, 0.5 μM), 7-methoxy-4-triflouromethylcoumarin-3-acetic acid (FCA; 2C9, 50 μM), 3-butyryl-7-methoxycoumarin (BMC; 2C19, 10 μM), 4-methylaminomethyl-7-methoxycoumarin (MMC; 2D6, 10 μM), diethoxyflourescein (DEF; 3A4, 1 μM) and 7-benzyloxyquinoline (7-BQ; 3A4, 25 μM). The test was performed in three replicates.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Intrinsic Clearance (Cl<sub>i</sub>) Assay</h4><div class="NLM_p last">Intrinsic clearance (CL<sub>i</sub>) values were determined in rat and human liver microsomes. Test compounds (0.5 μM) were incubated at 37 °C for 30 min in 50 mM potassium phosphate buffer (pH 7.4) containing 0.5 mg microsomal protein/mL. The reaction was started by addition of cofactor (NADPH; 8 mg/mL). The final concentration of solvent was 1% of the final volume. At 0, 3, 6, 9, 15, and 30 min an aliquot (50 μL) was taken, quenched with acetonitrile containing an appropriate internal standard, and analyzed by HPLC-MS/MS. The intrinsic clearance (CL<sub>i</sub>) was determined from the first-order elimination constant by nonlinear regression using Grafit v5 (Erithacus Software, UK), corrected for the volume of the incubation and assuming 52.5 mg microsomal protein/g of protein for all species. Values for CL<sub>i</sub> were expressed as mL/min/g of protein. The lower limit of quantification of clearance was determined to be when <15% of the compound had been metabolized by 30 min and this corresponded to a CL<sub>i</sub> value of 0.5 mL/min/g of protein. The upper limit was 50 mL/min/g of protein.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> VCD</h4><div class="NLM_p">Experimental VCD and IR spectra were acquired in the 2000−800 cm<sup>−1</sup> frequency range using a BioTools ChiralIR FT-VCD spectrometer operating at 4 cm<sup>−1</sup> resolution. Samples were analyzed in CDCl<sub>3</sub> at approximate concentrations of 10 mg/125μL. Harmonic frequencies and corresponding vibrational intensities were calculated using Gaussian 98 ((Gaussian ‘98, Gaussian, Inc., Pittsburgh, PA (<a href="http://www.gaussian.com/index.htm" class="extLink">www.gaussian.com/index.htm</a>)). Predicted gas-phase harmonic frequencies were shifted to the condensed phase region using a uniform scaling factor of 0.98.</div><div class="NLM_p">The observed and baseline-corrected VCD data for <b>15</b> and <b>16</b> are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>. The signs of the 15 marker bands identified in these spectra were used to assign the configurations. The VCD and IR spectra observed for <b>15</b> are compared in Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>a with VCD and IR spectra calculated for a full structure model with (1<i>S</i>,5<i>S</i>,6<i>S</i>) configuration. In the upper panel of this figure, marker bands in the observed VCD spectrum have the same signs as corresponding marker bands in the calculated VCD spectrum, indicating that this enantiomer has the same absolute configuration as the model. Therefore, <b>15</b> was assigned as the (1<i>S</i>,5<i>S</i>,6<i>S</i>)-isomer. The VCD and IR spectra observed for <b>16</b> are compared in Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>b with the same calculated and VCD and IR spectra. In this case, marker bands in the experimental VCD spectrum are oppositely signed relative to the corresponding marker bands in the calculated VCD spectrum, indicating that <b>16</b> is the mirror image enantiomer of the model, and therefore was assigned as the (1<i>R</i>,5<i>R</i>,6<i>R</i>)-isomer. Close overall agreement between calculated and observed VCD and IR spectra in Figures <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>a and <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>b indicates that these assignments are highly reliable.</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Upper panel: signal-to-noise and raw VCD spectra of <b>15</b> (red) and <b>16</b> (blue). Lower panel: baseline corrected VCD spectra of <b>15</b> (red) and <b>16</b> (blue). Bands in the experimental assignment set have been labeled in raw and baseline corrected VCD data.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0012.jpeg" id="_i24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (a) Upper panel: VCD spectrum of <b>15</b> (red) vs calculated VCD spectrum (black). Lower panel: IR spectrum of <b>15</b> (red) compared with calculated IR spectrum (black). Bands in the experimental assignment set have been labeled in both experimental and calculated VCD spectra. (b) Upper panel: VCD spectrum of <b>16</b> (blue) vs calculated VCD spectrum (black). Lower panel: IR spectrum of <b>16</b> (blue) compared with calculated IR spectrum (black). Bands in the experimental assignment set have been labeled in both experimental and calculated VCD spectra.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> In Vivo Studies</h4><div class="NLM_p">All experiments were prereviewed and approved by a local animal care committee in accordance with the guidelines of the “Principles of Laboratory Animal Care” (NIH publication no. 86−23, revised 1985), and with a project license that was obtained according to Italian law (Art. 7, Legislative Decree no. 116, 27 January 1992), which acknowledges European Directive 86/609/EEC on the care and welfare of laboratory animals.</div><div class="NLM_p last">Naive male CD-1 mice (Charles River, Italy) weighing 25−30 g were used in the 5-HTP potentiation test, in the forced swimming test, and for the assessment of spontaneous locomotor activity.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 5-HTP Potentiation</h4><div class="NLM_p">The administration of the precursor of 5-hydroxytryptophan (5-HTP) to mice leads to a serotonergic syndrome characterized by stereotypic behavior. The combination monoamine reuptake inhibitors with subthreshold doses of 5-HTP has been proposed as a model to evaluate in vivo effects of drug acting at the serotonin transporter (Ortmann, 1980).</div><div class="NLM_p last">Mice were pretreated with <b>15</b> 120 min before an intraperitoneal (ip) injection of 5-HTP (100 mg/kg) and placed individually into a perspex box (20.5 cm × 20.5 cm × 34 cm). Experiments were videotaped and the following behaviors were scored for the following 30 min: aimless hyper locomotor activity (aHLMA), abduction of hind limbs (HLA), flat body posture (FBP), head twiches/tremor (HT), body tremor (BT). Each behavior was scored either present (scored = 1) or absent (scored = 0) by an observer blind to the drug treatment.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Forced Swimming Test</h4><div class="NLM_p">The mouse forced swimming test (Porsolt et al., 1977) is widely used as an animal model for detecting and screening antidepressant activity. Mice were dropped individually into glass cylinders (height 25 cm, diameter 10 cm) containing 10 cm water maintained at 25 ± 1 °C and left there for 6 min. A mouse was judged immobile when it floated in an upright position and made only small movements to keep its head above water. The duration of immobility was recorded during the last 4 min of the 6 min testing period. All experiments were videotaped, and an observer who was unaware of the drug treatment scored immobility.</div><div class="NLM_p last">Compound <b>15</b> was administered orally 120 min before test.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Spontaneous Locomotor Activity</h4><div class="NLM_p last">Spontaneous locomotor activity was measured by using activity boxes equipped with infrared monitoring sensors (AccuScan model RXYZXCM-16, Columbus, OH). Each box (40 cm × 40 cm × 30.5 cm) was made of clear plexiglas and covered with a plexiglas lid with air-holes with infrared sensors located along the perimeter 2.5 cm above the floor. Data were collected and analyzed (AccuScan model CDA-8, Columbus, OH). Animals were treated orally with compound <b>15</b> 120 min before test, and spontaneous locomotor activity quantified as total distance traveled, was recorded over 30 min.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> MD and Locomotor Activity Data</h4><div id="sec4_1_13_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Animals</h5><div class="NLM_p last">Male CD rats (Charles River, Italy), weighing between 280 and 310 g at the beginning of the experiment, were housed in constant conditions of temperature (21 ± 1 °C) and moisture, under a 12 h light/dark cycle with water and food available ad libitum. They were handled every day to get accustomed to manipulation and presence of researchers.</div></div><div id="sec4_1_13_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Intracerebral Microdialysis Surgery</h5><div class="NLM_p last">Animals were anesthetized with proper concentrations of medetomidine hydrochloride (Domitor) and Xylazine (Zoletil) while Carpofren (Rymadil) was injected to induce analgesia. They were then placed on a stereotaxic apparatus for small animals. A guide cannula was lowered and positioned above the left medial prefrontal cortex (anteroposterior 3.2 mm; lateral 0.5 mm; dorsoventral 1.8 mm from bregma) or nucleus accumbens (anterior: + 1.7 mm; ventral: −6.0 mm; mediolateral: 1.2 mm from bregma) and secured to the skull using dental cement, anchored by four stainless steel screws. A removable stainless steel stylet was placed inside the cannula to maintain its patency throughout the experimental period. Following surgery, the animals were injected with atipamezole hydrochloride (antisedan), and rubrocillin antibiotic and housed in single cages for one week to recover.</div></div><div id="sec4_1_13_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Microdialysis Experiment</h5><div class="NLM_p last">The day before the experiment the stylette was removed from the guide cannula and a microdialysis probe with a 4-mm-long membrane was inserted (MAB 4 Agntho’s, Sweden). The following day microdialysis experiments were performed in their home cage. Both inlet and outlet of the probe were attached with FEP tubings (dead volume 1.2 μL/10 cm) to a dual quartz lined two-channel liquid swivel (model 375/D/22QM Instech Laboratories, Plymouth Meeting PA) mounted on a low mass spring counterbalanced arm (MCLA, Instech). One channel was connected to a gastight syringe (Hamilton 1002 LTN 2.5 mL, Bonaduz, Switzerland) on a microinfusion pump (the Univentor 802 syringe pump) to deliver artificial cerebrospinal fluid (KCl 2.5 mM, NaCl 125 mM, CaCl<sub>2</sub> 1.3 mM, MgCl<sub>2</sub> 1.18 mM, Na<sub>2</sub>HPO<sub>4</sub> 2 mM, pH 7.4 with H<sub>3</sub>PO<sub>4</sub> 85%) at a steady flow rate of 1.1 μL/min, and the second channel was connected to a refrigerated fraction collector (Univentor 820 Microsampler) containing microtubes with 3 μL of 1 mM oxalic acid solution. Length of the outlet tubing was calculated to achieve a 20 min delay of sample collection. Samples were collected every 20 min and frozen in dry ice for subsequent HPLC analysis. Two hours of perfusion were allowed before starting the experiment.</div></div><div id="sec4_1_13_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Probe Localization</h5><div class="NLM_p last">The position of the probe in the brain areas was verified at the end of each experiment. A blue dye was injected through a probe without the dialysis membrane and the brains were then removed and coronally sectioned at the level of the PFC or NAc. Trace localization was visually identified through comparison with a stereotaxic atlas of rat brain (Paxinos and Watson, 2005). Animals with incorrect probe position were discarded from the final analysis.</div></div><div id="sec4_1_13_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> HPLC Procedure</h5><div class="NLM_p last">NA, DA, and 5-HT concentrations were determined in dialysate samples by HPLC with electrochemical detection (Antec Decade). Separation was achieved using a mobile phase consisting of 12 mM Na<sub>2</sub>HPO<sub>4</sub>, 88 mM NaH<sub>2</sub>PO<sub>4</sub>, 5 mM NaCl, 0.1 mM EDTA·Na<sub>2</sub>, 20% MeOH, 10% MeCN, pH 6.00 ± 0.05. Chromatographic data were acquired and processed through Empower software.</div></div><div id="sec4_1_13_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> Data Analysis</h5><div class="NLM_p">For each animal absolute neurochemical data in pg were transformed in % values vs average of the three basal values. They were preliminary analyzed with 2D Box and Whiskers plot to determine and eliminate outlier and extreme values. Data eliminated were substituted with the mean of the same group at the same time. Final data were analyzed with two-way ANOVA for repeated measures with treatment and time as factors. Whenever allowed, preplanned post hoc multiple comparisons were applied to compare time points of different treatments.</div><div class="NLM_p last">Concurrent general motor activity was measured through an automated digital video analysis of animal movements (ViewPoint). Data were analyzed as previously described for microdialysis data.</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Chemical Procedures. General</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Experimental Section</h4><div class="NLM_p">Proton magnetic resonance (NMR) spectra are typically recorded either on Varian instruments at 300, 400, or 500 MHz or on a Bruker instrument at 300 and 400 MHz. Chemical shifts are expressed in δ (ppm) units, and peak multiplicity are expressed as follows: singlet (s), doublet (d), doublet of doublets (dd), triplet (t), multiplet (m), broad singlet (br s), broad multiplet (br m).The NMR spectra were recorded at a temperature ranging from 25 to 90 °C. When more than one conformer was detected, the chemical shifts for the most abundant one was reported.</div><div class="NLM_p">Mass spectra (MS) are typically taken on a 4 II triple quadrupole mass spectrometer (Micromass UK) or on a Agilent MSD 1100 mass spectrometer, operating in ES (+) and ES (−) ionization mode or on an Agilent LC/MSD 1100 mass spectrometer, operating in ES (+) and ES (−) ionization mode coupled with HPLC instrument Agilent 1100 series [LC/MS−ES (+):analysis performed on a Supelcosil ABZ +Plus (33 mm × 4.6 mm, 3 μm) (mobile phase: 100% [water + 0.1% HCO<sub>2</sub>H] for 1 min, then from 100% [water + 0.1% HCO<sub>2</sub>H] to 5% [water + 0.1% HCO<sub>2</sub>H] and 95% [CH<sub>3</sub>CN ] in 5 min, finally under these conditions for 2 min; <i>T</i> = 40 °C; flux = 1 mL/min; LC/MS−ES ( ): analysis performed on a Supelcosil ABZ +Plus (33 mm × 4.6 mm, 3 μm) (mobile phase: 100% [water + 0.05% NH<sub>3</sub>] for 1 min, then from 100% [water + 0.05% NH<sub>3</sub> to 5% [water + 0.05% NH<sub>3</sub>] and 95% [CH<sub>3</sub>CN ] in 5 min, finally under these conditions for 2 min; <i>T</i> = 40 °C; flux = 1 mL/min]; in the mass spectra, only one peak in the molecular ion cluster is reported.</div><div class="NLM_p">DAD chromatographic traces, mass chromatograms, and mass spectra may be taken on a on a UPLC/MS Acquity system coupled with a Micromass ZQ mass spectrometer operating in ESI positive or negative. The phases used are: (A) H<sub>2</sub>O/ACN 95/5 + 0.1% TFA; (B) H<sub>2</sub>O/ACN 5/95 + 0.1% TFA. The gradient is: <i>t</i> = 0 min, 95%A 5%B; <i>t</i> = 0.25, 95%A 5%B; <i>t</i> = 3.30, 100%B, <i>t</i> = 4.0) 100%B, followed by 1 min of reconditioning.</div><div class="NLM_p">Flash silica gel chromatography was carried out on silica gel 230−400 mesh (supplied by Merck AG Darmstadt, Germany) or over Varian Mega Be−Si prepacked cartridges or over prepacked Biotage silica cartridges. SPE-SCX cartridges are ion exchange solid phase extraction columns supplied by Varian. The eluent used with SPE-SCX cartridges is methanol followed by 2N ammonia solution in methanol. In a number of preparations, purification was performed using either Biotage manual flash chromatography (Flash+) or automatic flash chromatography (Horizon, SP1) systems. All these instruments work with Biotage Silica cartridges. SPE-Si cartridges are silica solid phase extraction columns supplied by Varian.</div><div class="NLM_p">The enantiomeric purity of each single enantiomer obtained after preparative chromatography on chiral columns was always verified on analytical column.</div><div class="NLM_p last">The purity of the compounds reported in the manuscript was established through HPLC methodology. All the compounds reported in the manuscript have a purity >95%.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> General Synthetic Procedures</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-(3,4-Dichlorophenyl)-1<i>H</i>-pyrrole-2,5-dione (<b>62</b>)</h4><div class="NLM_p last">To a stirred slurry of maleimide (<b>61</b>), anhydrous CuCl<sub>2</sub> and <i>tert</i>-butyl nitrite in CH<sub>3</sub>CN at 0 °C a solution of 3,4-dichloro aniline in CH<sub>3</sub>CN was added dropwise. The reaction mixture was stirred at room temperature for 1 h, and 20% aqueous HCl was added. The mixture was extracted with ethyl acetate, and the organic layer was washed with saturated aqueous NaCl and dried over Na<sub>2</sub>SO<sub>4</sub>. To a solution of the crude obtained in 2-propanol, 2,6-lutidine was added and the mixture was warmed at reflux for 30 min. After elimination of the solvent under vacuum, the crude was dissolved in ethyl acetate and the organic phase washed with water and dried over sodium sulfate. The organic phase was concentrated under vacuum and the crude treated with diethyl ether. The solid was filtrated and dried under vacuum to give the title compound as brown solid. MS <i>m</i>/<i>z</i> 241 [M − H]<sup>−</sup>.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Ethyl-1-(3,4-dichlorophenyl)-2,4-dioxo-3-azabicyclo[3.1.0]hexane-6-carboxylate (<b>63</b>)</h4><div class="NLM_p last">Sodium hydroxide 60% in mineral oil was added in small portions to a stirred solution of (ethoxycarbonylmethyl)-dimethylsulfonium bromide in anhydrous DMSO (20 mL). The resulting mixture was allowed to stir at room temperature for 1.5 h and then 3-(3,4-dichlorophenyl)-1<i>H</i>-pyrrole-2,5-dione (<b>62</b>) dissolved in DMSO (20 mL) was added dropwise, and the resulting mixture was stirred at room temperature for 1 min. Reaction temperature was brought to 0 °C, and aqueous saturated NH<sub>4</sub>Cl was slowly added, followed by Et<sub>2</sub>O. After separation of the two phases, the organic layer was washed twice with water and brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. Evaporation of the solvent under vacuum gave a crude compound which was purified by flash chromatography (eluting with ethyl acetate/cycloesane 20:80) to give the title compound. MS <i>m</i>/<i>z</i> 326 [M − H]<sup>−</sup>.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> [1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hex-6-yl]methanol (<b>2</b>)</h4><div class="NLM_p last">To a stirred solution of <b>63</b> in of dry THF, BH<sub>3</sub>−THF complex in THF was slowly added at 0 °C under N<sub>2</sub>. The reaction mixture was refluxed for 6 h and then cooled to 0 °C, and aqueous HCl was added cautiously and the reaction mixture stirred for 1 h. The solvent was partially removed under vacuum, and the residue was loaded on mixed-mode strong cation exchange (MCX) column eluting with NH<sub>3</sub>/MeOH (2M). The methanolic phase was evaporated under vacuum and the crude was purified by flash chromatography and separated through chiral HPLC to give the title compound. NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ 7.40 (m, 2H), 7.38 (d, 1H), 7.14 (dd, 1H), 3.51 (dd, 1H), 3.41 (dd, 1H), 3.32 (d, 1H), 3.12 (m, 2H), 2.91 (d, 1H), 1.69 (m, 1H), 1.39 (m, 1H). MS <i>m</i>/<i>z</i> 258 [MH]<sup>+</sup>.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(3,4-Dichlorophenyl)-6-[(methyloxy)methyl]-3-azabicyclo[3.1.0]hexane (<b>4</b>)</h4><div class="NLM_p">To a stirred solution of <b>2</b> in dichloromethane at room temperature, triethylamine and bis(1,1-dimethylethyl) dicarbonate were added. Stirring was continued for 6 h, and then the reaction mixture was concentrated under vacuum and the crude product treated with dichloromethane and bicarbonate. The organic phase was dried over sodium sulfate and the solvent evaporated under vacuum to give a crude product. To a stirred solution of this crude material in dry DMF, sodium hydride was added at 0 °C and the reaction mixture stirred at room temperature for 1 h. Methyl iodide was added, and the reaction mixture was stirred at room temperature for 4 h. Ethyl acetate and water were added and the organic phase separated, washed with brine, dried over sodium sulfate, and the solvent evaporated under vacuum to give a crude product. To a solution of this crude in DCM, TFA was added. The reaction mixture was stirred at room temperature for 1 h, it was concentrated in vacuo and the crude product was loaded on SCX column eluting with MeOH/NH<sub>3</sub>. The crude material obtained was purify by flash chromatography (eluting with dichloromethane/methanol/ammonia aq 95:5:0.5) to give 5 mg of the title compound as white oil. This was submitted to semipreparative HPLC to give the separated enantiomers by using a chiral column chiralpak AD-H, eluent A: <i>n</i>-hexane; B: ethanol, gradient isocratic 18% B, flow rate 14 mL/min, detection UV at 230 nm. Retention times given were obtained using an analytical HPLC using a chiral column chiralpak AD-H, 25 cm × 4.6 cm, eluent A: <i>n</i>-hexane; B: ethanol, gradient isocratic 20% B, flow rate 0.8 mL/min, detection UV at 230 nm. NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ 7.41 (d, 1H), 7.39 (d, 1H), 7.16 (dd, 1H), 3.30 (d, 1H), 3.21 (s, 3H), 3.20−3.10 (m, 4H), 3.90 (d, 1H), 1.74 (m, 1H), 1.37 (m, 1H). MS <i>m</i>/<i>z</i> 272 [MH]<sup>+</sup>. Retention time = 8.54 min.</div><div class="NLM_p last">Other compounds were prepared similarly. Further details can be found in refs <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">12</a> and <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a>.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 6-{[(Cyclopropylmethyl)oxy]methyl}-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane (<b>9</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, DMSO): δ 9.86−8.13 (br s, 2H), 7.73.7.70 (d, 1H), 7.62−7.58 (d, 1H), 7.42−7.36 (dd, 1H), 3.81−3.70 (d, 1H), 3.52−3.45 (dd, 1H), 3.41−3.36 (d, 1H), 3.28−3.22 (dd, 1H), 3.20−3.14 (d, 1H), 3.09−3.02 (dd, 1H), 2.95−2.80 (m, 2H), 2.24−2.14 (m, 1H), 1.68−1.54 (m, 1H), 0.88−0.74 (m, 1H), 0.45−0.20 (m, 2H), −0.06−0.09 (m, 2H). Retention time = 7.54 min.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-(3,4-Dichlorophenyl)-6-[(propyloxy)methyl]-3-azabicyclo[3.1.0]hexane (<b>13</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ 9.24 (br s 2H), 7.72 (d, 1H), 7.60 (d, 1H), 7.39 (dd, 1H), 3.78 (d, 1H), 3.50 (dd, 1H), 3.40 (d, 1H), 3.23 (m, 1H), 3.16 (m, 2H), 2.97 (m, 1H), 2.91 (dd, 1H), 2.22 (m, 1H), 1.66 (m, 1H), 1.34 (m, 2H), 0.73 (t, 3H). MS <i>m</i>/<i>z</i> 300 [MH]<sup>+</sup>. Retention time = 5.49 min.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-(3,4-Dichlorophenyl)-6-[(ethyloxy)methyl]-3-azabicyclo[3.1.0]hexane (<b>15</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ 7.43 (s, 1H), 7.37 (d, 1H), 7.18 (d, 1H), 3.41−3.20 (m, 4H), 3.15 (s, 2H), 3.07 (m, 1H), 2.91 (d, 1H), 1.94 (m, 1H), 1.63 (m, 1H), 1.38 (m, 1H), 1.13 (t, 3H), NH not observed. MS <i>m</i>/<i>z</i> 286 [MH]<sup>+</sup>. Retention time = 7.0 min.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 6-[(Ethyloxy)methyl]-3-methyl-3-azabicyclo[3.1.0]hexane (<b>18</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ 7.42 (s, 1H), 7.35 (d, 1H), 7.15 (d, 1H), 3.38−3.28 (m, 2H), 3.26−3.12 (m, 3H), 3.05−2.97 (m, 1H), 2.54 (m, 1H), 2.33 (s, 3H), 2.32 (m, 1H), 1.98 (m, 1H), 1.61 (m, 1H), 1.07 (t, 3H). MS <i>m</i>/<i>z</i> 300 [MH]<sup>+</sup>.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-(3,4-Dichlorophenyl)-6-{[(2,2,2-trifluoroethyl)oxy]methyl}-3-azabicyclo[3.1.0]hexane (<b>20</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, CDCl<sub>3</sub>) δ 7.41 (m, 2H), 7.16 (d, 1H), 3.67−3.51 (m, 3H), 3.35 (d, 1H), 3.27 (t, 1H), 3.16 (m, 2H), 2.92 (d, 1H), 1.67 (s, 1H), 1.41 (m, 1H). MS <i>m</i>/<i>z</i> 340 [MH]<sup>+</sup>. Retention time = 6.0 min.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-(3,4-Dichlorophenyl)-6-{[(1-methylethyl)oxy]methyl}-3-azabicyclo[3.1.0]hexane (<b>23</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.48 (1 H, d), 7.39 (1 H, d), 7.19 (1 H, dd), 3.36−3.46 (2 H, m), 3.24−3.35 (3 H, m), 2.94−3.06 (2 H, m), 1.65−1.71 (1 H, m), 1.44−1.53 (1 H, m), 1.08 (3 H, d), 1.01 (3 H, d). MS <i>m</i>/<i>z</i> 300 [MH]<sup>+</sup>. Retention time = 8.6 min.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 6-[(Cyclobutyloxy)methyl]-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>25</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.42−7.49 (m, <i>J</i> = 1.26 Hz, 1 H), 7.16 (dd, <i>J</i> = 8.15, 1.45 Hz, 1 H), 3.65−3.78 (m, 1 H), 3.33 (d, <i>J</i> = 11.49 Hz, 1 H), 3.13−3.23 (m, 3 H), 2.87−3.04 (m, 2 H), 1.97−2.20 (m, 4 H), 1.80−1.92 (m, 1 H), 1.58−1.72 (m, 3 H), 1.33−1.51 (m, 2 H). MS <i>m</i>/<i>z</i> 312 [MH]<sup>+</sup>. Retention time = 7.9 min.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 6-[(Cyclopentyloxy)methyl]-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane (<b>28</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.46 (d, 1 H), 7.37 (d, 1 H), 7.17 (dd, 1 H), 3.60−3.68 (m, 1 H), 3.30−3.39 (m, 2 H), 3.13−3.17 (m, 2 H), 2.87−2.97 (m, 2 H), 1.30−1.86 (m, 11 H). MS <i>m</i>/<i>z</i> 326 [MH]<sup>+</sup>. Retention time = 5.2 min.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 6-[(Cyclohexyloxy)methyl]-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane (<b>30</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 10.43 (br s, 1 H), 9.72 (br s, 1 H), 7.51 (d, 1 H), 7.44 (d, 1 H), 7.20 (dd, 1 H), 3.69−3.79 (m, 1 H), 3.54−3.69 (m, 2 H), 3.31−3.42 (m, 2 H), 2.95−3.09 (m, 2 H), 1.98 (t, 1 H), 1.57−1.86 (m, 5 H), 1.44−1.53 (m, 1 H), 1.11−1.23 (m, 5 H). MS <i>m</i>/<i>z</i> 340 [MH]<sup>+</sup>.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-(3,4-Dichlorophenyl)-6-{[(4-fluorophenyl)oxy]methyl}-3-azabicyclo[3.1.0]hexane (<b>31</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.43 (s, 1 H), 7.36 (d, 1 H), 7.18 (d, 1 H), 6.92 (m, 2 H), 6.70 (m, 2 H), 3.82 (m, 1 H), 3.60 (m, 1 H), 3.36 (d, 1 H), 3.19 (s, 2 H), 2.95 (d, 1 H), 2.15 (bs, 1 H) 1.75 (m, 1 H), 1.58 (m, 1 H). MS <i>m</i>/<i>z</i> 352 [MH]<sup>+</sup>.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hex-6-yl]methyl}dimethylamine (<b>32</b>)</h4><div class="NLM_p last">To a stirred solution of <b>2</b> in dichloromethane at room temperature, triethylamine and bis(1,1-dimethylethyl) dicarbonate were added. Stirring was continued for 6 h and then the reaction mixture was diluted with dichloromethane and quenched with a saturated solution of NH<sub>4</sub>Cl. The organic phase was dried and the solvent evaporated under vacuum. Dess−Martin periodinane was added at 25 °C, and after 30 min, sodium thiosulfate and a saturated NaHCO<sub>3</sub> aqueous solution were added and the mixture was stirred at room temperature for 30 min. The mixture was then extracted with dichloromethane; the organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The compound was dissolved in dry tetrahydrofuran, and dimethylamine (0.349 mL), acetic acid (0.043 mL), and sodium triacetoxyborohydride (173 mg) were added at 25 °C. After 1 h stirring at room temperature, the mixture was concentrated in vacuo. Dichloromethane was then added, and the organic phase was washed with an aqueous saturated NaHCO<sub>3</sub> solution and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude material was purified by flash chromatography (Biotage Si 12S column, gradient cyclohexane/ethyl acetate from 90/10 to 0/100 and then ethyl acetate/methanol 100/1) to give the title compound as a colorless oil. NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.40−7.32 (m, 2 H), 7.09 (m, 1 H), 3.30 (d, 1 H), 3.15 (s, 2H), 2.96 (d, 1 H), 2.40 (m, 1 H), 2.20 (s, 6 H), 2.19 (bs, 1 H), 1.75−1.62 (m, 2 H), 1.20 (m, 1 H). MS <i>m</i>/<i>z</i> 285 [MH]<sup>+</sup>.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 1-(3,4-Dichlorophenyl)-6-[(methylthio)methyl]-3-azabicyclo[3.1.0]hexane (<b>34</b>)</h4><div class="NLM_p">To a stirred solution of <b>2</b> in dichloromethane at room temperature, triethylamine and bis(1,1-dimethylethyl) dicarbonate were added. Stirring was continued for 6 h and then the reaction mixture was diluted with dichloromethane and quenched with a saturated solution of NH<sub>4</sub>Cl. The organic phase was dried and the solvent evaporated under vacuum. The compound was dissolved in THF, and triethylamine and methanesulfonyl chloride were added at 0 °C. The reaction mixture was stirred at 25 °C for 1 h, and then water was added and the mixture was extracted with dichloromethane. The organic phase was washed with an aqueous saturated NH<sub>4</sub>Cl solution, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. It was dissolved in dry <i>N</i>,<i>N</i>-dimethylformamide, and sodium thiomethoxide was added. The mixture was stirred overnight at room temperature. An aqueous saturated NaHCO<sub>3</sub> solution was then added, and the mixture was extracted with dichloromethane. The organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo and dissolved in dry dichloromethane; trifluoroacetic acid was added at room temperature. After 30 min, the reaction mixture was concentrated in vacuo and the residue was purified by a SCX cartridge to give the title compound.</div><div class="NLM_p last">The enantiomers of the title compound were separated by chiral HPLC by using a chiral column Chiralcel OJ-H (25 cm × 0.46 cm), eluent A: <i>n</i>-hexane; B: 2-propanol + 0.1% isopropylamine, isocratic 4% B, 10% B from 27 min, flow rate 1 mL/min, detection UV at 210−340 nm, CD 230 nm. Retention times given were obtained using an analytical HPLC using a chiral column Chiralcel OJ-H (25 cm × 0.46 cm), eluent A: <i>n</i>-hexane; B: 2-propanol + 0.1% isopropylamine, isocratic 4% B, flow rate 1 mL/min, detection UV at 210−340 nm, CD 230 nm. NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.42−7.32 (m, 2 H), 7.11 (m, 1 H), 3.32 (d, 1 H), 3.17 (s, 2H), 2.95 (d, 1 H), 2.40 (m, 1 H), 2.20−2.10 (m, 1 H), 2.10 (s, 3 H), 2.06 (bs, 1 H), 1.68 (m, 1 H), 1.32 (m, 1 H). MS <i>m</i>/<i>z</i> 288 [MH]<sup>+</sup>. Retention time = 17.2 min.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-(3,4-Dichlorophenyl)-6-propyl-3-azabicyclo[3.1.0]hexane (<b>36</b>)</h4><div class="NLM_p last">To a stirred solution of <b>2</b> in dichloromethane at room temperature, triethylamine and bis(1,1-dimethylethyl) dicarbonate were added. Stirring was continued for 6 h and then the reaction mixture was diluted with dichloromethane and quenched with a saturated solution of NH<sub>4</sub>Cl. The organic phase was dried, and the solvent evaporated under vacuum. The compound was dissolved in THF, and triethylamine and methanesulfonyl chloride were added at 0 °C. The reaction mixture was stirred at 25 °C for 1 h, and then water was added and the mixture was extracted with dichloromethane. The organic phase was washed with an aqueous saturated NH<sub>4</sub>Cl solution, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The compound was dissolved in THF and added to a stirred solution of copper(I) bromide−dimethylsulfide complex and EtMgBr 3 M in diethyl ether kept at −78 °C for 30 min. The mixture was heated to room temperature and stirred for 3 h. The reaction mixture was quenched saturated NH<sub>4</sub>Cl aqueous solution and filtered off through celite. The filtrate was washed with an ammonia solution and extracted with ethyl acetate. The extract was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue dissolved in CH<sub>2</sub>Cl<sub>2</sub>, and TFA was added at 0 °C. The reaction was left for 2 h at rt, and it was concentrated in vacuo; the residue was purified by a SCX cartridge. NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 9.66 (bs, 1H), 7.45 (d, 1 H), 7.30 (d, 1H), 7.09 (m, 1 H), 3.70 (d, 1 H), 3.56 (m, 2H), 3.36 (bs, 1H), 1.8 (s, 1 H), 1.48 (s, 1 H), 1.38−1.28 (m, 3 H), 0.90−0.78 (m, 3 H). MS <i>m</i>/<i>z</i> 271 [MH]<sup>+</sup>. Retention time = 17.2 min.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 6-[(Methyloxy)methyl]-1-(2-naphthalenyl)-3-azabicyclo[3.1.0]hexane (<b>39</b>)</h4><div class="NLM_p last">The racemate was separated by SFC HPLC using a chiral column Chiralcel OD-H, 25 cm × 0.46 cm, eluent ethanol + 0.1% isopropylamine 25%, flow rate 2 mL/min, detection UV at 230 nm. Retention time = 12.7 min. NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ 7.86−7.76 (m, 4H), 7.52−7.45 (m, 3H), 3.44 (d, 1H), 3.28−3.25 (m, 3H), 3.19 (s, 3H), 3.15−3.04 (m, 2H), 1.84 (m, 1H), 1.45 (m, 1H).</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hex-6-yl]ethanol (<b>40</b>)</h4><div class="NLM_p">To a stirred solution of <b>2</b> in dichloromethane at room temperature, triethylamine and bis(1,1-dimethylethyl) dicarbonate were added. Stirring was continued for 6 h and then the reaction mixture was diluted with dichloromethane and quenched with a saturated solution of NH<sub>4</sub>Cl. The organic phase was dried and the solvent evaporated under vacuum. Dess−Martin periodinane was added at 25 °C, and after 30 min, sodium thiosulfate and a saturated NaHCO<sub>3</sub> aqueous solution were added and the mixture was stirred at room temperature for 30 min. The mixture was then extracted with dichloromethane; the organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give the crude <b>64</b>. To a stirred suspension of methyl(triphenyl)phosphonium bromide in THF at 0 °C, butyllithium (2.5 M in hexane) was added dropwise. The dark-yellow reaction mixture was allowed to reach room temperature and stirred for 20 min and then cooled to 0 °C, and the above-described crude <b>64</b> in THF was added dropwise. The ice-bath was removed and the reaction mixture stirred for 6 h at room temperature. Diethyl ether and water were added, the organic phase was dried on sodium sulfate, the solvent evaporated <i>under vacuum</i>, and the crude product was purified by flash chromatography to achieve intermediate <b>65</b>. The intermediate was dissolved in THF at 0 °C, and under a nitrogen atmosphere, BH<sub>3</sub>−THF complex (1 M in THF) was added dropwise. The ice-bath was removed and the reaction mixture stirred for 3.5 h at room temperature. The mixture was cooled to 0 °C and quenched by adding water. Then 3 M NaOH and 30% H<sub>2</sub>O<sub>2</sub> were added and the resulting mixture stirred for 0.5 h. The reaction mixture was diluted with water and extracted with ethyl acetate; the organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent removed under reduced pressure. The compound was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, and TFA was added at room temperature. After 1 h, the reaction mixture was evaporated under vacuum, the residue dissolved in methanol, and 1 M NaOH was added. After 0.5 h, the solvent was removed under vacuum and the residue dissolved in CH<sub>2</sub>Cl<sub>2</sub>. The organic phase was separated through a separator phase cartridge and the solvent evaporated under reduced pressure to give the title compound.</div><div class="NLM_p last">NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.38 (d, 1 H) 7.32−7.34 (m, 1 H) 7.08 (dd, 1 H) 3.59−3.63 (m, 2 H) 3.31 (d, 1 H) 3.10−3.13 (m, 2 H) 2.93 (d, 1 H) 1.68 (none, 18 H) 1.50−1.61 (m, 2 H) 1.08−1.30 (m, 3 H). MS <i>m</i>/<i>z</i> 272 [MH]<sup>+</sup>.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 1-(3,4-Dichlorophenyl)-6-[2-(methyloxy)ethyl]-3-azabicyclo[3.1.0]hexane (<b>42</b>)</h4><div class="NLM_p last">To a stirred solution of <b>40</b> in THF, at room temperature, NaH (60% in oil) was added portion wise. After 20 min, methyl iodide was added dropwise and the resulting reaction mixture was stirred overnight. Diethyl ether and aqueous saturated NH<sub>4</sub>Cl were added, the organic phase washed with brine, dried on Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure to give the crude N-Boc intermediated. This product was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, TFA was added, and the reaction mixture was stirred at room temperature for 1 h. After this period of time, the mixture was evaporated under reduced pressure and the residue dissolved in CH<sub>2</sub>Cl<sub>2</sub>, washed with 1 M NaOH, and separated through a phase separator cartridge. The organic phase was evaporated under reduced pressure to give the title compound as an oil which was submitted to semipreparative chiral chromatography (column: Chiralcel OD-H (25 cm × 0.46 cm), mobile phase: <i>n</i>-hexane/2-propanol 95/5% v/v; flow rate: 1.0 mL/min; DAD: 210−340 nm; CD: 230 nm). NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.37 (dd, 1 H) 7.31−7.34 (m, 1 H) 7.07 (dd, 1 H) 3.25−3.36 (m, 6 H) 3.06−3.12 (m, 2 H) 2.91 (d, 1 H) 1.49−1.59 (m, 2 H) 1.23−1.30 (m, 2 H). MS <i>m</i>/<i>z</i> 286 [MH]<sup>+</sup>. Retention time = 18.8 min.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 1-(3,4-Dichlorophenyl)-6-[2-(ethyloxy)ethyl]-3-azabicyclo[3.1.0]hexane (<b>44</b>)</h4><div class="NLM_p last">Prepared in analogy to <b>42</b>. NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.37 (d, 1 H) 7.32 (d, 1 H) 7.04−7.10 (m, 1 H) 3.39−3.47 (m, 2 H) 3.28−3.39 (m, 3 H) 3.10−3.15 (m, 2 H) 2.93 (d, 1 H) 1.55−1.60 (m, 2 H) 1.15−1.21 (m, 4 H) 0.89−0.94 (m, 1 H). MS <i>m</i>/<i>z</i> 300 [MH]<sup>+</sup>.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 1-(3,4-Dichlorophenyl)-6-[(5-methyl-1,3-oxazol-2-yl)methyl]-3-azabicyclo[3.1.0]hexane (<b>45</b>)</h4><div class="NLM_p last">To a stirred solution of <b>2</b> in dichloromethane at room temperature, triethylamine and bis(1,1-dimethylethyl) dicarbonate were added. Stirring was continued for 6 h, and then the reaction mixture was diluted with dichloromethane and quenched with a saturated solution of NH<sub>4</sub>Cl. The organic phase was dried and the solvent evaporated under vacuum. The compound was dissolved in acetone, and at 0 °C, Jones reagent was added dropwise. After quenching and recovery of the product, the compound was dissolved in CH<sub>2</sub>Cl<sub>2</sub>; 1-hydroxybenzotriazole monohydrate and <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride were added. Subsequently, propargyl amine was added dropwise and the reaction mixture was stirred at rt overnight. After quenching and work up, the crude product was dissolved in glacial acetic acid, mercury(II) acetate was added, and the reaction mixture was heated to 110 °C and stirred for 2.5 h. The solvent was removed under vacuum and the residue dissolved in ethyl acetate. The organic phase was washed with saturated NaHCO<sub>3</sub> and then brine and dried over sodium sulfate. The solvent was evaporated under reduced pressure to give a crude product, which was purified by flash chromatography. This compound was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, TFA was added, and the reaction mixture was stirred at rt for 1 h. The reaction mixture was concentrated under reduced pressure and the residue was partitioned between DCM and saturated aqueous NaHCO<sub>3</sub>. The mixture was passed through a phase separator cartridge and the organic phase evaporated to give crude title compound. NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.30−7.40 (m, 2 H) 7.05−7.10 (m, 1 H) 6.58−6.61 (m, 1 H) 2.91−3.45 (m, 4 H) 2.40−2.61 (m, 2 H) 2.20−2.30 (m, 3 H) 1.72−1.79 (m, 1 H) 1.48−1.59 (m, 1 H)). MS <i>m</i>/<i>z</i> 323.05 [MH]<sup>+</sup>.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-(3,4-Dichlorophenyl)-6-(4-methyl-1,3-thiazol-2-yl)-3-azabicyclo[3.1.0]hexane (<b>46</b>)</h4><div class="NLM_p last">To a stirred solution of <b>2</b> in dichloromethane at room temperature, triethylamine and bis(1,1-dimethylethyl) dicarbonate were added. Stirring was continued for 6 h and then the reaction mixture was diluted with dichloromethane and quenched with a saturated solution of NH<sub>4</sub>Cl. The organic phase was dried and the solvent evaporated under vacuum. The compound was dissolved in acetone, and at 0 °C, Jones reagent was added dropwise. After quenching and work up, the compound was dissolved in AcOEt and <i>N</i>,<i>N</i>′-carbonyldiimidazole was added. The mixture was stirred for 1.5 h at rt. The mixture was then cooled to 0 °C, and concentrated NH<sub>4</sub>OH was added. After quenching and recovery of the compound, Lawesson’s reagent was used to prepare the corresponding thioamide, which was subsequently dissolved in toluene and chloroacetone was added. The reaction mixture was heated at 80 °C for 3 h. On cooling to room temperature, the solvent was removed under vacuum and the residue taken up in CH<sub>2</sub>Cl<sub>2</sub>. TFA was added, and the reaction mixture was stirred for 2 h at rt. The reaction mixture was concentrated under reduced pressure, the residue dissolved in CH<sub>2</sub>Cl<sub>2</sub>, and purified using a SCX cartridge. NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.19−7.36 (m, 2 H) 7.01 (dd, 1 H) 6.47−6.61 (m, 1 H) 3.05−3.54 (m, 4 H) 2.67−2.73 (m, 1 H) 2.47−2.54 (m, 1 H) 2.30−2.34 (m, 3 H). MS <i>m</i>/<i>z</i> 325 [MH]<sup>+</sup>.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 1-(3,4-Dichlorophenyl)-6-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-azabicyclo[3.1.0]hexane (<b>47</b>)</h4><div class="NLM_p last">Derivative N-BOC protected derivative <b>40</b> was dissolved in acetone, and Jones reagent was added dropwise 0 °C. After quenching and work up, the compound was dissolved in EtOAc and <i>N</i>,<i>N</i>′-carbonyldiimidazole followed by concentrated NH<sub>4</sub>OH at 0 °C. To a stirred solution of the crude amide in THF at rt, Lawesson’s reagent was added portion wise. The mixture was heated to 80 °C and stirred for 3 h. The intermediate thioamide obtained was reacted with toluene, and the mixture was stirred for 3 h at 80 °C. The solution was concentrated under reduced pressure to give a residue. This product was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, TFA was added, and the reaction mixture was stirred at rt for 1 h. The reaction mixture was concentrated under reduced pressure and purified to give the title product. NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.31−7.41 (m, 2 H) 7.05−7.12 (m, 1 H) 6.70−6.74 (m, 1 H) 3.30−3.40 (m, 1 H) 3.12−3.19 (m, 2 H) 2.86−3.01 (m, 2 H) 2.56−2.66 (m, 1 H) 2.36−2.44 (m, 3 H) 1.74−1.79 (m, 1 H) 1.47−1.54 (m, 1 H). MS <i>m</i>/<i>z</i> 339 [MH]<sup>+</sup>.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 6-(3,4-Dichlorophenyl)-6-[(ethyloxy)methyl]-3-azabicyclo[3.1.0]hexane (<b>60</b>)</h4><div class="NLM_p last">To a solution of methyl diazo(3,4-dichlorophenyl)acetate in toluene, maleimide was added and the reaction mixture was refluxed for 4 h. The solvent was removed under reduce pressure, and the residue was purified via flash chromatography. To a solution of the compound thus obtained in dry THF, at 0 °C, BH<sub>3</sub>·THF complex 1 M in THF was added and then the reaction mixture was refluxed for 4 h. MeOH and HCl 1 M in Et<sub>2</sub>O were added, and the solution was stirred at rt overnight. The mixture was concentrated in vacuo, and the residue was purified by SCX cartridge. To a solution of this intermediate in CH<sub>2</sub>Cl<sub>2</sub> at 0 °C, di-<i>tert</i>-butyl dicarbonate was added and the reaction mixture was stirred at rt overnight. After quenching and work up, the crude was purified by flash chromatography (Si 25M) to afford two isomers. The exo (NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm: 7.48 (s, 1H), 7.41 (d, 1H), 7.23 (d, 1H), 3.91−3.84 (m, 2H), 3.75−3.60 (m, 4H), 2.03 (s, 2H), 1.49 (s, 9H), 1.32 (t, 1H)) one was in dry CH<sub>2</sub>Cl<sub>2</sub> and at 0 °C, TEA (40 μL) and methansulfonylchloride (28.6 μL) were added and the reaction mixture was stirred at rt overnight. After quenching and work up, the compound was dissolved in dry DMF and EtONa in dry DMF was added at 0 °C. The reaction mixture was stirred at rt for 3 h and then 1 h at 60 °C. Aqueous NH<sub>4</sub>Cl saturated solution was added and then extracted with Et<sub>2</sub>O. The combined organic phases were washed with aqueous NaCl saturated solution, dried, and concentrated in vacuo. To a solution of the compound in CH<sub>2</sub>Cl<sub>2</sub>, at 0 °C, TFA was added and then the reaction mixture was stirred at rt for 2 h. The solution was concentrated in vacuo, and the residue was purified by SCX cartridge to give the title compound. NMR (<sup>1</sup>H, CDCl<sub>3</sub>): δ ppm 7.39 (d, 1 H) 7.31 (d, 1 H) 7.14 (dd, 1 H) 3.78 (s, 2 H) 3.41−3.42 (m, 2 H) 3.27−3.33 (m, 2 H) 3.21−3.26 (m, 2 H) 1.87−1.94 (m, 2 H) 1.13 (t, 3 H). MS <i>m</i>/<i>z</i> 286 [MH]<sup>+</sup>.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 6-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane (<b>52</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, MeOD) δ ppm 7.59 (s, 1 H) 7.47 (d, 1 H) 7.31 (d, 1 H) 3.74−3.81 (m, 4 H) 3.49 (d, 2 H) 3.40−3.28 (m, 2 H) 2.42 (s, 2 H) 1.02 (t, 1 H) 0.52−0.50 (m, 2 H) 0.19−0.18 (m, 2 H). MS <i>m</i>/<i>z</i> 312 [MH]<sup>+</sup>.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 6-[(Cyclobutyloxy)methyl]-6-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane (<b>53</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, MeOD) δ ppm7.52−7.59 (m, 1 H) 7.48 (d, 1 H) 7.30 (dd, 1 H) 3.86−4.00 (m, 1 H) 3.78 (d, 2 H) 3.61 (s, 2 H) 3.37−3.49 (m, 2 H) 2.41 (s, 2 H) 0.78−2.25 (m, 6 H). MS <i>m</i>/<i>z</i> 312 [MH]<sup>+</sup>.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 6-(3,4-Dichlorophenyl)-6-{[(2,2,2-trifluoroethyl)oxy]methyl}-3-azabicyclo[3.1.0]hexane (<b>54</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.70 (bs, 1 H) 9.43 (bs, 1 H) 7.58 (m, 2 H) 7.29 (d, 1 H) 4.09 (q, 2 H) 3.94 (s, 2 H) 3.64 (m, 2 H) 3.31 (m, 2 H) 2.39 (s, 2 H). MS <i>m</i>/<i>z</i> 340 [MH]<sup>+</sup>.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 6-(3,4-Dichlorophenyl)-6-{[(1-methylpropyl)oxy]methyl}-3-azabicyclo[3.1.0]hexane (<b>55</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, CDCl<sub>3</sub>)) δ ppm 7.46 (s, 1 H) 7.36 (d, 1 H) 7.18 (d, 1 H) 3.72−3.87 (dd, 2 H) 3.22−3.36 (m, 5 H) 1.95 (s, 2 H) 1.35−1.60 (m, 2 H) 1.09 (d, 3 H) 0.85 (t, 3 H).</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 6-(3,4-Dichlorophenyl)-6-[2-(methyloxy)ethyl]-3-azabicyclo[3.1.0]hexane Hydrochloride (<b>56</b>)</h4><div class="NLM_p last">To a solution of methyl diazo(3,4-dichlorophenyl)acetate in toluene, maleimide was added and the reaction mixture was refluxed for 4 h. The solvent was removed under reduced pressure, and the residue was purified via flash chromatography. To a solution of the compound thus obtained in dry THF, at 0 °C, BH<sub>3</sub>·THF complex 1 M in THF was added and then the reaction mixture was refluxed for 4 h. MeOH and HCl 1 M in Et<sub>2</sub>O were added and the solution was stirred at rt overnight. The mixture was concentrated in vacuo, and the residue was purified by SCX cartridge. To a solution of this intermediate in CH<sub>2</sub>Cl<sub>2</sub> at 0 °C, di-<i>tert</i>-butyl dicarbonate was added and the reaction mixture was stirred at rt overnight. After quenching and work up, the crude was purified by flash chromatography (Si 25M) to afford two isomers. The exo isomer in dry CH<sub>2</sub>Cl<sub>2</sub> at 0 °C, was added with Dess−Martin periodinane portion wise, and then the reaction mixture was stirred at rt overnight. The compound thus obtained was dissolved in and added dropwise to a stirred solution of the preformed ylide obtained by addition of BuLi to methyltriphenylphosphonium bromide in dry THF at 0 °C. After quenching and work up, the compound was dissolved in dry THF at 0 °C, and borane THF complex 1 M in THF was added dropwise. The ice-bath was removed, and the reaction mixture was stirred for 3.5 h at rt. The solution was then quenched at 0 °C with water, and NaOH 3 M and H<sub>2</sub>O<sub>2</sub> were added; the resulting mixture was stirred at 0 °C for 0.5 h. After quenching and work up, the compound was dissolved in DMF, NaH was added at 0 °C, and the reaction mixture was stirred at rt for 30 min. Iodomethane was added to the reaction mixture, and then the temperature was increased to 40 °C. After quenching and work up, the crude was purified to give the title compound. NMR (<sup>1</sup>H, MeOD) δ ppm 7.40−7.60 (m, 2 H) 7.27 (dd, 1 H) 3.72 (d, 2 H) 3.42−3.57 (m, 2 H) 3.24−3.30 (m, 5 H) 2.24−2.36 (m, 2 H) 1.86 (t, 2 H). MS <i>m</i>/<i>z</i> 286 [MH]<sup>+</sup>.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 6-(3,4-Dichlorophenyl)-6-[2-(ethyloxy)ethyl]-3-azabicyclo[3.1.0]hexane (<b>57</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, CDCl<sub>3</sub>) δ ppm 10.35 (s, 1 H) 9.72 (s, 1 H) 7.33−7.44 (m, 2 H) 7.07−7.15 (m, 1 H) 3.70−3.84 (m, 2 H) 3.64 (d, 2 H) 3.40 (q, 2 H) 3.29 (t, 2 H) 2.17 (s, 2 H) 1.89 (t, 2 H) 1.08−1.27 (m, 3 H). MS <i>m</i>/<i>z</i> 300 [MH]<sup>+</sup>.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 6-(3,4-Dichlorophenyl)-6-{2-[(1-methylethyl)oxy]ethyl}-3-azabicyclo[3.1.0]hexane (<b>58</b>)</h4><div class="NLM_p last">NMR (<sup>1</sup>H, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.47−9.79 (m, 1 H) 8.81−9.08 (m, 1 H) 7.50−7.67 (m, 2 H) 7.16−7.37 (m, 1 H) 3.52−3.65 (m, 2 H) 3.36−3.47 (m, 1 H) 3.23−3.32 (m, 2 H) 3.13−3.23 (m, 2 H) 2.15−2.27 (m, 2 H) 1.73−1.85 (m, 2 H) 1.03 (d, 6 H). MS <i>m</i>/<i>z</i> 314 [MH]<sup>+</sup>.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/jm901818u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">An example of TRUI minimal pharmacophore construction. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901818u/suppl_file/jm901818u_si_001.pdf">jm901818u_si_001.pdf (105.32 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm901818u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51644" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51644" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Micheli</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cc8aadaebea5b6a5a3e289e281a5afa4a9a0a58cabbfa7e2afa3a1"><span class="__cf_email__" data-cfemail="cd8bacafbfa4b7a4a2e388e380a4aea5a8a1a48daabea6e3aea2a0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paolo Cavanni</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Arban</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Benedetti</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Bertani</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michela Bettati</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Letizia Bettelini</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giorgio Bonanomi</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simone Braggio</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Checchia</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Davalli</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romano Di Fabio</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elettra Fazzolari</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Fontana</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carla Marchioro</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Doug Minick</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span>; 
    <span class="hlFld-Affiliation affiliation">Molecular Discovery Research, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michele Negri</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beatrice Oliosi</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin D. Read</span> - <span class="hlFld-Affiliation affiliation">Biological Chemistry and Drug Discovery, College of Life Sciences, Sir James Black Centre, University of Dundee, Dundee DD1 5EH, Scotland, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ilaria Sartori</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanna Tedesco</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luca Tarsi</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Terreni</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Filippo Visentini</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro Zocchi</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Zonzini</span> - <span class="hlFld-Affiliation affiliation">Neurosciences Centre of Excellence for Drug Discovery</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52488" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52488" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank all the colleagues who helped in generating the data reported in this manuscript, in particular Dr. A. Feriani and Dr. D. Dal Ben. We also thank Dr. D. Donati, Dr. J. Hagan, and Dr. T. Rossi for their support during the programme life.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 13 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kulkarni, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhir, A.</span><span> </span><span class="NLM_article-title">Current investigational drugs for major depression</span> <span class="citation_source-journal">Exp. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=767-788&author=S.+K.+Kulkarniauthor=A.+Dhir&title=Current+investigational+drugs+for+major+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DS.%2BK.%26aulast%3DDhir%26aufirst%3DA.%26atitle%3DCurrent%2520investigational%2520drugs%2520for%2520major%2520depression%26jtitle%3DExp.%2520Opin.%2520Investig.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D767%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wong, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licinio, J.</span><span> </span><span class="NLM_article-title">From monoamines to genomic targets: a paradigm shift for drug discovery in depression</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=136-151&author=M.+L.+Wongauthor=J.+Licinio&title=From+monoamines+to+genomic+targets%3A+a+paradigm+shift+for+drug+discovery+in+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DM.%2BL.%26aulast%3DLicinio%26aufirst%3DJ.%26atitle%3DFrom%2520monoamines%2520to%2520genomic%2520targets%253A%2520a%2520paradigm%2520shift%2520for%2520drug%2520discovery%2520in%2520depression%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D136%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">The role of monoamines in the actions of established and “novel” antidepressant agents: a critical review</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">500</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1016%2Fj.ejphar.2004.07.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=15464046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFCksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=500&publication_year=2004&pages=371-384&author=M.+J.+Millan&title=The+role+of+monoamines+in+the+actions+of+established+and+%E2%80%9Cnovel%E2%80%9D+antidepressant+agents%3A+a+critical+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review</span></div><div class="casAuthors">Millan, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">500</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">371-384</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with refs.  Monoaminergic pathways are highly responsive to aversive stimuli and play a crucial role in the control of affect, cognition, endocrine secretion, chronobiotic rhythms, appetite, and motor function, all of which are profoundly disrupted in depressive states.  Accordingly, a perturbation of monoaminergic transmission is implicated in the etiol. of depressive disorders, and all clin. available antidepressants increase corticolimbic availability of monoamines.  However, their limited efficacy, delayed onset of action, and undesirable side effects underlie ongoing efforts to identify improved therapeutic agents.  Sequencing the human genome has raised the hope not only of better symptomatic control of depression, but even of the prevention or cure of depressive states.  In the pursuit of these goals, there is currently a tendency to focus on selective ligands of "novel" nonmonoaminergic targets.  However, certain classes of novel agent (such as neurokinin1 receptor antagonists) indirectly modulate the activity of monoaminergic networks.  Others may act "downstream" of them, converging onto common cellular substrates controlling gene expression, synaptic plasticity, and neuro-genesis.  Further, by analogy to the broad-based actions of currently employed drugs, multitarget agents may be better adapted than selective agents to the management of depression-a complex disorder with hereditary, developmental, and environmental origins.  It is, thus, important to continue the creative exploration of clin. validated and innovative monoaminergic strategies within a multitarget framework.  In this light, drugs combining monoaminergic and nonmonoaminergic mechanisms of action may be of particular interest.  The present article provides a crit. overview of monoaminergic strategies for the treatment of depressive states, both established and under development, and discusses interactions of novel "nonmonoaminergic" antidepressants with monoaminergic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX0IAhuXmLZLVg90H21EOLACvtfcHk0li0w132Z6bNDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFCksrs%253D&md5=3a3daa1e9f11b905a3117b73945f144c</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.07.038%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520role%2520of%2520monoamines%2520in%2520the%2520actions%2520of%2520established%2520and%2520%25E2%2580%259Cnovel%25E2%2580%259D%2520antidepressant%2520agents%253A%2520a%2520critical%2520review%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D500%26spage%3D371%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Nemeroff, C. B.</span><span> </span><span class="NLM_article-title">The burden of severe depression: a review of diagnostic challenges and treatment alternatives</span> <span class="citation_source-journal">J. Psychiatry Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1016%2Fj.jpsychires.2006.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=16870212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A280%3ADC%252BD28jitFyjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2007&pages=189-206&author=C.+B.+Nemeroff&title=The+burden+of+severe+depression%3A+a+review+of+diagnostic+challenges+and+treatment+alternatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">The burden of severe depression: a review of diagnostic challenges and treatment alternatives</span></div><div class="casAuthors">Nemeroff Charles B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">189-206</span>
        ISSN:<span class="NLM_cas:issn">0022-3956</span>.
    </div><div class="casAbstract">Among the factors making recognition of severe depression problematic for clinicians are the heterogeneous nature of the condition, lack of standardized definitions, and concomitant comorbidities that confound differential diagnosis of symptoms.  The spectrum of severity in depressive disorders is extraordinarily broad, and severity assessment is comprised of several metrics including symptom intensity, diagnostic subtypes, suicidality risk, and hospitalization status.  The overall diagnosis is achieved through consideration of symptom types and severities together with the degree of functional impairment as assessed by the psychiatric interview.  It is likely that no single fundamental neurobiological defect underlies severe depression.  The chronicity and heterogeneity of this disorder lead to frequent clinic visits and a longer course of treatment; therefore, successful approaches may require an arsenal of treatments with numerous mechanisms of action.  The categories of drugs used to treat severe depression are detailed herein, as are several non-pharmacologic options including a number of experimental treatments.  Pharmacotherapies include tricyclic antidepressants, selective serotonin reuptake inhibitors, atypical antidepressants such as serotonin-norepinephrine reuptake inhibitors and monoamine oxidase inhibitors, and combination and augmentation therapies.  Drugs within each class are not equivalent, and efficacy may vary with symptom severity.  Patient adherence makes tolerability another critical consideration in antidepressant choice.  The role of non-pharmacological treatments such as electroconvulsive therapy, vagus nerve stimulation, transcranial magnetic stimulation, and deep brain stimulation remain active avenues of investigation.  Improved knowledge and treatment approaches for severe depression are necessary to facilitate remission, the ideal treatment goal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTa1sdgx26OuvcsfMJQC1ZdfW6udTcc2eaB2a8YRv2qkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jitFyjsw%253D%253D&md5=139d46fa0bc3eb364c7ffb8f338e080b</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1016%2Fj.jpsychires.2006.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpsychires.2006.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DThe%2520burden%2520of%2520severe%2520depression%253A%2520a%2520review%2520of%2520diagnostic%2520challenges%2520and%2520treatment%2520alternatives%26jtitle%3DJ.%2520Psychiatry%2520Res.%26date%3D2007%26volume%3D41%26spage%3D189%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Arnt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyttel, J.</span><span> </span><span class="NLM_article-title">Pharmacology in vivo of the phenylindan derivative, Lu-19,005, a new potent inhibitor of dopamine, noradrenaline, and 5-hydroxytryptamine uptake in rat brain</span> <span class="citation_source-journal">Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1007%2FBF00501197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADyaL2MXksVyjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1985&pages=101-107&author=J.+Arntauthor=A.+V.+Christensenauthor=J.+Hyttel&title=Pharmacology+in+vivo+of+the+phenylindan+derivative%2C+Lu-19%2C005%2C+a+new+potent+inhibitor+of+dopamine%2C+noradrenaline%2C+and+5-hydroxytryptamine+uptake+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology in vivo of the phenylindan derivative, Lu 19005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain</span></div><div class="casAuthors">Arnt, Joern; Vibeke Christensen, Anne; Hyttel, John</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-7</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">Lu 19005 (I)  [97229-15-7] induced stereotyped behavior in rats after parenteral and oral administration with a duration of action of more than 24 h.  The stereotyped licking and biting induced by Lu 19005 was antagonized by reserpine and cis-(Z)-flupentixol, but not affected by prazosin, p-chlorophenylalanine and α-methyl-p-tyrosine pretreatments.  Metergoline slightly facilitated the onset of stereotypy.  Lower doses of Lu 19005 induced ipsilateral circling in unilaterally 6-hydroxydopamine-lesioned rats.  Lu 19005 antagonized the catalepsy induced by perphenazine.  In mice, Lu 19005 potentiated the apomorphine-induced gnawing, reversed tetrabenazine-induced ptosis and potentiated the behavioral effects of 5-HTP within a similar dose range.  The effects of Lu 19005 were compared with those of other ref. compds.  Nomifensine had qual. similar effects in rats although of much shorter duration.  In mice, nomifensine selectively reversed tetrabenazine-induced ptosis.  Weaker effects in all test models were found with bupropion, LR 5182 and GBR 13069, compds. with inhibitory effect on dopamine (DA)  [51-61-6] and noradrenaline (NA)  [51-41-2] uptake.  The DA-, NA- and 5-HT  [50-67-9]-uptake inhibitor diclofensine, however, had no effect in rats except in the 6-hydroxy-DA-circling test and had low potency in mice.  The specific 5-HT- and NA-uptake inhibitors citalopram and talsupram, resp., were ineffective in all rat models.  They selectively potentiated 5-HTP or reversed tetrabenazine-induced ptosis in mice, resp., as expected according to their in vitro profile.  Apparently, DA mechanisms are responsible for the behavioral activity of the test compds. in the rat models and the circling model is the most sensitive.  Since DA may be involved in some depressive states, Lu 19-005 could be an attractive new antidepressant as it combines the pharmacol. profile of established antidepressants (effect on NA and/or 5-HT uptake) with equipotent activity on DA uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYH_fmJknOFrVg90H21EOLACvtfcHk0li0w132Z6bNDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXksVyjtb4%253D&md5=91efaa8773f2ebdc1cb1fc1d58cd23fa</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1007%2FBF00501197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00501197%26sid%3Dliteratum%253Aachs%26aulast%3DArnt%26aufirst%3DJ.%26aulast%3DChristensen%26aufirst%3DA.%2BV.%26aulast%3DHyttel%26aufirst%3DJ.%26atitle%3DPharmacology%2520in%2520vivo%2520of%2520the%2520phenylindan%2520derivative%252C%2520Lu-19%252C005%252C%2520a%2520new%2520potent%2520inhibitor%2520of%2520dopamine%252C%2520noradrenaline%252C%2520and%25205-hydroxytryptamine%2520uptake%2520in%2520rat%2520brain%26jtitle%3DArch.%2520Pharmacol.%26date%3D1985%26volume%3D329%26spage%3D101%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnick, P.</span><span> </span><span class="NLM_article-title">Triple uptake inhibitors: therapeutic potential in depression and beyond</span> <span class="citation_source-journal">Expert Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1365</span><span class="NLM_x">–</span> <span class="NLM_lpage">1377</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=1365-1377&author=Z.+Chenauthor=P.+Skolnick&title=Triple+uptake+inhibitors%3A+therapeutic+potential+in+depression+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DTriple%2520uptake%2520inhibitors%253A%2520therapeutic%2520potential%2520in%2520depression%2520and%2520beyond%26jtitle%3DExpert%2520Opin.%2520Investig.%2520Drugs%26date%3D2007%26volume%3D16%26spage%3D1365%26epage%3D1377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rakofsky, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzheimer, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeroff, C. B.</span><span> </span><span class="NLM_article-title">Emerging targets for antidepressant therapies</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1016%2Fj.cbpa.2009.04.617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=19501541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVWlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=291-302&author=J.+J.+Rakofskyauthor=P.+E.+Holtzheimerauthor=C.+B.+Nemeroff&title=Emerging+targets+for+antidepressant+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging targets for antidepressant therapies</span></div><div class="casAuthors">Rakofsky, Jeffrey J.; Holtzheimer, Paul E.; Nemeroff, Charles B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-302</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Despite adequate antidepressant monotherapy, the majority of depressed patients do not achieve remission.  Even optimal and aggressive therapy leads to a substantial no. of patients who show minimal and often only transient improvement.  In order to address this substantial problem of treatment-resistant depression, a no. of novel targets for antidepressant therapy have emerged as a consequence of major advances in the neurobiol. of depression.  Three major approaches to uncover novel therapeutic interventions are: first, optimizing the modulation of monoaminergic neurotransmission; second, developing medications that act upon neurotransmitter systems other than monoaminergic circuits; and third, using focal brain stimulation to directly modulate neuronal activity.  We review the most recent data on novel therapeutic compds. and their antidepressant potential.  These include triple monoamine reuptake inhibitors, atypical antipsychotic augmentation, and dopamine receptor agonists.  Compds. affecting extra-monoamine neurotransmitter systems include CRF1 receptor antagonists, glucocorticoid receptor antagonists, substance P receptor antagonists, NMDA receptor antagonists, nemifitide, omega-3 fatty acids, and melatonin receptor agonists.  Focal brain stimulation therapies include vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), magnetic seizure therapy (MST), transcranial d.c. stimulation (tDCS), and deep brain stimulation (DBS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu5V4xl00lILVg90H21EOLACvtfcHk0ljiDBzZ5XPTLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVWlurw%253D&md5=c397dbd55b1527943fb35d204ddc057f</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2009.04.617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2009.04.617%26sid%3Dliteratum%253Aachs%26aulast%3DRakofsky%26aufirst%3DJ.%2BJ.%26aulast%3DHoltzheimer%26aufirst%3DP.%2BE.%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DEmerging%2520targets%2520for%2520antidepressant%2520therapies%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D13%26spage%3D291%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boules, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briody, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveros, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blazar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlier, P. R</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Antidepressant like pharmacological profile of a novel triple reuptake inhibitor, (1<i>S</i>,2<i>S</i>)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1124%2Fjpet.108.143610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=18689611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=573-583&author=Y.+Liangauthor=A.+M.+Shawauthor=M.+Boulesauthor=S.+Briodyauthor=J.+Robinsonauthor=A.+Oliverosauthor=E.+Blazarauthor=K.+Williamsauthor=Y.+Zhangauthor=P.+R+Carlier&title=Antidepressant+like+pharmacological+profile+of+a+novel+triple+reuptake+inhibitor%2C+%281S%2C2S%29-3-%28methylamino%29-2-%28naphthalen-2-yl%29-1-phenylpropan-1-ol+%28PRC200-SS%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)</span></div><div class="casAuthors">Liang, Yanqi; Shaw, Amanda M.; Boules, Mona; Briody, Siobhan; Robinson, Jessica; Oliveros, Alfredo; Blazar, Eric; Williams, Katrina; Zhang, Yiqun; Carlier, Paul R.; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-583</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Due to the putative involvement of dopaminergic circuits in depression, triple reuptake inhibitors are being developed as a new class of antidepressant, which is hypothesized to produce a more rapid onset and better efficacy than current antidepressants selective for serotonin or norepinephrine neurotransmission.  (1S,2S)-3-(Methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC 200SS), a new triple reuptake inhibitor, potently bound to the human serotonin, norepinephrine, and dopamine transporters with Kd values of 2.3, 0.63, and 18 nM, resp.  Inhibition of serotonin, norepinephrine, and dopamine uptake by PRC 200SS was also shown in cells expressing the corresponding transporter (Ki values of 2.1, 1.5, and 61 nM, resp.).  In vivo, PRC 200SS dose-dependently decreased immobility in the forced-swim test in rats and in the tail-suspension test in mice, models predictive of antidepressant activity, with effects comparable with imipramine.  These results in the behavioral models did not seem to result from the stimulation of locomotor activity.  Consistent with the in vitro data and behavioral effects, peripheral administration of PRC 200SS (5 and 10 mg/kg i.p.) significantly increased extracellular levels of serotonin and norepinephrine in the medial prefrontal cortex, and of serotonin and dopamine in the core of nucleus accumbens, with redn. of levels of 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindoleacetic acid compared with levels for saline control.  Furthermore, PRC 200SS self-administration, which was used as a marker of abuse liability, was not obsd. with rats.  Therefore, it seems that PRC 200SS may represent a novel triple reuptake inhibitor and possess antidepressant activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsjq1Ko19NBbVg90H21EOLACvtfcHk0ljiDBzZ5XPTLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vJ&md5=1cfb6ece94bf5fa1187219d03f676d09</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.143610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.143610%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DShaw%26aufirst%3DA.%2BM.%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DBriody%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DOliveros%26aufirst%3DA.%26aulast%3DBlazar%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCarlier%26aufirst%3DP.%2BR%26atitle%3DAntidepressant%2520like%2520pharmacological%2520profile%2520of%2520a%2520novel%2520triple%2520reuptake%2520inhibitor%252C%2520%25281S%252C2S%2529-3-%2528methylamino%2529-2-%2528naphthalen-2-yl%2529-1-phenylpropan-1-ol%2520%2528PRC200-SS%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D573%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Skolnick, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, A. S.</span><span> </span><span class="NLM_article-title">‘‘Broad spectrum’’ antidepressants: is more better for the treatment of depression?</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">3175</span><span class="NLM_x">–</span> <span class="NLM_lpage">3179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=3175-3179&author=P.+Skolnickauthor=P.+Popikauthor=A.+Janowskyauthor=B.+Beerauthor=A.+S.+Lippa&title=%E2%80%98%E2%80%98Broad+spectrum%E2%80%99%E2%80%99+antidepressants%3A+is+more+better+for+the+treatment+of+depression%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DPopik%26aufirst%3DP.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DBeer%26aufirst%3DB.%26aulast%3DLippa%26aufirst%3DA.%2BS.%26atitle%3D%25E2%2580%2598%25E2%2580%2598Broad%2520spectrum%25E2%2580%2599%25E2%2580%2599%2520antidepressants%253A%2520is%2520more%2520better%2520for%2520the%2520treatment%2520of%2520depression%253F%26jtitle%3DLife%2520Sci.%26date%3D2003%26volume%3D73%26spage%3D3175%26epage%3D3179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span> </span><span class="NLM_article-title">In vitro and in vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">587</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2f&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1016%2Fj.ejphar.2008.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2f&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=18499098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2f&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFGltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=587&publication_year=2008&pages=141-146&author=L.+Aluisioauthor=B.+Lordauthor=A.+J.+Barbierauthor=I.+C.+Fraserauthor=S.+J.+Wilsonauthor=J.+Boggsauthor=L.+K.+Dvorakauthor=M.+A.+Letavicauthor=B.+E.+Maryanoffauthor=N.+I.+Carruthers&title=In+vitro+and+in+vivo+characterization+of+JNJ-7925476%2C+a+novel+triple+monoamine+uptake+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2fR"><div class="casContent"><span class="casTitleNuber">2f</span><div class="casTitle"><span class="NLM_cas:atitle">In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor</span></div><div class="casAuthors">Aluisio, Leah; Lord, Brian; Barbier, Ann J.; Fraser, Ian C.; Wilson, Sandy J.; Boggs, Jamin; Dvorak, Lisa K.; Letavic, Michael A.; Maryanoff, Bruce E.; Carruthers, Nicholas I.; Bonaventure, Pascal; Lovenberg, Timothy W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">587</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">141-146</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Triple reuptake inhibitors, which block the serotonin transporter (SERT), norepinephrine transporter (NET) and dopamine transporter (DAT) in the central nervous system have been described as therapeutic alternatives for classical selective serotonin reuptake inhibitors, with advantages due to their multiple mechanisms of action.  JNJ-7925476 (trans-6-(4-ethynylphenyl)-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline) is a selective and potent inhibitor of the SERT, NET, and DAT (K i = 0.9, 17 and 5.2 nM, resp.).  Following s.c. dosing in rat, JNJ-7925476 was rapidly absorbed into the plasma, and drug concns. in the brain tracked with those in the plasma but were 7-fold higher.  The ED50 values for JNJ-7925476 occupancy of the SERT, NET, and DAT in rat brain were 0.18, 0.09 and 2.4 mg/kg, resp.  JNJ-7925476 (0.1-10 mg/kg, s.c.) rapidly induced a robust, dose-dependent increase in extracellular serotonin, dopamine, and norepinephrine levels in rat cerebral cortex.  The compd. also showed potent antidepressant-like activity in the mouse tail suspension test (ED50 = 0.3 mg/kg, i.p.).  These results demonstrate that JNJ-7925476 is a triple reuptake inhibitor with in-vivo efficacy in biochem. and behavioral models of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrLdkhiOEPU7Vg90H21EOLACvtfcHk0ljiDBzZ5XPTLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFGltbc%253D&md5=e55497330670d8ce48403bb2283efe3d</span></div><a href="/servlet/linkout?suffix=cit2f&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBarbier%26aufirst%3DA.%2BJ.%26aulast%3DFraser%26aufirst%3DI.%2BC.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DDvorak%26aufirst%3DL.%2BK.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520characterization%2520of%2520JNJ-7925476%252C%2520a%2520novel%2520triple%2520monoamine%2520uptake%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D587%26spage%3D141%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Bannwart, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenhouse, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaime-Figueroa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, M. C.</span><span> </span><span class="NLM_article-title">Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6062</span><span class="NLM_x">–</span> <span class="NLM_lpage">6066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6062-6066&author=L.+M.+Bannwartauthor=D.+S.+Carterauthor=H.+Y.+Caiauthor=J.+C.+Choyauthor=R.+Greenhouseauthor=S.+Jaime-Figueroaauthor=P.+S.+Iyerauthor=C.+J.+Linauthor=E.+K.+Leeauthor=M.+C.+Lucas&title=Novel+3%2C3-disubstituted+pyrrolidines+as+selective+triple+serotonin%2Fnorepinephrine%2Fdopamine+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBannwart%26aufirst%3DL.%2BM.%26aulast%3DCarter%26aufirst%3DD.%2BS.%26aulast%3DCai%26aufirst%3DH.%2BY.%26aulast%3DChoy%26aufirst%3DJ.%2BC.%26aulast%3DGreenhouse%26aufirst%3DR.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DLin%26aufirst%3DC.%2BJ.%26aulast%3DLee%26aufirst%3DE.%2BK.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26atitle%3DNovel%25203%252C3-disubstituted%2520pyrrolidines%2520as%2520selective%2520triple%2520serotonin%252Fnorepinephrine%252Fdopamine%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6062%26epage%3D6066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Papakostas, G. I.</span><span> </span><span class="NLM_article-title">Dopaminergic-based pharmacotherapies for depression</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2h&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1016%2Fj.euroneuro.2005.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2h&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=16413172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2h&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFSktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=391-402&author=G.+I.+Papakostas&title=Dopaminergic-based+pharmacotherapies+for+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2hR"><div class="casContent"><span class="casTitleNuber">2h</span><div class="casTitle"><span class="NLM_cas:atitle">Dopaminergic-based pharmacotherapies for depression</span></div><div class="casAuthors">Papakostas, George I.</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">391-402</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The serendipitous discovery of the precursors of two of the major contemporary antidepressant families during the late 1950s, iproniazid for the monoamine oxidase inhibitors (MAOIs) and imipramine for the tricyclic antidepressants (TCAs), has guided the subsequent development of antidepressant compds. with predominantly serotonergic, noradrenergic or combined serotonergic and noradrenergic activity.  Unfortunately, however, many depressed patients continue to remain symptomatic despite adequate treatment with pharmacol. agents currently available.  When one reviews the list of pharmacol. agents currently approved for the treatment of Major Depressive Disorder (MDD), it is apparent that relatively few treatments with dopaminergic activity have been developed to date.  Therefore, developing effective antidepressant treatments with pro-dopaminergic properties which also possess a relatively wide safety margin may further improve the std. of care for depression.  In the present article we will briefly review studies focusing on the role of dopamine in depression followed by a comprehensive review of pharmacotherapies for depression with pro-dopaminergic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJSaNt7Y60YLVg90H21EOLACvtfcHk0lgAs_GqsZJBUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFSktr8%253D&md5=d8c07a50f819444bf5d432b99f1d6af4</span></div><a href="/servlet/linkout?suffix=cit2h&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2005.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2005.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DPapakostas%26aufirst%3DG.%2BI.%26atitle%3DDopaminergic-based%2520pharmacotherapies%2520for%2520depression%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2006%26volume%3D16%26spage%3D391%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Skolnick, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, A. S.</span><span> </span><span class="NLM_article-title">Antidepressant-like actions of DOV21,947: a “triple” reuptake inhibitor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">461</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2i&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1016%2FS0014-2999%2803%2901310-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2i&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=12586204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2i&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVanu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2003&pages=99-104&author=P.+Skolnickauthor=P.+Popikauthor=A.+Janowskyauthor=B.+Beerauthor=A.+S.+Lippa&title=Antidepressant-like+actions+of+DOV21%2C947%3A+a+%E2%80%9Ctriple%E2%80%9D+reuptake+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2iR"><div class="casContent"><span class="casTitleNuber">2i</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor</span></div><div class="casAuthors">Skolnick, Phil; Popik, Piotr; Janowsky, Aaron; Beer, Bernard; Lippa, Arnold S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">99-104</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">DOV 21,947 [(+)-1-(3,4-dichlorophenyl)-3-azabicyclo-[3.1.0]hexane hydrochloride] inhibits the reuptake of [3H]serotonin, [3H]norepinephrine, and [3H]dopamine in human embryonic kidney (HEK) 293 cells expressing the corresponding human recombinant transporters (IC50 values of 12, 23, and 96 nM, resp.).  This compd. also inhibits [125I]RTI 55 (3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester) binding to the corresponding transporter proteins in membranes prepd. from these cells (Ki values of 99, 262, and 213 nM, resp.).  DOV 21,947 reduces the duration of immobility in the forced swim test (using rats) with an oral min. ED of 5 mg/kg.  This antidepressant-like effect manifests in the absence of significant increases in motor activity at doses of up to 20 mg/kg.  DOV 21,947 also produces a dose-dependent redn. in immobility in the tail suspension test, with a min. effective oral dose of 5 mg/kg.  The ability of DOV 21,947 to inhibit the reuptake of three biogenic amines closely linked to the etiol. of depression may result in a therapeutic profile different from antidepressants that inhibit the reuptake of serotonin and/or norepinephrine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2Q0j1ranmerVg90H21EOLACvtfcHk0lgAs_GqsZJBUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVanu7s%253D&md5=6d48dc293c8237d42932da3effa40b8a</span></div><a href="/servlet/linkout?suffix=cit2i&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2901310-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252901310-4%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DPopik%26aufirst%3DP.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DBeer%26aufirst%3DB.%26aulast%3DLippa%26aufirst%3DA.%2BS.%26atitle%3DAntidepressant-like%2520actions%2520of%2520DOV21%252C947%253A%2520a%2520%25E2%2580%259Ctriple%25E2%2580%259D%2520reuptake%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D461%26spage%3D99%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Scheel-Kruger, J.; Moldt, P; Watjen, F.</span><span> </span><span class="NLM_article-title">Tropane-derivatives, their preparation and use</span>. U.S. Patent 6395748,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+Scheel-Kruger&author=P+Moldt&author=F.+Watjen&title=Tropane-derivatives%2C+their+preparation+and+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26atitle%3DTropane-derivatives%252C%2520their%2520preparation%2520and%2520use%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Scheel-Kruger, J.; Moldt, P; Watjen, F.</span><span> </span><span class="NLM_article-title">Tropane-derivatives, their preparation and use</span>. U.S. Patent 6288079,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=J.+Scheel-Kruger&author=P+Moldt&author=F.+Watjen&title=Tropane-derivatives%2C+their+preparation+and+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26atitle%3DTropane-derivatives%252C%2520their%2520preparation%2520and%2520use%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Scheel-Kruger, J.; Moldt, P; Watjen, F.</span><span> </span><span class="NLM_article-title">Tropane-derivatives, their preparation and use</span>. Patent WO 9730997,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=J.+Scheel-Kruger&author=P+Moldt&author=F.+Watjen&title=Tropane-derivatives%2C+their+preparation+and+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26atitle%3DTropane-derivatives%252C%2520their%2520preparation%2520and%2520use%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Scheel-Kruger, J.; Olsen, G. M.; Nielsen, E. O.; Dahl, B. H.; Jensen, L. H.</span><span> </span><span class="NLM_article-title">Fused tropane derivatives as neurotransmitter reuptake inhibitors</span>. Patent WO 9716451,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=J.+Scheel-Kruger&author=G.+M.+Olsen&author=E.+O.+Nielsen&author=B.+H.+Dahl&author=L.+H.+Jensen&title=Fused+tropane+derivatives+as+neurotransmitter+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26atitle%3DFused%2520tropane%2520derivatives%2520as%2520neurotransmitter%2520reuptake%2520inhibitors%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span>Maestro, version 8.5.111; <span class="NLM_publisher-name">Schrodinger LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+8.5.111%3B+Schrodinger+LLC%3A+New+York%2C+2006%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMaestro%26pub%3DSchrodinger%2520LLC%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span>BatchMin, version 9.6; <span class="NLM_publisher-name">Schrodinger LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=BatchMin%2C+version+9.6%3B+Schrodinger+LLC%3A+New+York%2C+2008%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DBatchMin%26pub%3DSchrodinger%2520LLC%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span>Phase, version 3.0.110; <span class="NLM_publisher-name">Schrodinger LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Phase%2C+version+3.0.110%3B+Schrodinger+LLC%3A+New+York%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPhase%26pub%3DSchrodinger%2520LLC%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="note"><p class="first last">The research complied with national legislation and with company policy on the Care and Use of Animals and with related codes of practice.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Minick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutkowske, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. A. D.</span><span> </span><span class="NLM_article-title">Strategies for successfully applying vibrational circular dichroism in a pharmaceutical research environment</span> <span class="citation_source-journal">Am. Pharmaceut. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVyrsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=118-123&author=D.+J.+Minickauthor=R.+D.+Rutkowskeauthor=L.+A.+D.+Miller&title=Strategies+for+successfully+applying+vibrational+circular+dichroism+in+a+pharmaceutical+research+environment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for successfully applying vibrational circular dichroism in a pharmaceutical research environment</span></div><div class="casAuthors">Minick, Douglas J.; Rutkowske, Randy D.; Miller, Luke A. D.</div><div class="citationInfo"><span class="NLM_cas:title">American Pharmaceutical Review</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">118-123</span>CODEN:
                <span class="NLM_cas:coden">APHRFS</span>;
        ISSN:<span class="NLM_cas:issn">1099-8012</span>.
    
            (<span class="NLM_cas:orgname">Russell Publishing L.L.C</span>)
        </div><div class="casAbstract">A review on ab initio vibrational CD (VCD) for anal. of chiral drug mols.  Key aspects for successfully applying ab initio VCD anal. in an industrial research environment are discussed.  These recommended procedures should not only help to expedite and simplify ab initio VCD analyses, but, most importantly, provide an increased level of confidence in VCD assignments.  Features described include: (1) the use of a large no. of computer processors to maximize sample throughput, (2) a strategy for combining ab initio and comparative VCD studies to assure reliable configurational assignments for series of structurally-related mols., (3) advantages of reduced structure modeling, (4) linear regression anal. for estg. VCD confidence limits, and (5) establishment of a min. acceptability criterion (CL ≥ 90%) for reliable assignments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-j-XQCR9M47Vg90H21EOLACvtfcHk0lhCMPJlRnCAEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVyrsrzJ&md5=673dc3fdd64f3dafbc926fc0b372f7dc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinick%26aufirst%3DD.%2BJ.%26aulast%3DRutkowske%26aufirst%3DR.%2BD.%26aulast%3DMiller%26aufirst%3DL.%2BA.%2BD.%26atitle%3DStrategies%2520for%2520successfully%2520applying%2520vibrational%2520circular%2520dichroism%2520in%2520a%2520pharmaceutical%2520research%2520environment%26jtitle%3DAm.%2520Pharmaceut.%2520Rev.%26date%3D2007%26volume%3D10%26spage%3D118%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span>Aptuit Limited, 3 Simpson Parkway, Livingston, West Lothian, EH54 7BH, Scotland; <a href="http://www.aptuit.uk" class="extLink">www.aptuit.uk</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Aptuit+Limited%2C+3+Simpson+Parkway%2C+Livingston%2C+West+Lothian%2C+EH54+7BH%2C+Scotland%3B+www.aptuit.uk."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Zocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span> </span><span class="NLM_article-title">Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2005&pages=157-161&author=A.+Zocchiauthor=D.+Fabbriauthor=C.+A.+Heidbreder&title=Aripiprazole+increases+dopamine+but+not+noradrenaline+and+serotonin+levels+in+the+mouse+prefrontal+cortex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZocchi%26aufirst%3DA.%26aulast%3DFabbri%26aufirst%3DD.%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26atitle%3DAripiprazole%2520increases%2520dopamine%2520but%2520not%2520noradrenaline%2520and%2520serotonin%2520levels%2520in%2520the%2520mouse%2520prefrontal%2520cortex%26jtitle%3DNeurosci.%2520Lett.%26date%3D2005%26volume%3D387%26spage%3D157%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Burchall, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroko, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigdon, G. C.</span><span> </span><span class="NLM_article-title">Potentiation of the behavioral effects of 5-hydroxytryptophan by BW 1370U87, a selective monoamine oxidase-A inhibitor</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1992&pages=209-213&author=C.+J.+Burchallauthor=F.+E.+Sorokoauthor=G.+C.+Rigdon&title=Potentiation+of+the+behavioral+effects+of+5-hydroxytryptophan+by+BW+1370U87%2C+a+selective+monoamine+oxidase-A+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurchall%26aufirst%3DC.%2BJ.%26aulast%3DSoroko%26aufirst%3DF.%2BE.%26aulast%3DRigdon%26aufirst%3DG.%2BC.%26atitle%3DPotentiation%2520of%2520the%2520behavioral%2520effects%2520of%25205-hydroxytryptophan%2520by%2520BW%25201370U87%252C%2520a%2520selective%2520monoamine%2520oxidase-A%2520inhibitor%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1992%26volume%3D25%26spage%3D209%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Martin, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendesky, R. J.</span><span> </span><span class="NLM_article-title">Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">706</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=6144790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADyaL2cXks1GnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1984&pages=706-711&author=G.+E.+Martinauthor=R.+J.+Bendesky&title=Mouse+locomotor+activity%3A+an+in+vivo+test+for+dopamine+autoreceptor+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse locomotor activity:  an in vivo test for dopamine autoreceptor activation</span></div><div class="casAuthors">Martin, Gregory E.; Bendesky, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">706-11</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">A pharmacol. test is described for assessing selective dopamine (DA) autoreceptor activation using locomotor activity (LMA) of the mouse as the dependent variable.  In this test, 3 criteria must be satisfied to indicate selectivity for the DA autoreceptor.  First, a dose-related fall in LMA, taken as a measure of DA autoreceptor activation, should be produced by the putative autoreceptor agonist.  Second, to demonstrate a DA system is involved, the redn. in LMA should be blocked by a DA receptor antagonist.  Finally, the test compd. should produce no LMA-stimulating (i.e., postsynaptic DA receptor agonist) effects over prolonged periods of observation.  Using these criteria, 15 DA agonists were evaluated for DA autoreceptor selectivity.  Four agents satisfied all criteria as selective DA autoreceptor agonists: CF 25-397, N-n-3-propyl-3-hydroxyphenylpiperidine, 6,7-dihydroxy-2-methylaminotetralin (TL-99) and 2-amino-6,7-dibenzoyloxy-1,2,3,4-tetrahydronaphthalene.  Seven DA agonists produced U-shaped dose-response curves indicative of activity at both the autoreceptor and postsynaptic DA receptor.  These agents were: apomorphine, n-propylnorapomorphine, pergolide, RU24213, RU24926, (-)-6-ethyl-9-oxaergoline and lisuride.  SKF 38393 failed to exert any significant effect on the LMA of the mouse.  Both lergotrile and bromocriptine produced dose-related falls in LMA, but both caused a rebound increase in LMA before their durations of action were terminated.  Although 3,4-dihydroxyphenylamino-2-imidazoline did produce a dose-related fall in LMA, the inhibition produced by 3,4-dihydroxyphenylamino-2-imidazoline was not reduced by sulpiride, suggesting a nondopaminergic action for 3,4-dihydroxyphenylamino-2-imidazoline.  Potency relative to apomorphine for producing a 30% fall in LMA was computed for each compd.  The overall significance of these results in studying the pharmacol. of DA receptor agonists is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvizZLXvG8gbVg90H21EOLACvtfcHk0lgsAJyINxQAHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1GnsLw%253D&md5=65d8ec4cb1c58379af3dd59f81779a5e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DG.%2BE.%26aulast%3DBendesky%26aufirst%3DR.%2BJ.%26atitle%3DMouse%2520locomotor%2520activity%253A%2520an%2520in%2520vivo%2520test%2520for%2520dopamine%2520autoreceptor%2520activation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1984%26volume%3D229%26spage%3D706%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bourin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prica, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascoet, M.</span><span> </span><span class="NLM_article-title">Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice</span> <span class="citation_source-journal">Psychopharmacology (Heidelberg, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1007%2Fs00213-009-1583-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=19517098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVKlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2009&pages=97-107&author=M.+Bourinauthor=F.+Chenuauthor=C.+Pricaauthor=M.+Hascoet&title=Augmentation+effect+of+combination+therapy+of+aripiprazole+and+antidepressants+on+forced+swimming+test+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice</span></div><div class="casAuthors">Bourin, Michel; Chenu, Franck; Prica, Corina; Hascoet, Martine</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-107</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A deficiency in brain monoamine systems (serotonin, dopamine, and/or norepinephrine) have long been hypothesized for the pathogenesis of depression.  Drugs enhancing neurotransmission of those monoamines were proven to have antidepressant effects.  We hypothesized that aripiprazole, a partial D2 agonist, could increase the activity of various antidepressants in the mice forced swimming test (FST), an animal model of depression.  The scope of this study was to investigate the antidepressant-like effect of aripiprazole, when combined with conventional antidepressants drugs.  This study assessed the effects of co-administration of aripiprazole with selective serotonin reuptake inhibitors (SSRIs; sertraline, paroxetine, and citalopram), selective serotonin-norepinephrine reuptake inhibitors (SNRIs; venlafaxine and minalcipran), selective norepinephrine reuptake inhibitor (NRI; desipramine), and the dual dopamine and norepinephrine reuptake inhibitor (bupropion), using the FST in mice.  Subactive doses of aripiprazole and antidepressants sertraline, paroxetine, citalopram, venlafaxine, minalcipran, bupropion (4 and 8 mg/kg), and desipramine (2 and 4 mg/kg) were given i.p. 30 and 45 min, resp., before the test.  Aripiprazole (0.03 and 0.06 mg/kg) combined with inactive doses of antidepressants, increased the activity of all antidepressants with the exception of bupropion and desipramine.  The augmentation effects of aripiprazole, in the present study, are in agreement with clin. evidence suggesting that aripiprazole may enhance the efficacy of therapeutic effect of SSRIs and SNRIs but not of NRI.  These results suggest that augmentation effect of aripiprazole only appears when 5-HT system is activated and might implicate complex regulation between dopamine and 5-HT1A and 5-HT2A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnDRD6PeRWcrVg90H21EOLACvtfcHk0lgsAJyINxQAHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVKlu7o%253D&md5=b163156e7158e19f8efa3e941aa393be</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1583-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1583-7%26sid%3Dliteratum%253Aachs%26aulast%3DBourin%26aufirst%3DM.%26aulast%3DChenu%26aufirst%3DF.%26aulast%3DPrica%26aufirst%3DC.%26aulast%3DHascoet%26aufirst%3DM.%26atitle%3DAugmentation%2520effect%2520of%2520combination%2520therapy%2520of%2520aripiprazole%2520and%2520antidepressants%2520on%2520forced%2520swimming%2520test%2520in%2520mice%26jtitle%3DPsychopharmacology%2520%2528Heidelberg%252C%2520Ger.%2529%26date%3D2009%26volume%3D206%26spage%3D97%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bonanomi, G.; Micheli, F.; Terreni, S.</span><span> </span><span class="NLM_article-title">Azabicyclic compounds as serotonin, dopamine and norepinephrine re-uptake inhibitors and their preparation, pharmaceutical compositions and use in the treatment of depression</span>. Patent WO 2008074716,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+Bonanomi&author=F.+Micheli&author=S.+Terreni&title=Azabicyclic+compounds+as+serotonin%2C+dopamine+and+norepinephrine+re-uptake+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBonanomi%26aufirst%3DG.%26atitle%3DAzabicyclic%2520compounds%2520as%2520serotonin%252C%2520dopamine%2520and%2520norepinephrine%2520re-uptake%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520depression%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bertani, B.; Bonanomi, G.; Di Fabio, R.; Fazzolari, E.; Micheli, F.; Tarsi, L.</span><span> </span><span class="NLM_article-title">Preparation of 3-azabicyclo[3.1.0]hexane compounds as monoamine neurotransmitter re-uptake inhibitors</span>. Patent WO 2009027293,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=B.+Bertani&author=G.+Bonanomi&author=R.+Di+Fabio&author=E.+Fazzolari&author=F.+Micheli&author=L.+Tarsi&title=Preparation+of+3-azabicyclo%5B3.1.0%5Dhexane+compounds+as+monoamine+neurotransmitter+re-uptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBertani%26aufirst%3DB.%26atitle%3DPreparation%2520of%25203-azabicyclo%255B3.1.0%255Dhexane%2520compounds%2520as%2520monoamine%2520neurotransmitter%2520re-uptake%2520inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d'],'ref2':['cit2a','cit2b','cit2c','cit2d','cit2e','cit2f','cit2g','cit2h','cit2i'],'ref3':['cit3a','cit3b','cit3c','cit3d'],'ref4':['cit4a','cit4b','cit4c'],'ref5':[],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 34 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Gao Tu, Tingting Fu, Fengyuan Yang, Jingyi Yang, Zhao Zhang, Xiaojun Yao, Weiwei Xue, <span class="NLM_string-name hlFld-ContribAuthor">Feng Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding the Polypharmacological Profiles of Triple Reuptake Inhibitors by Molecular Simulation. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (11)
                                     , 2013-2026. <a href="https://doi.org/10.1021/acschemneuro.1c00127" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00127%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DUnderstanding%252Bthe%252BPolypharmacological%252BProfiles%252Bof%252BTriple%252BReuptake%252BInhibitors%252Bby%252BMolecular%252BSimulation%26aulast%3DTu%26aufirst%3DGao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08032021%26date%3D07052021%26date%3D12052021%26volume%3D12%26issue%3D11%26spage%3D2013%26epage%3D2026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Murugaiah A. M. Subbaiah</span>. </span><span class="cited-content_cbyCitation_article-title">Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (6)
                                     , 2133-2165. <a href="https://doi.org/10.1021/acs.jmedchem.6b01827" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01827</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01827%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTriple%252BReuptake%252BInhibitors%252Bas%252BPotential%252BTherapeutics%252Bfor%252BDepression%252Band%252BOther%252BDisorders%25253A%252BDesign%252BParadigm%252Band%252BDevelopmental%252BChallenges%26aulast%3DSubbaiah%26aufirst%3DMurugaiah%2BA.%2BM.%26date%3D2018%26date%3D2017%26date%3D2016%26date%3D13122016%26date%3D25082017%26date%3D21072017%26volume%3D61%26issue%3D6%26spage%3D2133%26epage%3D2165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julia  Pedroni</span> and <span class="hlFld-ContribAuthor ">Nicolai  Cramer</span>  . </span><span class="cited-content_cbyCitation_article-title">Enantioselective C–H Functionalization–Addition Sequence Delivers Densely Substituted 3-Azabicyclo[3.1.0]hexanes. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2017,</strong> <em>139 </em>
                                    (36)
                                     , 12398-12401. <a href="https://doi.org/10.1021/jacs.7b07024" title="DOI URL">https://doi.org/10.1021/jacs.7b07024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.7b07024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.7b07024%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DEnantioselective%252BC%2525E2%252580%252593H%252BFunctionalization%2525E2%252580%252593Addition%252BSequence%252BDelivers%252BDensely%252BSubstituted%252B3-Azabicyclo%25255B3.1.0%25255Dhexanes%26aulast%3DPedroni%26aufirst%3DJulia%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10072017%26date%3D01092017%26date%3D13092017%26date%3D23082017%26volume%3D139%26issue%3D36%26spage%3D12398%26epage%3D12401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael R.  Harris</span>, <span class="hlFld-ContribAuthor ">Qifang  Li</span>, <span class="hlFld-ContribAuthor ">Yajing  Lian</span>, <span class="hlFld-ContribAuthor ">Jun  Xiao</span>, and <span class="hlFld-ContribAuthor ">Allyn T.  Londregan</span>  . </span><span class="cited-content_cbyCitation_article-title">Construction of 1-Heteroaryl-3-azabicyclo[3.1.0]hexanes by sp3–sp2 Suzuki–Miyaura and Chan–Evans–Lam Coupling Reactions of Tertiary Trifluoroborates. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (9)
                                     , 2450-2453. <a href="https://doi.org/10.1021/acs.orglett.7b01097" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b01097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b01097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b01097%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DConstruction%252Bof%252B1-Heteroaryl-3-azabicyclo%25255B3.1.0%25255Dhexanes%252Bby%252Bsp3%2525E2%252580%252593sp2%252BSuzuki%2525E2%252580%252593Miyaura%252Band%252BChan%2525E2%252580%252593Evans%2525E2%252580%252593Lam%252BCoupling%252BReactions%252Bof%252BTertiary%252BTrifluoroborates%26aulast%3DHarris%26aufirst%3DMichael%2BR.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D11042017%26date%3D24042017%26date%3D05052017%26volume%3D19%26issue%3D9%26spage%3D2450%26epage%3D2453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott P.  Runyon</span>, <span class="hlFld-ContribAuthor ">Chad M.  Kormos</span>, <span class="hlFld-ContribAuthor ">Moses G.  Gichinga</span>, <span class="hlFld-ContribAuthor ">S. Wayne  Mascarella</span>, <span class="hlFld-ContribAuthor ">Hernán A.  Navarro</span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Deschamps</span>, <span class="hlFld-ContribAuthor ">Gregory H.  Imler</span>, and <span class="hlFld-ContribAuthor ">F. Ivy  Carroll</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Structurally Rigid Analogues of 4-(3-Hydroxyphenyl)piperidine Opioid Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (21)
                                     , 10383-10391. <a href="https://doi.org/10.1021/acs.joc.6b01366" title="DOI URL">https://doi.org/10.1021/acs.joc.6b01366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b01366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b01366%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BStructurally%252BRigid%252BAnalogues%252Bof%252B4-%2525283-Hydroxyphenyl%252529piperidine%252BOpioid%252BReceptor%252BAntagonists%26aulast%3DRunyon%26aufirst%3DScott%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D08062016%26date%3D02082016%26date%3D04112016%26date%3D27072016%26volume%3D81%26issue%3D21%26spage%3D10383%26epage%3D10391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob C.  Timmerman</span>, <span class="hlFld-ContribAuthor ">William W.  Schmitt</span>, and <span class="hlFld-ContribAuthor ">Ross A.  Widenhoefer</span>  . </span><span class="cited-content_cbyCitation_article-title">Gold-Catalyzed Intermolecular, anti-Markovnikov Hydroarylation of Methylenecyclopropanes with Indoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (19)
                                     , 4966-4969. <a href="https://doi.org/10.1021/acs.orglett.6b02431" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b02431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b02431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b02431%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DGold-Catalyzed%252BIntermolecular%25252C%252Banti-Markovnikov%252BHydroarylation%252Bof%252BMethylenecyclopropanes%252Bwith%252BIndoles%26aulast%3DTimmerman%26aufirst%3DJacob%2BC.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14082016%26date%3D15092016%26date%3D07102016%26volume%3D18%26issue%3D19%26spage%3D4966%26epage%3D4969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuang  Liu</span>, <span class="hlFld-ContribAuthor ">Congxiang  Zha</span>, <span class="hlFld-ContribAuthor ">Kassoum  Nacro</span>, <span class="hlFld-ContribAuthor ">Min  Hu</span>, <span class="hlFld-ContribAuthor ">Wenge  Cui</span>, <span class="hlFld-ContribAuthor ">Yuh-Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Ulhas  Bhatt</span>, <span class="hlFld-ContribAuthor ">Aruna  Sambandam</span>, <span class="hlFld-ContribAuthor ">Matthew  Isherwood</span>, <span class="hlFld-ContribAuthor ">Larry  Yet</span>, <span class="hlFld-ContribAuthor ">Michael T.  Herr</span>, <span class="hlFld-ContribAuthor ">Sarah  Ebeltoft</span>, <span class="hlFld-ContribAuthor ">Carla  Hassler</span>, <span class="hlFld-ContribAuthor ">Linda  Fleming</span>, <span class="hlFld-ContribAuthor ">Anthony D.  Pechulis</span>, <span class="hlFld-ContribAuthor ">Anne  Payen-Fornicola</span>, <span class="hlFld-ContribAuthor ">Nicholas  Holman</span>, <span class="hlFld-ContribAuthor ">Dennis  Milanowski</span>, <span class="hlFld-ContribAuthor ">Ian  Cotterill</span>, <span class="hlFld-ContribAuthor ">Vadim  Mozhaev</span>, <span class="hlFld-ContribAuthor ">Yuri  Khmelnitsky</span>, <span class="hlFld-ContribAuthor ">Peter R.  Guzzo</span>, <span class="hlFld-ContribAuthor ">Bruce J.  Sargent</span>, and <span class="hlFld-ContribAuthor ">Bruce F.  Molino</span>  , <span class="hlFld-ContribAuthor ">Richard  Olson</span>, <span class="hlFld-ContribAuthor ">Dalton  King</span>, <span class="hlFld-ContribAuthor ">Snjezana  Lelas</span>, <span class="hlFld-ContribAuthor ">Yu-Wen  Li</span>, <span class="hlFld-ContribAuthor ">Kim  Johnson</span>, <span class="hlFld-ContribAuthor ">Thaddeus  Molski</span>, <span class="hlFld-ContribAuthor ">Anitra  Orie</span>, <span class="hlFld-ContribAuthor ">Alicia  Ng</span>, <span class="hlFld-ContribAuthor ">Roy  Haskell</span>, <span class="hlFld-ContribAuthor ">Wendy  Clarke</span>, <span class="hlFld-ContribAuthor ">Robert  Bertekap</span>, <span class="hlFld-ContribAuthor ">Jonathan  O’Connell</span>, <span class="hlFld-ContribAuthor ">Nicholas  Lodge</span>, <span class="hlFld-ContribAuthor ">Michael  Sinz</span>, <span class="hlFld-ContribAuthor ">Stephen  Adams</span>, <span class="hlFld-ContribAuthor ">Robert  Zaczek</span>, and <span class="hlFld-ContribAuthor ">John E.  Macor</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of 4-Heteroaryl 1,2,3,4-Tetrahydroisoquinolines as Triple Reuptake Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (7)
                                     , 760-765. <a href="https://doi.org/10.1021/ml500053b" title="DOI URL">https://doi.org/10.1021/ml500053b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500053b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500053b%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252B4-Heteroaryl%252B1%25252C2%25252C3%25252C4-Tetrahydroisoquinolines%252Bas%252BTriple%252BReuptake%252BInhibitors%26aulast%3DLiu%26aufirst%3DShuang%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D31012014%26date%3D13052014%26date%3D27052014%26date%3D10072014%26date%3D13052014%26volume%3D5%26issue%3D7%26spage%3D760%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward C.  Sherer</span>, <span class="hlFld-ContribAuthor ">Claire H.  Lee</span>, <span class="hlFld-ContribAuthor ">Joseph  Shpungin</span>, <span class="hlFld-ContribAuthor ">James F.  Cuff</span>, <span class="hlFld-ContribAuthor ">Chenxiao  Da</span>, <span class="hlFld-ContribAuthor ">Richard  Ball</span>, <span class="hlFld-ContribAuthor ">Richard  Bach</span>, <span class="hlFld-ContribAuthor ">Alejandro  Crespo</span>, <span class="hlFld-ContribAuthor ">Xiaoyi  Gong</span>, and <span class="hlFld-ContribAuthor ">Christopher J.  Welch</span>  . </span><span class="cited-content_cbyCitation_article-title">Systematic Approach to Conformational Sampling for Assigning Absolute Configuration Using Vibrational Circular Dichroism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (2)
                                     , 477-494. <a href="https://doi.org/10.1021/jm401600u" title="DOI URL">https://doi.org/10.1021/jm401600u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401600u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401600u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSystematic%252BApproach%252Bto%252BConformational%252BSampling%252Bfor%252BAssigning%252BAbsolute%252BConfiguration%252BUsing%252BVibrational%252BCircular%252BDichroism%26aulast%3DSherer%26aufirst%3DEdward%2BC.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D15102013%26date%3D02012014%26date%3D23012014%26volume%3D57%26issue%3D2%26spage%3D477%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anton V.  Gulevich</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Dudnik</span>, <span class="hlFld-ContribAuthor ">Natalia  Chernyak</span>, and <span class="hlFld-ContribAuthor ">Vladimir  Gevorgyan</span>  . </span><span class="cited-content_cbyCitation_article-title">Transition Metal-Mediated Synthesis of Monocyclic Aromatic Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2013,</strong> <em>113 </em>
                                    (5)
                                     , 3084-3213. <a href="https://doi.org/10.1021/cr300333u" title="DOI URL">https://doi.org/10.1021/cr300333u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr300333u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr300333u%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DTransition%252BMetal-Mediated%252BSynthesis%252Bof%252BMonocyclic%252BAromatic%252BHeterocycles%26aulast%3DGulevich%26aufirst%3DAnton%2BV.%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D14082012%26date%3D10012013%26date%3D08052013%26volume%3D113%26issue%3D5%26spage%3D3084%26epage%3D3213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kah Kah  Toh</span>, <span class="hlFld-ContribAuthor ">Yi-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Eileen Pei Jian  Ng</span>, and <span class="hlFld-ContribAuthor ">Shunsuke  Chiba</span>  . </span><span class="cited-content_cbyCitation_article-title">Copper-Mediated Aerobic Synthesis of 3-Azabicyclo[3.1.0]hex-2-enes and 4-Carbonylpyrroles from N-Allyl/Propargyl Enamine Carboxylates. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2011,</strong> <em>133 </em>
                                    (35)
                                     , 13942-13945. <a href="https://doi.org/10.1021/ja206580j" title="DOI URL">https://doi.org/10.1021/ja206580j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja206580j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja206580j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DCopper-Mediated%252BAerobic%252BSynthesis%252Bof%252B3-Azabicyclo%25255B3.1.0%25255Dhex-2-enes%252Band%252B4-Carbonylpyrroles%252Bfrom%252BN-Allyl%25252FPropargyl%252BEnamine%252BCarboxylates%26aulast%3DToh%26aufirst%3DKah%2BKah%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D15072011%26date%3D11082011%26date%3D07092011%26date%3D08082011%26volume%3D133%26issue%3D35%26spage%3D13942%26epage%3D13945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>, <span class="hlFld-ContribAuthor ">Paolo  Cavanni</span>, <span class="hlFld-ContribAuthor ">Daniele  Andreotti</span>, <span class="hlFld-ContribAuthor ">Roberto  Arban</span>, <span class="hlFld-ContribAuthor ">Roberto  Benedetti</span>, <span class="hlFld-ContribAuthor ">Barbara  Bertani</span>, <span class="hlFld-ContribAuthor ">Michela  Bettati</span>, <span class="hlFld-ContribAuthor ">Letizia  Bettelini</span>, <span class="hlFld-ContribAuthor ">Giorgio  Bonanomi</span>, <span class="hlFld-ContribAuthor ">Simone  Braggio</span>, <span class="hlFld-ContribAuthor ">Renzo  Carletti</span>, <span class="hlFld-ContribAuthor ">Anna  Checchia</span>, <span class="hlFld-ContribAuthor ">Mauro  Corsi</span>, <span class="hlFld-ContribAuthor ">Elettra  Fazzolari</span>, <span class="hlFld-ContribAuthor ">Stefano  Fontana</span>, <span class="hlFld-ContribAuthor ">Carla  Marchioro</span>, <span class="hlFld-ContribAuthor ">Emilio  Merlo-Pich</span>, <span class="hlFld-ContribAuthor ">Michele  Negri</span>, <span class="hlFld-ContribAuthor ">Beatrice  Oliosi</span>, <span class="hlFld-ContribAuthor ">Emiliangelo  Ratti</span>, <span class="hlFld-ContribAuthor ">Kevin D.  Read</span>, <span class="hlFld-ContribAuthor ">Maja  Roscic</span>, <span class="hlFld-ContribAuthor ">Ilaria  Sartori</span>, <span class="hlFld-ContribAuthor ">Simone  Spada</span>, <span class="hlFld-ContribAuthor ">Giovanna  Tedesco</span>, <span class="hlFld-ContribAuthor ">Luca  Tarsi</span>, <span class="hlFld-ContribAuthor ">Silvia  Terreni</span>, <span class="hlFld-ContribAuthor ">Filippo  Visentini</span>, <span class="hlFld-ContribAuthor ">Alessandro  Zocchi</span>, <span class="hlFld-ContribAuthor ">Laura  Zonzini</span> and <span class="hlFld-ContribAuthor ">Romano  Di Fabio</span>  . </span><span class="cited-content_cbyCitation_article-title">6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (13)
                                     , 4989-5001. <a href="https://doi.org/10.1021/jm100481d" title="DOI URL">https://doi.org/10.1021/jm100481d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100481d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100481d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D6-%2525283%25252C4-Dichlorophenyl%252529-1-%25255B%252528Methyloxy%252529methyl%25255D-3-azabicyclo%25255B4.1.0%25255Dheptane%25253A%252BA%252BNew%252BPotent%252Band%252BSelective%252BTriple%252BReuptake%252BInhibitor%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D20042010%26date%3D09062010%26date%3D08072010%26volume%3D53%26issue%3D13%26spage%3D4989%26epage%3D5001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siqi  Wang</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Filatov</span>, <span class="hlFld-ContribAuthor ">Stanislav V.  Lozovskiy</span>, <span class="hlFld-ContribAuthor ">Stanislav V.  Shmakov</span>, <span class="hlFld-ContribAuthor ">Olesya V.  Khoroshilova</span>, <span class="hlFld-ContribAuthor ">Anna G.  Larina</span>, <span class="hlFld-ContribAuthor ">Stanislav I.  Selivanov</span>, <span class="hlFld-ContribAuthor ">Vitali M.  Boitsov</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Stepakov</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of Spiro[3-azabicyclo[3.1.0]hexanes] via 1,3-Dipolar Cycloaddition of 1,2-Diphenylcyclopropenes to Ninhydrin-Derived Azomethine Ylides. </span><span class="cited-content_cbyCitation_journal-name">Synthesis</span><span> <strong>2021,</strong> <em>53 </em>
                                    (12)
                                     , 2114-2132. <a href="https://doi.org/10.1055/a-1360-9716" title="DOI URL">https://doi.org/10.1055/a-1360-9716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/a-1360-9716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fa-1360-9716%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthesis%26atitle%3DConstruction%252Bof%252BSpiro%25255B3-azabicyclo%25255B3.1.0%25255Dhexanes%25255D%252Bvia%252B1%25252C3-Dipolar%252BCycloaddition%252Bof%252B1%25252C2-Diphenylcyclopropenes%252Bto%252BNinhydrin-Derived%252BAzomethine%252BYlides%26aulast%3DWang%26aufirst%3DSiqi%26date%3D2021%26date%3D2021%26volume%3D53%26issue%3D12%26spage%3D2114%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Xue</span>, <span class="hlFld-ContribAuthor ">Tingting  Fu</span>, <span class="hlFld-ContribAuthor ">Guoxun  Zheng</span>, <span class="hlFld-ContribAuthor ">Gao  Tu</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Fengyuan  Yang</span>, <span class="hlFld-ContribAuthor ">Lin  Tao</span>, <span class="hlFld-ContribAuthor ">Lixia  Yao</span>, <span class="hlFld-ContribAuthor ">Feng  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (23)
                                     , 3830-3876. <a href="https://doi.org/10.2174/0929867325666181009123218" title="DOI URL">https://doi.org/10.2174/0929867325666181009123218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666181009123218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666181009123218%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Band%252BChallenges%252Bof%252Bthe%252BDrugs%252BActing%252Bon%252BMonoamine%252BTransporters%26aulast%3DXue%26aufirst%3DWeiwei%26date%3D2020%26volume%3D27%26issue%3D23%26spage%3D3830%26epage%3D3876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolei  Huang</span>, <span class="hlFld-ContribAuthor ">Minh Hieu  Nguyen</span>, <span class="hlFld-ContribAuthor ">Maoping  Pu</span>, <span class="hlFld-ContribAuthor ">Luoqiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yonggui Robin  Chi</span>, <span class="hlFld-ContribAuthor ">Yun‐Dong  Wu</span>, <span class="hlFld-ContribAuthor ">Jianrong Steve  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Reductive and Alkynylative Heck Bicyclization of Enynes to Access Conformationally Restricted Aza[3.1.0]bicycles. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (27)
                                     , 10906-10910. <a href="https://doi.org/10.1002/ange.202000859" title="DOI URL">https://doi.org/10.1002/ange.202000859</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202000859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202000859%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DAsymmetric%252BReductive%252Band%252BAlkynylative%252BHeck%252BBicyclization%252Bof%252BEnynes%252Bto%252BAccess%252BConformationally%252BRestricted%252BAza%25255B3.1.0%25255Dbicycles%26aulast%3DHuang%26aufirst%3DXiaolei%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D27%26spage%3D10906%26epage%3D10910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolei  Huang</span>, <span class="hlFld-ContribAuthor ">Minh Hieu  Nguyen</span>, <span class="hlFld-ContribAuthor ">Maoping  Pu</span>, <span class="hlFld-ContribAuthor ">Luoqiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yonggui Robin  Chi</span>, <span class="hlFld-ContribAuthor ">Yun‐Dong  Wu</span>, <span class="hlFld-ContribAuthor ">Jianrong Steve  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Reductive and Alkynylative Heck Bicyclization of Enynes to Access Conformationally Restricted Aza[3.1.0]bicycles. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (27)
                                     , 10814-10818. <a href="https://doi.org/10.1002/anie.202000859" title="DOI URL">https://doi.org/10.1002/anie.202000859</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202000859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202000859%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DAsymmetric%252BReductive%252Band%252BAlkynylative%252BHeck%252BBicyclization%252Bof%252BEnynes%252Bto%252BAccess%252BConformationally%252BRestricted%252BAza%25255B3.1.0%25255Dbicycles%26aulast%3DHuang%26aufirst%3DXiaolei%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D27%26spage%3D10814%26epage%3D10818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bijan Mohon  Chaki</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Takenaka</span>, <span class="hlFld-ContribAuthor ">Linpeng  Zhu</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Tsujihara</span>, <span class="hlFld-ContribAuthor ">Shinobu  Takizawa</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Sasai</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective One‐pot Synthesis of 3‐Azabicyclo[3.1.0]hexanes
              via
              Allylic Substitution and Oxidative Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (7)
                                     , 1537-1547. <a href="https://doi.org/10.1002/adsc.202000044" title="DOI URL">https://doi.org/10.1002/adsc.202000044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000044%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DEnantioselective%252BOne%2525E2%252580%252590pot%252BSynthesis%252Bof%252B3%2525E2%252580%252590Azabicyclo%25255B3.1.0%25255Dhexanes%252Bvia%252BAllylic%252BSubstitution%252Band%252BOxidative%252BCyclization%26aulast%3DChaki%26aufirst%3DBijan%2BMohon%26date%3D2020%26volume%3D362%26issue%3D7%26spage%3D1537%26epage%3D1547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parisa  Gholamzadeh</span>. </span><span class="cited-content_cbyCitation_article-title">The Pictet–Spengler Reaction: A Powerful Strategy for the Synthesis of Heterocycles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 153-226. <a href="https://doi.org/10.1016/bs.aihch.2018.09.002" title="DOI URL">https://doi.org/10.1016/bs.aihch.2018.09.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2018.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2018.09.002%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BPictet%2525E2%252580%252593Spengler%252BReaction%25253A%252BA%252BPowerful%252BStrategy%252Bfor%252Bthe%252BSynthesis%252Bof%252BHeterocycles%26aulast%3DGholamzadeh%26aufirst%3DParisa%26date%3D2019%26spage%3D153%26epage%3D226%26pub%3DElsevier%26date%3D2019%26volume%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. S.  Filatov</span>, <span class="hlFld-ContribAuthor ">N. A.  Knyazev</span>, <span class="hlFld-ContribAuthor ">M. N.  Ryazantsev</span>, <span class="hlFld-ContribAuthor ">V. V.  Suslonov</span>, <span class="hlFld-ContribAuthor ">A. G.  Larina</span>, <span class="hlFld-ContribAuthor ">A. P.  Molchanov</span>, <span class="hlFld-ContribAuthor ">R. R.  Kostikov</span>, <span class="hlFld-ContribAuthor ">V. M.  Boitsov</span>, <span class="hlFld-ContribAuthor ">A. V.  Stepakov</span>. </span><span class="cited-content_cbyCitation_article-title">A highly diastereoselective one-pot three-component 1,3-dipolar cycloaddition of cyclopropenes with azomethine ylides generated from 11
              H
              -indeno[1,2-
              b
              ]-quinoxalin-11-ones. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2018,</strong> <em>5 </em>
                                    (4)
                                     , 595-605. <a href="https://doi.org/10.1039/C7QO00888K" title="DOI URL">https://doi.org/10.1039/C7QO00888K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00888K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00888K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DA%252Bhighly%252Bdiastereoselective%252Bone-pot%252Bthree-component%252B1%25252C3-dipolar%252Bcycloaddition%252Bof%252Bcyclopropenes%252Bwith%252Bazomethine%252Bylides%252Bgenerated%252Bfrom%252B11%252BH%252B-indeno%25255B1%25252C2-%252Bb%252B%25255D-quinoxalin-11-ones%26aulast%3DFilatov%26aufirst%3DA.%2BS.%26date%3D2018%26date%3D2018%26volume%3D5%26issue%3D4%26spage%3D595%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Costantino</span>, <span class="hlFld-ContribAuthor ">Daniela  Barlocco</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Approaches to Multitarget Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 161-205. <a href="https://doi.org/10.1002/9783527674381.ch7" title="DOI URL">https://doi.org/10.1002/9783527674381.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DDesigning%252BApproaches%252Bto%252BMultitarget%252BDrugs%26aulast%3DCostantino%26aufirst%3DLuca%26date%3D2017%26date%3D2017%26spage%3D161%26epage%3D205%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Peng  Chen</span>, <span class="hlFld-ContribAuthor ">Shu-Song  Ying</span>, <span class="hlFld-ContribAuthor ">Hong-Hong  Zheng</span>, <span class="hlFld-ContribAuthor ">Yan-Ting  Liu</span>, <span class="hlFld-ContribAuthor ">Zhong-Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Hu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xu  Deng</span>, <span class="hlFld-ContribAuthor ">Yi-Jing  Wu</span>, <span class="hlFld-ContribAuthor ">Xiu-Mei  Gao</span>, <span class="hlFld-ContribAuthor ">Tian-Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Yan-Tong  Xu</span>, <span class="hlFld-ContribAuthor ">Hong-Hua  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel serotonin transporter regulators: Natural aristolane- and nardosinane- types of sesquiterpenoids from Nardostachys chinensis Batal. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-15483-6" title="DOI URL">https://doi.org/10.1038/s41598-017-15483-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-15483-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-15483-6%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DNovel%252Bserotonin%252Btransporter%252Bregulators%25253A%252BNatural%252Baristolane-%252Band%252Bnardosinane-%252Btypes%252Bof%252Bsesquiterpenoids%252Bfrom%252BNardostachys%252Bchinensis%252BBatal%26aulast%3DChen%26aufirst%3DYing-Peng%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengquan  Chen</span>, <span class="hlFld-ContribAuthor ">Chuanle  Zhu</span>, <span class="hlFld-ContribAuthor ">Rui  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhiming  Lin</span>, <span class="hlFld-ContribAuthor ">Wanqing  Wu</span>, <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-azabicyclo[3.1.0]hexane derivatives via palladium-catalyzed cyclopropanation of maleimides with N-tosylhydrazones: practical and facile access to CP-866,087. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (5)
                                     , 1228-1235. <a href="https://doi.org/10.1039/C6OB02137A" title="DOI URL">https://doi.org/10.1039/C6OB02137A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB02137A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB02137A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252B3-azabicyclo%25255B3.1.0%25255Dhexane%252Bderivatives%252Bvia%252Bpalladium-catalyzed%252Bcyclopropanation%252Bof%252Bmaleimides%252Bwith%252BN-tosylhydrazones%25253A%252Bpractical%252Band%252Bfacile%252Baccess%252Bto%252BCP-866%25252C087%26aulast%3DChen%26aufirst%3DPengquan%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D5%26spage%3D1228%26epage%3D1235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen-Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Zhong-Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Yu-Long  An</span>, <span class="hlFld-ContribAuthor ">Sheng-Yin  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Selective and tunable synthesis of 3-arylsuccinimides and 3-arylmaleimides from arenediazonium tetrafluoroborates and maleimides. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (28)
                                     , 23438-23447. <a href="https://doi.org/10.1039/C6RA00136J" title="DOI URL">https://doi.org/10.1039/C6RA00136J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA00136J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA00136J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSelective%252Band%252Btunable%252Bsynthesis%252Bof%252B3-arylsuccinimides%252Band%252B3-arylmaleimides%252Bfrom%252Barenediazonium%252Btetrafluoroborates%252Band%252Bmaleimides%26aulast%3DYang%26aufirst%3DZhen-Hua%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D28%26spage%3D23438%26epage%3D23447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Yong  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhi-Jie  Weng</span>, <span class="hlFld-ContribAuthor ">Peng  Xie</span>, <span class="hlFld-ContribAuthor ">Mei-Yu  Zhu</span>, <span class="hlFld-ContribAuthor ">Long-Xuan  Xing</span>, <span class="hlFld-ContribAuthor ">Jian-Qi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>86 </em>, 219-234. <a href="https://doi.org/10.1016/j.ejmech.2014.08.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.08.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.08.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bpharmacological%252Binvestigation%252Bof%252Baralkyl%252Bdiamine%252Bderivatives%252Bas%252Bpotential%252Btriple%252Breuptake%252Binhibitors%26aulast%3DZheng%26aufirst%3DYong-Yong%26date%3D2014%26volume%3D86%26spage%3D219%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eiji  Honda</span>, <span class="hlFld-ContribAuthor ">Yuji  Ishichi</span>, <span class="hlFld-ContribAuthor ">Eiji  Kimura</span>, <span class="hlFld-ContribAuthor ">Masato  Yoshikawa</span>, <span class="hlFld-ContribAuthor ">Naoyuki  Kanzaki</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Yasuko  Terao</span>, <span class="hlFld-ContribAuthor ">Atsuko  Suzuki</span>, <span class="hlFld-ContribAuthor ">Takayuki  Kawai</span>, <span class="hlFld-ContribAuthor ">Yuuichi  Arakawa</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Ohta</span>, <span class="hlFld-ContribAuthor ">Jun  Terauchi</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 3898-3902. <a href="https://doi.org/10.1016/j.bmcl.2014.06.046" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.06.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.06.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.06.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bactivities%252Bof%252B1-aryl-1%25252C4-diazepan-2-one%252Bderivatives%252Bas%252Bnovel%252Btriple%252Breuptake%252Binhibitors%26aulast%3DHonda%26aufirst%3DEiji%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3898%26epage%3D3902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jung-eun  Park</span>, <span class="hlFld-ContribAuthor ">Chiman  Song</span>, <span class="hlFld-ContribAuthor ">Keehyun  Choi</span>, <span class="hlFld-ContribAuthor ">Taebo  Sim</span>, <span class="hlFld-ContribAuthor ">Bongjin  Moon</span>, <span class="hlFld-ContribAuthor ">Eun Joo  Roh</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (20)
                                     , 5515-5518. <a href="https://doi.org/10.1016/j.bmcl.2013.08.062" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.08.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.08.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.08.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B3%25252C4-diaryl%252Blactam%252Bderivatives%252Bas%252Btriple%252Breuptake%252Binhibitors%26aulast%3DPark%26aufirst%3DJung-eun%26date%3D2013%26volume%3D23%26issue%3D20%26spage%3D5515%26epage%3D5518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benoît  de Carné-Carnavalet</span>, <span class="hlFld-ContribAuthor ">Alexis  Archambeau</span>, <span class="hlFld-ContribAuthor ">Christophe  Meyer</span>, <span class="hlFld-ContribAuthor ">Janine  Cossy</span>, <span class="hlFld-ContribAuthor ">Benoît  Folléas</span>, <span class="hlFld-ContribAuthor ">Jean-Louis  Brayer</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Demoute</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Substituted 3-Azabicyclo[3.1.0]hexan-2-ones from 2-Iodocyclopropanecarboxamides Using a Copper-Free Sonogashira Coupling. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2012,</strong> <em>18 </em>
                                    (52)
                                     , 16716-16727. <a href="https://doi.org/10.1002/chem.201203153" title="DOI URL">https://doi.org/10.1002/chem.201203153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201203153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201203153%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DEfficient%252BSynthesis%252Bof%252BSubstituted%252B3-Azabicyclo%25255B3.1.0%25255Dhexan-2-ones%252Bfrom%252B2-Iodocyclopropanecarboxamides%252BUsing%252Ba%252BCopper-Free%252BSonogashira%252BCoupling%26aulast%3Dde%25E2%2580%2585Carn%25C3%25A9-Carnavalet%26aufirst%3DBeno%25C3%25AEt%26date%3D2012%26date%3D2012%26volume%3D18%26issue%3D52%26spage%3D16716%26epage%3D16727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Yong  Zheng</span>, <span class="hlFld-ContribAuthor ">Lin  Guo</span>, <span class="hlFld-ContribAuthor ">Xue-Chu  Zhen</span>, <span class="hlFld-ContribAuthor ">Jian-Qi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>54 </em>, 123-136. <a href="https://doi.org/10.1016/j.ejmech.2012.04.030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.04.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.04.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.04.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantidepressant%252Bactivity%252Bof%252Barylalkanol-piperidine%252Bderivatives%252Bas%252Btriple%252Breuptake%252Binhibitors%26aulast%3DZheng%26aufirst%3DYong-Yong%26date%3D2012%26volume%3D54%26spage%3D123%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krystyna  Golembiowska</span>, <span class="hlFld-ContribAuthor ">Magdalena  Kowalska</span>, <span class="hlFld-ContribAuthor ">Frank P.  Bymaster</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activity. </span><span class="cited-content_cbyCitation_journal-name">Synapse</span><span> <strong>2012,</strong> <em>66 </em>
                                    (5)
                                     , 435-444. <a href="https://doi.org/10.1002/syn.21531" title="DOI URL">https://doi.org/10.1002/syn.21531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/syn.21531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fsyn.21531%26sid%3Dliteratum%253Aachs%26jtitle%3DSynapse%26atitle%3DEffects%252Bof%252Bthe%252Btriple%252Breuptake%252Binhibitor%252Bamitifadine%252Bon%252Bextracellular%252Blevels%252Bof%252Bmonoamines%252Bin%252Brat%252Bbrain%252Bregions%252Band%252Bon%252Blocomotor%252Bactivity%26aulast%3DGolembiowska%26aufirst%3DKrystyna%26date%3D2012%26date%3D2012%26volume%3D66%26issue%3D5%26spage%3D435%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. B.  Lapa</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular-biological problems of drug design and mechanism of drug action. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Chemistry Journal</span><span> <strong>2011,</strong> <em>45 </em>
                                    (6)
                                     , 323-328. <a href="https://doi.org/10.1007/s11094-011-0626-7" title="DOI URL">https://doi.org/10.1007/s11094-011-0626-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11094-011-0626-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11094-011-0626-7%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Chemistry%2520Journal%26atitle%3DMolecular-biological%252Bproblems%252Bof%252Bdrug%252Bdesign%252Band%252Bmechanism%252Bof%252Bdrug%252Baction%26aulast%3DLapa%26aufirst%3DG.%2BB.%26date%3D2011%26date%3D2011%26volume%3D45%26issue%3D6%26spage%3D323%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jolanda  Prins</span>, <span class="hlFld-ContribAuthor ">Berend  Olivier</span>, <span class="hlFld-ContribAuthor ">S Mechiel  Korte</span>. </span><span class="cited-content_cbyCitation_article-title">Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2011,</strong> <em>20 </em>
                                    (8)
                                     , 1107-1130. <a href="https://doi.org/10.1517/13543784.2011.594039" title="DOI URL">https://doi.org/10.1517/13543784.2011.594039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2011.594039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2011.594039%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DTriple%252Breuptake%252Binhibitors%252Bfor%252Btreating%252Bsubtypes%252Bof%252Bmajor%252Bdepressive%252Bdisorder%25253A%252Bthe%252Bmonoamine%252Bhypothesis%252Brevisited%26aulast%3DPrins%26aufirst%3DJolanda%26date%3D2011%26date%3D2011%26volume%3D20%26issue%3D8%26spage%3D1107%26epage%3D1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>, <span class="hlFld-ContribAuthor ">Paolo  Cavanni</span>, <span class="hlFld-ContribAuthor ">Michela  Bettati</span>, <span class="hlFld-ContribAuthor ">Giorgio  Bonanomi</span>, <span class="hlFld-ContribAuthor ">Romano  Di Fabio</span>, <span class="hlFld-ContribAuthor ">Elettra  Fazzolari</span>, <span class="hlFld-ContribAuthor ">Carla  Marchioro</span>, <span class="hlFld-ContribAuthor ">Maja  Roscic</span>, <span class="hlFld-ContribAuthor ">Luca  Tarsi</span>, <span class="hlFld-ContribAuthor ">Filippo  Visentini</span>, <span class="hlFld-ContribAuthor ">Laura  Zonzini</span>, <span class="hlFld-ContribAuthor ">Angela  Worby</span>. </span><span class="cited-content_cbyCitation_article-title">1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2011,</strong> <em>19 </em>
                                    (11)
                                     , 3451-3461. <a href="https://doi.org/10.1016/j.bmc.2011.04.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.04.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.04.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D1-Heteroaryl-6-%2525283%25252C4-dichlorophenyl%252529-3-azabicyclo%25255B4.1.0%25255Dheptane%25253A%252BFurther%252Binsights%252Binto%252Ba%252Bclass%252Bof%252Btriple%252Bre-uptake%252Binhibitors%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2011%26volume%3D19%26issue%3D11%26spage%3D3451%26epage%3D3461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guillaume  Hache</span>, <span class="hlFld-ContribAuthor ">François  Coudore</span>, <span class="hlFld-ContribAuthor ">Alain M.  Gardier</span>, <span class="hlFld-ContribAuthor ">Bruno P.  Guiard</span>. </span><span class="cited-content_cbyCitation_article-title">Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs). </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2011,</strong> <em>4 </em>
                                    (2)
                                     , 285-342. <a href="https://doi.org/10.3390/ph4020285" title="DOI URL">https://doi.org/10.3390/ph4020285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph4020285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph4020285%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DMonoaminergic%252BAntidepressants%252Bin%252Bthe%252BRelief%252Bof%252BPain%25253A%252BPotential%252BTherapeutic%252BUtility%252Bof%252BTriple%252BReuptake%252BInhibitors%252B%252528TRIs%252529%26aulast%3DHache%26aufirst%3DGuillaume%26date%3D2011%26date%3D2011%26volume%3D4%26issue%3D2%26spage%3D285%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Prins</span>, <span class="hlFld-ContribAuthor ">K.G.C.  Westphal</span>, <span class="hlFld-ContribAuthor ">G.A.H.  Korte-Bouws</span>, <span class="hlFld-ContribAuthor ">M.S.  Quinton</span>, <span class="hlFld-ContribAuthor ">R.  Schreiber</span>, <span class="hlFld-ContribAuthor ">B.  Olivier</span>, <span class="hlFld-ContribAuthor ">S.M.  Korte</span>. </span><span class="cited-content_cbyCitation_article-title">The potential and limitations of DOV 216,303 as a triple reuptake inhibitor for the treatment of major depression: A microdialyis study in olfactory bulbectomized rats. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Biochemistry and Behavior</span><span> <strong>2011,</strong> <em>97 </em>
                                    (3)
                                     , 444-452. <a href="https://doi.org/10.1016/j.pbb.2010.10.001" title="DOI URL">https://doi.org/10.1016/j.pbb.2010.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbb.2010.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbb.2010.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Biochemistry%2520and%2520Behavior%26atitle%3DThe%252Bpotential%252Band%252Blimitations%252Bof%252BDOV%252B216%25252C303%252Bas%252Ba%252Btriple%252Breuptake%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252Bmajor%252Bdepression%25253A%252BA%252Bmicrodialyis%252Bstudy%252Bin%252Bolfactory%252Bbulbectomized%252Brats%26aulast%3DPrins%26aufirst%3DJ.%26date%3D2011%26volume%3D97%26issue%3D3%26spage%3D444%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto  Profeta</span>, <span class="hlFld-ContribAuthor ">Jens  Klein</span>, <span class="hlFld-ContribAuthor ">Simone  Spada</span>, <span class="hlFld-ContribAuthor ">Francesco  Ferroni</span>, <span class="hlFld-ContribAuthor ">Alfredo  Paio</span>, <span class="hlFld-ContribAuthor ">Daniele  Andreotti</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 5-(3,4-dichlorophenyl)-4-[(methyloxy)methyl]-2-azabicyclo[3.2.1]octane derivatives as constrained aryl-piperidines with activity as triple re-uptake inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2010,</strong> <em>51 </em>
                                    (42)
                                     , 5521-5524. <a href="https://doi.org/10.1016/j.tetlet.2010.07.145" title="DOI URL">https://doi.org/10.1016/j.tetlet.2010.07.145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2010.07.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2010.07.145%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252B5-%2525283%25252C4-dichlorophenyl%252529-4-%25255B%252528methyloxy%252529methyl%25255D-2-azabicyclo%25255B3.2.1%25255Doctane%252Bderivatives%252Bas%252Bconstrained%252Baryl-piperidines%252Bwith%252Bactivity%252Bas%252Btriple%252Bre-uptake%252Binhibitors%26aulast%3DProfeta%26aufirst%3DRoberto%26date%3D2010%26volume%3D51%26issue%3D42%26spage%3D5521%26epage%3D5524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of known monoaminergic reuptake inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. The triple reuptake inhibitors pharmacophore. Coding of features: blue sphere, positive ionizable; pink spheres, H-bond acceptor; green spheres, hydrophobic; orange sphere, aromatic ring. Distances among the pharmacophoric points are shown in angstroms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0013.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Procedures for the Preparation of Compounds <b>1</b>−<b>39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>X = O, S, C; Ar = napthyl for derivatives <b>37</b>, <b>38</b>, <b>39</b>, and 3,4-dichlorophenyl for the other mentioned compounds. (i) ArNH<sub>2</sub>, CuCl<sub>2</sub>, tBuNO<sub>2</sub>, CH3CN, 0 °C; (ii) Me<sub>2</sub>SCH<sub>2</sub>CO<sub>2</sub>Et<sup>+</sup> Br<sup>−</sup>, NaH, or ethyldiazoacetate/THF 0 °C to rt; (iii) BH<sub>3</sub>−THF in THF at reflux; (iv) (a) BOC<sub>2</sub>O, TEA, CH<sub>2</sub>Cl<sub>2</sub>, (b) NaH, RX in THF/DMF, (c) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt; (v) (a) BOC<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, (b) MsCl/Et<sub>3</sub>N followed by RONa or RSNa or RMgBr, (c) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. The exo derivatives <b>15</b> and <b>16</b> fitted in the pharmacophore model in comparison with the potential endo isomers. It can be clearly seen, both in terms of visual overlapping and in terms of phase Fitness (ranging from 0 to 1, the higher the better), that the triple reuptake inhibitors pharmacophore superimposes much better with the exo isomers with respect to the corresponding endo isomers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0014.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Procedures for the Preparation of Compounds <b>40</b>−<b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>PG = H or BOC (i) (a) BOC<sub>2</sub>O, TEA, CH<sub>2</sub>Cl<sub>2</sub>, (b) Dess−Martin periodinane; (ii) Me(Ph)<sub>3</sub>P<sup>+</sup>Br<sup>−</sup>, BuLi, THF; (iii) (a) BH<sub>3</sub>−THF, THF, (b) NaOH, H<sub>2</sub>O<sub>2</sub> 30%, (c) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt; (iv) NaH, RX in THF/DMF; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0015.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. General Synthetic Procedures for the Preparation of Compounds <b>45</b>−<b>49</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>PG = H or BOC, R = OH or NHAlk, HET = heterocycle (i) (a) Jones reagent at 0 °C in CH<sub>2</sub>Cl<sub>2</sub>, (b) HOBT, EDC, NH<sub>4</sub>R; (ii) (a) heating with appropriate halo-ketone, (b) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt; (iii) steps from (i) to (iii) in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>; (iv) (a) Jones reagent at 0 °C in CH<sub>2</sub>Cl<sub>2</sub>, (b) HOBT, EDC, NH<sub>4</sub>OH, (c) Lawesson’s reagent, (d) heating with appropriate halo-ketone, (e) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt.</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. The exo derivative <b>50</b> fitted in the pharmacophore model in comparison with the endo isomer <b>51</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0016.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Synthetic Procedures for the Preparation of Compounds <b>50</b>−<b>55</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>PG = H or BOC; (i) toluene, reflux; (ii) BH<sub>3</sub>−THF, refluxing THF; (iii) (a) RX, NaH, DMF from 0 °C to rt, (b) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt.</p></p></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0017.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. General Synthetic Procedures for the Preparation of Compounds <b>56</b>−<b>60</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>PG = H or BOC; (i) (a) BOC<sub>2</sub>O, TEA, CH<sub>2</sub>Cl<sub>2</sub>, (b) Dess−Martin periodinane; (ii) Me(Ph)<sub>3</sub>P<sup>+</sup>Br<sup>−</sup>, BuLi, THF; (iii) (a) BH<sub>3</sub>−THF, THF, (b) NaOH, H<sub>2</sub>O<sub>2</sub> 30%; (iv) (a) or MsCl/TEA in CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt followed by RONa in DMF, (b) TFA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to rt.</p></p></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Time course of the effect of <b>15</b> on norepinephrine (diamond), dopamine (square), and serotonin (triangle) outflow in the rat medial prefrontal cortex. Arrow shows injection. Data are mean ± SEM of neurotransmitter concentration expressed as percentage of basal values. Doses tested = 1 mg/kg, ip.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Time course of the effect of <b>15</b> on rat locomotor activity at 1 mg/kg ip.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of derivative <b>15</b> in the FST model (left panel) on the spontaneous locomotor activity (middle panel) and in the 5-HTP model (right panel) in mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Upper panel: signal-to-noise and raw VCD spectra of <b>15</b> (red) and <b>16</b> (blue). Lower panel: baseline corrected VCD spectra of <b>15</b> (red) and <b>16</b> (blue). Bands in the experimental assignment set have been labeled in raw and baseline corrected VCD data.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/medium/jm-2009-01818u_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0012.jpeg" id="rightTab-_i24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (a) Upper panel: VCD spectrum of <b>15</b> (red) vs calculated VCD spectrum (black). Lower panel: IR spectrum of <b>15</b> (red) compared with calculated IR spectrum (black). Bands in the experimental assignment set have been labeled in both experimental and calculated VCD spectra. (b) Upper panel: VCD spectrum of <b>16</b> (blue) vs calculated VCD spectrum (black). Lower panel: IR spectrum of <b>16</b> (blue) compared with calculated IR spectrum (black). Bands in the experimental assignment set have been labeled in both experimental and calculated VCD spectra.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm901818u/production/images/large/jm-2009-01818u_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901818u&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 13 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kulkarni, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhir, A.</span><span> </span><span class="NLM_article-title">Current investigational drugs for major depression</span> <span class="citation_source-journal">Exp. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=767-788&author=S.+K.+Kulkarniauthor=A.+Dhir&title=Current+investigational+drugs+for+major+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DS.%2BK.%26aulast%3DDhir%26aufirst%3DA.%26atitle%3DCurrent%2520investigational%2520drugs%2520for%2520major%2520depression%26jtitle%3DExp.%2520Opin.%2520Investig.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D767%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wong, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licinio, J.</span><span> </span><span class="NLM_article-title">From monoamines to genomic targets: a paradigm shift for drug discovery in depression</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=136-151&author=M.+L.+Wongauthor=J.+Licinio&title=From+monoamines+to+genomic+targets%3A+a+paradigm+shift+for+drug+discovery+in+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DM.%2BL.%26aulast%3DLicinio%26aufirst%3DJ.%26atitle%3DFrom%2520monoamines%2520to%2520genomic%2520targets%253A%2520a%2520paradigm%2520shift%2520for%2520drug%2520discovery%2520in%2520depression%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D136%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">The role of monoamines in the actions of established and “novel” antidepressant agents: a critical review</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">500</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1016%2Fj.ejphar.2004.07.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=15464046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFCksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=500&publication_year=2004&pages=371-384&author=M.+J.+Millan&title=The+role+of+monoamines+in+the+actions+of+established+and+%E2%80%9Cnovel%E2%80%9D+antidepressant+agents%3A+a+critical+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review</span></div><div class="casAuthors">Millan, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">500</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">371-384</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with refs.  Monoaminergic pathways are highly responsive to aversive stimuli and play a crucial role in the control of affect, cognition, endocrine secretion, chronobiotic rhythms, appetite, and motor function, all of which are profoundly disrupted in depressive states.  Accordingly, a perturbation of monoaminergic transmission is implicated in the etiol. of depressive disorders, and all clin. available antidepressants increase corticolimbic availability of monoamines.  However, their limited efficacy, delayed onset of action, and undesirable side effects underlie ongoing efforts to identify improved therapeutic agents.  Sequencing the human genome has raised the hope not only of better symptomatic control of depression, but even of the prevention or cure of depressive states.  In the pursuit of these goals, there is currently a tendency to focus on selective ligands of "novel" nonmonoaminergic targets.  However, certain classes of novel agent (such as neurokinin1 receptor antagonists) indirectly modulate the activity of monoaminergic networks.  Others may act "downstream" of them, converging onto common cellular substrates controlling gene expression, synaptic plasticity, and neuro-genesis.  Further, by analogy to the broad-based actions of currently employed drugs, multitarget agents may be better adapted than selective agents to the management of depression-a complex disorder with hereditary, developmental, and environmental origins.  It is, thus, important to continue the creative exploration of clin. validated and innovative monoaminergic strategies within a multitarget framework.  In this light, drugs combining monoaminergic and nonmonoaminergic mechanisms of action may be of particular interest.  The present article provides a crit. overview of monoaminergic strategies for the treatment of depressive states, both established and under development, and discusses interactions of novel "nonmonoaminergic" antidepressants with monoaminergic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX0IAhuXmLZLVg90H21EOLACvtfcHk0lg0Ex9VTLACrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFCksrs%253D&md5=3a3daa1e9f11b905a3117b73945f144c</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.07.038%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520role%2520of%2520monoamines%2520in%2520the%2520actions%2520of%2520established%2520and%2520%25E2%2580%259Cnovel%25E2%2580%259D%2520antidepressant%2520agents%253A%2520a%2520critical%2520review%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D500%26spage%3D371%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Nemeroff, C. B.</span><span> </span><span class="NLM_article-title">The burden of severe depression: a review of diagnostic challenges and treatment alternatives</span> <span class="citation_source-journal">J. Psychiatry Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1016%2Fj.jpsychires.2006.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=16870212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A280%3ADC%252BD28jitFyjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2007&pages=189-206&author=C.+B.+Nemeroff&title=The+burden+of+severe+depression%3A+a+review+of+diagnostic+challenges+and+treatment+alternatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">The burden of severe depression: a review of diagnostic challenges and treatment alternatives</span></div><div class="casAuthors">Nemeroff Charles B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">189-206</span>
        ISSN:<span class="NLM_cas:issn">0022-3956</span>.
    </div><div class="casAbstract">Among the factors making recognition of severe depression problematic for clinicians are the heterogeneous nature of the condition, lack of standardized definitions, and concomitant comorbidities that confound differential diagnosis of symptoms.  The spectrum of severity in depressive disorders is extraordinarily broad, and severity assessment is comprised of several metrics including symptom intensity, diagnostic subtypes, suicidality risk, and hospitalization status.  The overall diagnosis is achieved through consideration of symptom types and severities together with the degree of functional impairment as assessed by the psychiatric interview.  It is likely that no single fundamental neurobiological defect underlies severe depression.  The chronicity and heterogeneity of this disorder lead to frequent clinic visits and a longer course of treatment; therefore, successful approaches may require an arsenal of treatments with numerous mechanisms of action.  The categories of drugs used to treat severe depression are detailed herein, as are several non-pharmacologic options including a number of experimental treatments.  Pharmacotherapies include tricyclic antidepressants, selective serotonin reuptake inhibitors, atypical antidepressants such as serotonin-norepinephrine reuptake inhibitors and monoamine oxidase inhibitors, and combination and augmentation therapies.  Drugs within each class are not equivalent, and efficacy may vary with symptom severity.  Patient adherence makes tolerability another critical consideration in antidepressant choice.  The role of non-pharmacological treatments such as electroconvulsive therapy, vagus nerve stimulation, transcranial magnetic stimulation, and deep brain stimulation remain active avenues of investigation.  Improved knowledge and treatment approaches for severe depression are necessary to facilitate remission, the ideal treatment goal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTa1sdgx26OuvcsfMJQC1ZdfW6udTcc2eaaNpFAsi4-oLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jitFyjsw%253D%253D&md5=139d46fa0bc3eb364c7ffb8f338e080b</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1016%2Fj.jpsychires.2006.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpsychires.2006.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DThe%2520burden%2520of%2520severe%2520depression%253A%2520a%2520review%2520of%2520diagnostic%2520challenges%2520and%2520treatment%2520alternatives%26jtitle%3DJ.%2520Psychiatry%2520Res.%26date%3D2007%26volume%3D41%26spage%3D189%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Arnt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyttel, J.</span><span> </span><span class="NLM_article-title">Pharmacology in vivo of the phenylindan derivative, Lu-19,005, a new potent inhibitor of dopamine, noradrenaline, and 5-hydroxytryptamine uptake in rat brain</span> <span class="citation_source-journal">Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1007%2FBF00501197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADyaL2MXksVyjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1985&pages=101-107&author=J.+Arntauthor=A.+V.+Christensenauthor=J.+Hyttel&title=Pharmacology+in+vivo+of+the+phenylindan+derivative%2C+Lu-19%2C005%2C+a+new+potent+inhibitor+of+dopamine%2C+noradrenaline%2C+and+5-hydroxytryptamine+uptake+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology in vivo of the phenylindan derivative, Lu 19005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain</span></div><div class="casAuthors">Arnt, Joern; Vibeke Christensen, Anne; Hyttel, John</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-7</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">Lu 19005 (I)  [97229-15-7] induced stereotyped behavior in rats after parenteral and oral administration with a duration of action of more than 24 h.  The stereotyped licking and biting induced by Lu 19005 was antagonized by reserpine and cis-(Z)-flupentixol, but not affected by prazosin, p-chlorophenylalanine and α-methyl-p-tyrosine pretreatments.  Metergoline slightly facilitated the onset of stereotypy.  Lower doses of Lu 19005 induced ipsilateral circling in unilaterally 6-hydroxydopamine-lesioned rats.  Lu 19005 antagonized the catalepsy induced by perphenazine.  In mice, Lu 19005 potentiated the apomorphine-induced gnawing, reversed tetrabenazine-induced ptosis and potentiated the behavioral effects of 5-HTP within a similar dose range.  The effects of Lu 19005 were compared with those of other ref. compds.  Nomifensine had qual. similar effects in rats although of much shorter duration.  In mice, nomifensine selectively reversed tetrabenazine-induced ptosis.  Weaker effects in all test models were found with bupropion, LR 5182 and GBR 13069, compds. with inhibitory effect on dopamine (DA)  [51-61-6] and noradrenaline (NA)  [51-41-2] uptake.  The DA-, NA- and 5-HT  [50-67-9]-uptake inhibitor diclofensine, however, had no effect in rats except in the 6-hydroxy-DA-circling test and had low potency in mice.  The specific 5-HT- and NA-uptake inhibitors citalopram and talsupram, resp., were ineffective in all rat models.  They selectively potentiated 5-HTP or reversed tetrabenazine-induced ptosis in mice, resp., as expected according to their in vitro profile.  Apparently, DA mechanisms are responsible for the behavioral activity of the test compds. in the rat models and the circling model is the most sensitive.  Since DA may be involved in some depressive states, Lu 19-005 could be an attractive new antidepressant as it combines the pharmacol. profile of established antidepressants (effect on NA and/or 5-HT uptake) with equipotent activity on DA uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYH_fmJknOFrVg90H21EOLACvtfcHk0lhZDaYPVLb4Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXksVyjtb4%253D&md5=91efaa8773f2ebdc1cb1fc1d58cd23fa</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1007%2FBF00501197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00501197%26sid%3Dliteratum%253Aachs%26aulast%3DArnt%26aufirst%3DJ.%26aulast%3DChristensen%26aufirst%3DA.%2BV.%26aulast%3DHyttel%26aufirst%3DJ.%26atitle%3DPharmacology%2520in%2520vivo%2520of%2520the%2520phenylindan%2520derivative%252C%2520Lu-19%252C005%252C%2520a%2520new%2520potent%2520inhibitor%2520of%2520dopamine%252C%2520noradrenaline%252C%2520and%25205-hydroxytryptamine%2520uptake%2520in%2520rat%2520brain%26jtitle%3DArch.%2520Pharmacol.%26date%3D1985%26volume%3D329%26spage%3D101%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnick, P.</span><span> </span><span class="NLM_article-title">Triple uptake inhibitors: therapeutic potential in depression and beyond</span> <span class="citation_source-journal">Expert Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1365</span><span class="NLM_x">–</span> <span class="NLM_lpage">1377</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=1365-1377&author=Z.+Chenauthor=P.+Skolnick&title=Triple+uptake+inhibitors%3A+therapeutic+potential+in+depression+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DTriple%2520uptake%2520inhibitors%253A%2520therapeutic%2520potential%2520in%2520depression%2520and%2520beyond%26jtitle%3DExpert%2520Opin.%2520Investig.%2520Drugs%26date%3D2007%26volume%3D16%26spage%3D1365%26epage%3D1377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rakofsky, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzheimer, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeroff, C. B.</span><span> </span><span class="NLM_article-title">Emerging targets for antidepressant therapies</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1016%2Fj.cbpa.2009.04.617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=19501541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVWlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=291-302&author=J.+J.+Rakofskyauthor=P.+E.+Holtzheimerauthor=C.+B.+Nemeroff&title=Emerging+targets+for+antidepressant+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging targets for antidepressant therapies</span></div><div class="casAuthors">Rakofsky, Jeffrey J.; Holtzheimer, Paul E.; Nemeroff, Charles B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-302</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Despite adequate antidepressant monotherapy, the majority of depressed patients do not achieve remission.  Even optimal and aggressive therapy leads to a substantial no. of patients who show minimal and often only transient improvement.  In order to address this substantial problem of treatment-resistant depression, a no. of novel targets for antidepressant therapy have emerged as a consequence of major advances in the neurobiol. of depression.  Three major approaches to uncover novel therapeutic interventions are: first, optimizing the modulation of monoaminergic neurotransmission; second, developing medications that act upon neurotransmitter systems other than monoaminergic circuits; and third, using focal brain stimulation to directly modulate neuronal activity.  We review the most recent data on novel therapeutic compds. and their antidepressant potential.  These include triple monoamine reuptake inhibitors, atypical antipsychotic augmentation, and dopamine receptor agonists.  Compds. affecting extra-monoamine neurotransmitter systems include CRF1 receptor antagonists, glucocorticoid receptor antagonists, substance P receptor antagonists, NMDA receptor antagonists, nemifitide, omega-3 fatty acids, and melatonin receptor agonists.  Focal brain stimulation therapies include vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), magnetic seizure therapy (MST), transcranial d.c. stimulation (tDCS), and deep brain stimulation (DBS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu5V4xl00lILVg90H21EOLACvtfcHk0lhZDaYPVLb4Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVWlurw%253D&md5=c397dbd55b1527943fb35d204ddc057f</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2009.04.617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2009.04.617%26sid%3Dliteratum%253Aachs%26aulast%3DRakofsky%26aufirst%3DJ.%2BJ.%26aulast%3DHoltzheimer%26aufirst%3DP.%2BE.%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DEmerging%2520targets%2520for%2520antidepressant%2520therapies%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D13%26spage%3D291%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boules, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briody, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveros, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blazar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlier, P. R</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Antidepressant like pharmacological profile of a novel triple reuptake inhibitor, (1<i>S</i>,2<i>S</i>)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1124%2Fjpet.108.143610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=18689611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=573-583&author=Y.+Liangauthor=A.+M.+Shawauthor=M.+Boulesauthor=S.+Briodyauthor=J.+Robinsonauthor=A.+Oliverosauthor=E.+Blazarauthor=K.+Williamsauthor=Y.+Zhangauthor=P.+R+Carlier&title=Antidepressant+like+pharmacological+profile+of+a+novel+triple+reuptake+inhibitor%2C+%281S%2C2S%29-3-%28methylamino%29-2-%28naphthalen-2-yl%29-1-phenylpropan-1-ol+%28PRC200-SS%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)</span></div><div class="casAuthors">Liang, Yanqi; Shaw, Amanda M.; Boules, Mona; Briody, Siobhan; Robinson, Jessica; Oliveros, Alfredo; Blazar, Eric; Williams, Katrina; Zhang, Yiqun; Carlier, Paul R.; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-583</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Due to the putative involvement of dopaminergic circuits in depression, triple reuptake inhibitors are being developed as a new class of antidepressant, which is hypothesized to produce a more rapid onset and better efficacy than current antidepressants selective for serotonin or norepinephrine neurotransmission.  (1S,2S)-3-(Methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC 200SS), a new triple reuptake inhibitor, potently bound to the human serotonin, norepinephrine, and dopamine transporters with Kd values of 2.3, 0.63, and 18 nM, resp.  Inhibition of serotonin, norepinephrine, and dopamine uptake by PRC 200SS was also shown in cells expressing the corresponding transporter (Ki values of 2.1, 1.5, and 61 nM, resp.).  In vivo, PRC 200SS dose-dependently decreased immobility in the forced-swim test in rats and in the tail-suspension test in mice, models predictive of antidepressant activity, with effects comparable with imipramine.  These results in the behavioral models did not seem to result from the stimulation of locomotor activity.  Consistent with the in vitro data and behavioral effects, peripheral administration of PRC 200SS (5 and 10 mg/kg i.p.) significantly increased extracellular levels of serotonin and norepinephrine in the medial prefrontal cortex, and of serotonin and dopamine in the core of nucleus accumbens, with redn. of levels of 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindoleacetic acid compared with levels for saline control.  Furthermore, PRC 200SS self-administration, which was used as a marker of abuse liability, was not obsd. with rats.  Therefore, it seems that PRC 200SS may represent a novel triple reuptake inhibitor and possess antidepressant activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsjq1Ko19NBbVg90H21EOLACvtfcHk0liWnV1-7qUijA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vJ&md5=1cfb6ece94bf5fa1187219d03f676d09</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.143610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.143610%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DShaw%26aufirst%3DA.%2BM.%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DBriody%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DOliveros%26aufirst%3DA.%26aulast%3DBlazar%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCarlier%26aufirst%3DP.%2BR%26atitle%3DAntidepressant%2520like%2520pharmacological%2520profile%2520of%2520a%2520novel%2520triple%2520reuptake%2520inhibitor%252C%2520%25281S%252C2S%2529-3-%2528methylamino%2529-2-%2528naphthalen-2-yl%2529-1-phenylpropan-1-ol%2520%2528PRC200-SS%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D573%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Skolnick, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, A. S.</span><span> </span><span class="NLM_article-title">‘‘Broad spectrum’’ antidepressants: is more better for the treatment of depression?</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">3175</span><span class="NLM_x">–</span> <span class="NLM_lpage">3179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=3175-3179&author=P.+Skolnickauthor=P.+Popikauthor=A.+Janowskyauthor=B.+Beerauthor=A.+S.+Lippa&title=%E2%80%98%E2%80%98Broad+spectrum%E2%80%99%E2%80%99+antidepressants%3A+is+more+better+for+the+treatment+of+depression%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DPopik%26aufirst%3DP.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DBeer%26aufirst%3DB.%26aulast%3DLippa%26aufirst%3DA.%2BS.%26atitle%3D%25E2%2580%2598%25E2%2580%2598Broad%2520spectrum%25E2%2580%2599%25E2%2580%2599%2520antidepressants%253A%2520is%2520more%2520better%2520for%2520the%2520treatment%2520of%2520depression%253F%26jtitle%3DLife%2520Sci.%26date%3D2003%26volume%3D73%26spage%3D3175%26epage%3D3179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span> </span><span class="NLM_article-title">In vitro and in vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">587</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2f&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1016%2Fj.ejphar.2008.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2f&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=18499098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2f&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFGltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=587&publication_year=2008&pages=141-146&author=L.+Aluisioauthor=B.+Lordauthor=A.+J.+Barbierauthor=I.+C.+Fraserauthor=S.+J.+Wilsonauthor=J.+Boggsauthor=L.+K.+Dvorakauthor=M.+A.+Letavicauthor=B.+E.+Maryanoffauthor=N.+I.+Carruthers&title=In+vitro+and+in+vivo+characterization+of+JNJ-7925476%2C+a+novel+triple+monoamine+uptake+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2fR"><div class="casContent"><span class="casTitleNuber">2f</span><div class="casTitle"><span class="NLM_cas:atitle">In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor</span></div><div class="casAuthors">Aluisio, Leah; Lord, Brian; Barbier, Ann J.; Fraser, Ian C.; Wilson, Sandy J.; Boggs, Jamin; Dvorak, Lisa K.; Letavic, Michael A.; Maryanoff, Bruce E.; Carruthers, Nicholas I.; Bonaventure, Pascal; Lovenberg, Timothy W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">587</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">141-146</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Triple reuptake inhibitors, which block the serotonin transporter (SERT), norepinephrine transporter (NET) and dopamine transporter (DAT) in the central nervous system have been described as therapeutic alternatives for classical selective serotonin reuptake inhibitors, with advantages due to their multiple mechanisms of action.  JNJ-7925476 (trans-6-(4-ethynylphenyl)-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline) is a selective and potent inhibitor of the SERT, NET, and DAT (K i = 0.9, 17 and 5.2 nM, resp.).  Following s.c. dosing in rat, JNJ-7925476 was rapidly absorbed into the plasma, and drug concns. in the brain tracked with those in the plasma but were 7-fold higher.  The ED50 values for JNJ-7925476 occupancy of the SERT, NET, and DAT in rat brain were 0.18, 0.09 and 2.4 mg/kg, resp.  JNJ-7925476 (0.1-10 mg/kg, s.c.) rapidly induced a robust, dose-dependent increase in extracellular serotonin, dopamine, and norepinephrine levels in rat cerebral cortex.  The compd. also showed potent antidepressant-like activity in the mouse tail suspension test (ED50 = 0.3 mg/kg, i.p.).  These results demonstrate that JNJ-7925476 is a triple reuptake inhibitor with in-vivo efficacy in biochem. and behavioral models of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrLdkhiOEPU7Vg90H21EOLACvtfcHk0liWnV1-7qUijA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFGltbc%253D&md5=e55497330670d8ce48403bb2283efe3d</span></div><a href="/servlet/linkout?suffix=cit2f&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBarbier%26aufirst%3DA.%2BJ.%26aulast%3DFraser%26aufirst%3DI.%2BC.%26aulast%3DWilson%26aufirst%3DS.%2BJ.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DDvorak%26aufirst%3DL.%2BK.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520characterization%2520of%2520JNJ-7925476%252C%2520a%2520novel%2520triple%2520monoamine%2520uptake%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D587%26spage%3D141%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Bannwart, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenhouse, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaime-Figueroa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, M. C.</span><span> </span><span class="NLM_article-title">Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6062</span><span class="NLM_x">–</span> <span class="NLM_lpage">6066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6062-6066&author=L.+M.+Bannwartauthor=D.+S.+Carterauthor=H.+Y.+Caiauthor=J.+C.+Choyauthor=R.+Greenhouseauthor=S.+Jaime-Figueroaauthor=P.+S.+Iyerauthor=C.+J.+Linauthor=E.+K.+Leeauthor=M.+C.+Lucas&title=Novel+3%2C3-disubstituted+pyrrolidines+as+selective+triple+serotonin%2Fnorepinephrine%2Fdopamine+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBannwart%26aufirst%3DL.%2BM.%26aulast%3DCarter%26aufirst%3DD.%2BS.%26aulast%3DCai%26aufirst%3DH.%2BY.%26aulast%3DChoy%26aufirst%3DJ.%2BC.%26aulast%3DGreenhouse%26aufirst%3DR.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DLin%26aufirst%3DC.%2BJ.%26aulast%3DLee%26aufirst%3DE.%2BK.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26atitle%3DNovel%25203%252C3-disubstituted%2520pyrrolidines%2520as%2520selective%2520triple%2520serotonin%252Fnorepinephrine%252Fdopamine%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6062%26epage%3D6066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Papakostas, G. I.</span><span> </span><span class="NLM_article-title">Dopaminergic-based pharmacotherapies for depression</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2h&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1016%2Fj.euroneuro.2005.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2h&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=16413172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2h&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFSktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=391-402&author=G.+I.+Papakostas&title=Dopaminergic-based+pharmacotherapies+for+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2hR"><div class="casContent"><span class="casTitleNuber">2h</span><div class="casTitle"><span class="NLM_cas:atitle">Dopaminergic-based pharmacotherapies for depression</span></div><div class="casAuthors">Papakostas, George I.</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">391-402</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The serendipitous discovery of the precursors of two of the major contemporary antidepressant families during the late 1950s, iproniazid for the monoamine oxidase inhibitors (MAOIs) and imipramine for the tricyclic antidepressants (TCAs), has guided the subsequent development of antidepressant compds. with predominantly serotonergic, noradrenergic or combined serotonergic and noradrenergic activity.  Unfortunately, however, many depressed patients continue to remain symptomatic despite adequate treatment with pharmacol. agents currently available.  When one reviews the list of pharmacol. agents currently approved for the treatment of Major Depressive Disorder (MDD), it is apparent that relatively few treatments with dopaminergic activity have been developed to date.  Therefore, developing effective antidepressant treatments with pro-dopaminergic properties which also possess a relatively wide safety margin may further improve the std. of care for depression.  In the present article we will briefly review studies focusing on the role of dopamine in depression followed by a comprehensive review of pharmacotherapies for depression with pro-dopaminergic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJSaNt7Y60YLVg90H21EOLACvtfcHk0liyWrZLuyI8aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFSktr8%253D&md5=d8c07a50f819444bf5d432b99f1d6af4</span></div><a href="/servlet/linkout?suffix=cit2h&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2005.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2005.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DPapakostas%26aufirst%3DG.%2BI.%26atitle%3DDopaminergic-based%2520pharmacotherapies%2520for%2520depression%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2006%26volume%3D16%26spage%3D391%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Skolnick, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, A. S.</span><span> </span><span class="NLM_article-title">Antidepressant-like actions of DOV21,947: a “triple” reuptake inhibitor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">461</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2i&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1016%2FS0014-2999%2803%2901310-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2i&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=12586204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2i&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVanu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2003&pages=99-104&author=P.+Skolnickauthor=P.+Popikauthor=A.+Janowskyauthor=B.+Beerauthor=A.+S.+Lippa&title=Antidepressant-like+actions+of+DOV21%2C947%3A+a+%E2%80%9Ctriple%E2%80%9D+reuptake+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2iR"><div class="casContent"><span class="casTitleNuber">2i</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor</span></div><div class="casAuthors">Skolnick, Phil; Popik, Piotr; Janowsky, Aaron; Beer, Bernard; Lippa, Arnold S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">99-104</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">DOV 21,947 [(+)-1-(3,4-dichlorophenyl)-3-azabicyclo-[3.1.0]hexane hydrochloride] inhibits the reuptake of [3H]serotonin, [3H]norepinephrine, and [3H]dopamine in human embryonic kidney (HEK) 293 cells expressing the corresponding human recombinant transporters (IC50 values of 12, 23, and 96 nM, resp.).  This compd. also inhibits [125I]RTI 55 (3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester) binding to the corresponding transporter proteins in membranes prepd. from these cells (Ki values of 99, 262, and 213 nM, resp.).  DOV 21,947 reduces the duration of immobility in the forced swim test (using rats) with an oral min. ED of 5 mg/kg.  This antidepressant-like effect manifests in the absence of significant increases in motor activity at doses of up to 20 mg/kg.  DOV 21,947 also produces a dose-dependent redn. in immobility in the tail suspension test, with a min. effective oral dose of 5 mg/kg.  The ability of DOV 21,947 to inhibit the reuptake of three biogenic amines closely linked to the etiol. of depression may result in a therapeutic profile different from antidepressants that inhibit the reuptake of serotonin and/or norepinephrine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2Q0j1ranmerVg90H21EOLACvtfcHk0liyWrZLuyI8aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVanu7s%253D&md5=6d48dc293c8237d42932da3effa40b8a</span></div><a href="/servlet/linkout?suffix=cit2i&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2901310-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252901310-4%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DPopik%26aufirst%3DP.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DBeer%26aufirst%3DB.%26aulast%3DLippa%26aufirst%3DA.%2BS.%26atitle%3DAntidepressant-like%2520actions%2520of%2520DOV21%252C947%253A%2520a%2520%25E2%2580%259Ctriple%25E2%2580%259D%2520reuptake%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D461%26spage%3D99%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Scheel-Kruger, J.; Moldt, P; Watjen, F.</span><span> </span><span class="NLM_article-title">Tropane-derivatives, their preparation and use</span>. U.S. Patent 6395748,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+Scheel-Kruger&author=P+Moldt&author=F.+Watjen&title=Tropane-derivatives%2C+their+preparation+and+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26atitle%3DTropane-derivatives%252C%2520their%2520preparation%2520and%2520use%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Scheel-Kruger, J.; Moldt, P; Watjen, F.</span><span> </span><span class="NLM_article-title">Tropane-derivatives, their preparation and use</span>. U.S. Patent 6288079,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=J.+Scheel-Kruger&author=P+Moldt&author=F.+Watjen&title=Tropane-derivatives%2C+their+preparation+and+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26atitle%3DTropane-derivatives%252C%2520their%2520preparation%2520and%2520use%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Scheel-Kruger, J.; Moldt, P; Watjen, F.</span><span> </span><span class="NLM_article-title">Tropane-derivatives, their preparation and use</span>. Patent WO 9730997,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=J.+Scheel-Kruger&author=P+Moldt&author=F.+Watjen&title=Tropane-derivatives%2C+their+preparation+and+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26atitle%3DTropane-derivatives%252C%2520their%2520preparation%2520and%2520use%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Scheel-Kruger, J.; Olsen, G. M.; Nielsen, E. O.; Dahl, B. H.; Jensen, L. H.</span><span> </span><span class="NLM_article-title">Fused tropane derivatives as neurotransmitter reuptake inhibitors</span>. Patent WO 9716451,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=J.+Scheel-Kruger&author=G.+M.+Olsen&author=E.+O.+Nielsen&author=B.+H.+Dahl&author=L.+H.+Jensen&title=Fused+tropane+derivatives+as+neurotransmitter+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26atitle%3DFused%2520tropane%2520derivatives%2520as%2520neurotransmitter%2520reuptake%2520inhibitors%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span>Maestro, version 8.5.111; <span class="NLM_publisher-name">Schrodinger LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+8.5.111%3B+Schrodinger+LLC%3A+New+York%2C+2006%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMaestro%26pub%3DSchrodinger%2520LLC%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span>BatchMin, version 9.6; <span class="NLM_publisher-name">Schrodinger LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=BatchMin%2C+version+9.6%3B+Schrodinger+LLC%3A+New+York%2C+2008%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DBatchMin%26pub%3DSchrodinger%2520LLC%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span>Phase, version 3.0.110; <span class="NLM_publisher-name">Schrodinger LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Phase%2C+version+3.0.110%3B+Schrodinger+LLC%3A+New+York%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPhase%26pub%3DSchrodinger%2520LLC%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="note"><p class="first last">The research complied with national legislation and with company policy on the Care and Use of Animals and with related codes of practice.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Minick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutkowske, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. A. D.</span><span> </span><span class="NLM_article-title">Strategies for successfully applying vibrational circular dichroism in a pharmaceutical research environment</span> <span class="citation_source-journal">Am. Pharmaceut. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVyrsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=118-123&author=D.+J.+Minickauthor=R.+D.+Rutkowskeauthor=L.+A.+D.+Miller&title=Strategies+for+successfully+applying+vibrational+circular+dichroism+in+a+pharmaceutical+research+environment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for successfully applying vibrational circular dichroism in a pharmaceutical research environment</span></div><div class="casAuthors">Minick, Douglas J.; Rutkowske, Randy D.; Miller, Luke A. D.</div><div class="citationInfo"><span class="NLM_cas:title">American Pharmaceutical Review</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">118-123</span>CODEN:
                <span class="NLM_cas:coden">APHRFS</span>;
        ISSN:<span class="NLM_cas:issn">1099-8012</span>.
    
            (<span class="NLM_cas:orgname">Russell Publishing L.L.C</span>)
        </div><div class="casAbstract">A review on ab initio vibrational CD (VCD) for anal. of chiral drug mols.  Key aspects for successfully applying ab initio VCD anal. in an industrial research environment are discussed.  These recommended procedures should not only help to expedite and simplify ab initio VCD analyses, but, most importantly, provide an increased level of confidence in VCD assignments.  Features described include: (1) the use of a large no. of computer processors to maximize sample throughput, (2) a strategy for combining ab initio and comparative VCD studies to assure reliable configurational assignments for series of structurally-related mols., (3) advantages of reduced structure modeling, (4) linear regression anal. for estg. VCD confidence limits, and (5) establishment of a min. acceptability criterion (CL ≥ 90%) for reliable assignments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-j-XQCR9M47Vg90H21EOLACvtfcHk0liyWrZLuyI8aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVyrsrzJ&md5=673dc3fdd64f3dafbc926fc0b372f7dc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinick%26aufirst%3DD.%2BJ.%26aulast%3DRutkowske%26aufirst%3DR.%2BD.%26aulast%3DMiller%26aufirst%3DL.%2BA.%2BD.%26atitle%3DStrategies%2520for%2520successfully%2520applying%2520vibrational%2520circular%2520dichroism%2520in%2520a%2520pharmaceutical%2520research%2520environment%26jtitle%3DAm.%2520Pharmaceut.%2520Rev.%26date%3D2007%26volume%3D10%26spage%3D118%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span>Aptuit Limited, 3 Simpson Parkway, Livingston, West Lothian, EH54 7BH, Scotland; <a href="http://www.aptuit.uk" class="extLink">www.aptuit.uk</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Aptuit+Limited%2C+3+Simpson+Parkway%2C+Livingston%2C+West+Lothian%2C+EH54+7BH%2C+Scotland%3B+www.aptuit.uk."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Zocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span> </span><span class="NLM_article-title">Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2005&pages=157-161&author=A.+Zocchiauthor=D.+Fabbriauthor=C.+A.+Heidbreder&title=Aripiprazole+increases+dopamine+but+not+noradrenaline+and+serotonin+levels+in+the+mouse+prefrontal+cortex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZocchi%26aufirst%3DA.%26aulast%3DFabbri%26aufirst%3DD.%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26atitle%3DAripiprazole%2520increases%2520dopamine%2520but%2520not%2520noradrenaline%2520and%2520serotonin%2520levels%2520in%2520the%2520mouse%2520prefrontal%2520cortex%26jtitle%3DNeurosci.%2520Lett.%26date%3D2005%26volume%3D387%26spage%3D157%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Burchall, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroko, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigdon, G. C.</span><span> </span><span class="NLM_article-title">Potentiation of the behavioral effects of 5-hydroxytryptophan by BW 1370U87, a selective monoamine oxidase-A inhibitor</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1992&pages=209-213&author=C.+J.+Burchallauthor=F.+E.+Sorokoauthor=G.+C.+Rigdon&title=Potentiation+of+the+behavioral+effects+of+5-hydroxytryptophan+by+BW+1370U87%2C+a+selective+monoamine+oxidase-A+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurchall%26aufirst%3DC.%2BJ.%26aulast%3DSoroko%26aufirst%3DF.%2BE.%26aulast%3DRigdon%26aufirst%3DG.%2BC.%26atitle%3DPotentiation%2520of%2520the%2520behavioral%2520effects%2520of%25205-hydroxytryptophan%2520by%2520BW%25201370U87%252C%2520a%2520selective%2520monoamine%2520oxidase-A%2520inhibitor%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1992%26volume%3D25%26spage%3D209%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Martin, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendesky, R. J.</span><span> </span><span class="NLM_article-title">Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">706</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=6144790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADyaL2cXks1GnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1984&pages=706-711&author=G.+E.+Martinauthor=R.+J.+Bendesky&title=Mouse+locomotor+activity%3A+an+in+vivo+test+for+dopamine+autoreceptor+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse locomotor activity:  an in vivo test for dopamine autoreceptor activation</span></div><div class="casAuthors">Martin, Gregory E.; Bendesky, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">706-11</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">A pharmacol. test is described for assessing selective dopamine (DA) autoreceptor activation using locomotor activity (LMA) of the mouse as the dependent variable.  In this test, 3 criteria must be satisfied to indicate selectivity for the DA autoreceptor.  First, a dose-related fall in LMA, taken as a measure of DA autoreceptor activation, should be produced by the putative autoreceptor agonist.  Second, to demonstrate a DA system is involved, the redn. in LMA should be blocked by a DA receptor antagonist.  Finally, the test compd. should produce no LMA-stimulating (i.e., postsynaptic DA receptor agonist) effects over prolonged periods of observation.  Using these criteria, 15 DA agonists were evaluated for DA autoreceptor selectivity.  Four agents satisfied all criteria as selective DA autoreceptor agonists: CF 25-397, N-n-3-propyl-3-hydroxyphenylpiperidine, 6,7-dihydroxy-2-methylaminotetralin (TL-99) and 2-amino-6,7-dibenzoyloxy-1,2,3,4-tetrahydronaphthalene.  Seven DA agonists produced U-shaped dose-response curves indicative of activity at both the autoreceptor and postsynaptic DA receptor.  These agents were: apomorphine, n-propylnorapomorphine, pergolide, RU24213, RU24926, (-)-6-ethyl-9-oxaergoline and lisuride.  SKF 38393 failed to exert any significant effect on the LMA of the mouse.  Both lergotrile and bromocriptine produced dose-related falls in LMA, but both caused a rebound increase in LMA before their durations of action were terminated.  Although 3,4-dihydroxyphenylamino-2-imidazoline did produce a dose-related fall in LMA, the inhibition produced by 3,4-dihydroxyphenylamino-2-imidazoline was not reduced by sulpiride, suggesting a nondopaminergic action for 3,4-dihydroxyphenylamino-2-imidazoline.  Potency relative to apomorphine for producing a 30% fall in LMA was computed for each compd.  The overall significance of these results in studying the pharmacol. of DA receptor agonists is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvizZLXvG8gbVg90H21EOLACvtfcHk0liQEjXqz6cKBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1GnsLw%253D&md5=65d8ec4cb1c58379af3dd59f81779a5e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DG.%2BE.%26aulast%3DBendesky%26aufirst%3DR.%2BJ.%26atitle%3DMouse%2520locomotor%2520activity%253A%2520an%2520in%2520vivo%2520test%2520for%2520dopamine%2520autoreceptor%2520activation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1984%26volume%3D229%26spage%3D706%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bourin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prica, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascoet, M.</span><span> </span><span class="NLM_article-title">Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice</span> <span class="citation_source-journal">Psychopharmacology (Heidelberg, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm901818u&amp;key=10.1007%2Fs00213-009-1583-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901818u&amp;key=19517098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901818u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVKlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2009&pages=97-107&author=M.+Bourinauthor=F.+Chenuauthor=C.+Pricaauthor=M.+Hascoet&title=Augmentation+effect+of+combination+therapy+of+aripiprazole+and+antidepressants+on+forced+swimming+test+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice</span></div><div class="casAuthors">Bourin, Michel; Chenu, Franck; Prica, Corina; Hascoet, Martine</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-107</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A deficiency in brain monoamine systems (serotonin, dopamine, and/or norepinephrine) have long been hypothesized for the pathogenesis of depression.  Drugs enhancing neurotransmission of those monoamines were proven to have antidepressant effects.  We hypothesized that aripiprazole, a partial D2 agonist, could increase the activity of various antidepressants in the mice forced swimming test (FST), an animal model of depression.  The scope of this study was to investigate the antidepressant-like effect of aripiprazole, when combined with conventional antidepressants drugs.  This study assessed the effects of co-administration of aripiprazole with selective serotonin reuptake inhibitors (SSRIs; sertraline, paroxetine, and citalopram), selective serotonin-norepinephrine reuptake inhibitors (SNRIs; venlafaxine and minalcipran), selective norepinephrine reuptake inhibitor (NRI; desipramine), and the dual dopamine and norepinephrine reuptake inhibitor (bupropion), using the FST in mice.  Subactive doses of aripiprazole and antidepressants sertraline, paroxetine, citalopram, venlafaxine, minalcipran, bupropion (4 and 8 mg/kg), and desipramine (2 and 4 mg/kg) were given i.p. 30 and 45 min, resp., before the test.  Aripiprazole (0.03 and 0.06 mg/kg) combined with inactive doses of antidepressants, increased the activity of all antidepressants with the exception of bupropion and desipramine.  The augmentation effects of aripiprazole, in the present study, are in agreement with clin. evidence suggesting that aripiprazole may enhance the efficacy of therapeutic effect of SSRIs and SNRIs but not of NRI.  These results suggest that augmentation effect of aripiprazole only appears when 5-HT system is activated and might implicate complex regulation between dopamine and 5-HT1A and 5-HT2A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnDRD6PeRWcrVg90H21EOLACvtfcHk0liQEjXqz6cKBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVKlu7o%253D&md5=b163156e7158e19f8efa3e941aa393be</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1583-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1583-7%26sid%3Dliteratum%253Aachs%26aulast%3DBourin%26aufirst%3DM.%26aulast%3DChenu%26aufirst%3DF.%26aulast%3DPrica%26aufirst%3DC.%26aulast%3DHascoet%26aufirst%3DM.%26atitle%3DAugmentation%2520effect%2520of%2520combination%2520therapy%2520of%2520aripiprazole%2520and%2520antidepressants%2520on%2520forced%2520swimming%2520test%2520in%2520mice%26jtitle%3DPsychopharmacology%2520%2528Heidelberg%252C%2520Ger.%2529%26date%3D2009%26volume%3D206%26spage%3D97%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bonanomi, G.; Micheli, F.; Terreni, S.</span><span> </span><span class="NLM_article-title">Azabicyclic compounds as serotonin, dopamine and norepinephrine re-uptake inhibitors and their preparation, pharmaceutical compositions and use in the treatment of depression</span>. Patent WO 2008074716,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+Bonanomi&author=F.+Micheli&author=S.+Terreni&title=Azabicyclic+compounds+as+serotonin%2C+dopamine+and+norepinephrine+re-uptake+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBonanomi%26aufirst%3DG.%26atitle%3DAzabicyclic%2520compounds%2520as%2520serotonin%252C%2520dopamine%2520and%2520norepinephrine%2520re-uptake%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520depression%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bertani, B.; Bonanomi, G.; Di Fabio, R.; Fazzolari, E.; Micheli, F.; Tarsi, L.</span><span> </span><span class="NLM_article-title">Preparation of 3-azabicyclo[3.1.0]hexane compounds as monoamine neurotransmitter re-uptake inhibitors</span>. Patent WO 2009027293,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=B.+Bertani&author=G.+Bonanomi&author=R.+Di+Fabio&author=E.+Fazzolari&author=F.+Micheli&author=L.+Tarsi&title=Preparation+of+3-azabicyclo%5B3.1.0%5Dhexane+compounds+as+monoamine+neurotransmitter+re-uptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBertani%26aufirst%3DB.%26atitle%3DPreparation%2520of%25203-azabicyclo%255B3.1.0%255Dhexane%2520compounds%2520as%2520monoamine%2520neurotransmitter%2520re-uptake%2520inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a href="/doi/suppl/10.1021/jm901818u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26636"></div></div></div></div></div><hr /></hr><p class="last">An example of TRUI minimal pharmacophore construction. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901818u/suppl_file/jm901818u_si_001.pdf">jm901818u_si_001.pdf (105.32 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901818u&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm901818u%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901818u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990f6d58e924d3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
